MKSAP 16 audio file | 14E6A63ED638CBA105F98767131DC3542D0BF45F

MKSAP 16 audio file

Name	MKSAP 16 audio file	DOWNLOAD Copy Link
Total Size	7.7 GB
Total Files	3419
Hash	14E6A63ED638CBA105F98767131DC3542D0BF45F

/Part B/Nephrology/10 Nephrology/
4-09 Item 017 A 23 Year-Old Woman Wi.mp3	13.6 MB
4-14 Item 020 A 59-Year-Old Man With.mp3	8.9 MB
6-18 - Item 077 A 66 Year-Old Woman with Acute Kidney Injury.mp3	8.5 MB
3-16 - Item 015 An 81 Year-Old Man with Progressive Fatigue.mp3	8.0 MB
5-18 - Item 025 A 26 Year-Old Man is Somnolent and Minimally.mp3	7.7 MB
8-32 - Session Key Points.mp3	7.1 MB
2-15 Item 011 A 62 Year-Old Man With.mp3	7.0 MB
3-08 - Item 013 A 75-Year-Old Man with Alcoholic Liver Disea.mp3	6.6 MB
9-18 - Anemia.mp3	5.9 MB
4-02 Metabolic Alkalosis.mp3	5.9 MB
8-30 - Agents That Help Preserve Kidney Function.mp3	5.9 MB
7-34 - Session Key Points.mp3	5.8 MB
6-11 - Item 070 A 25 Year-Old Woman with Hypertension Asks f.mp3	5.2 MB
5-08 - Item 021 A 51-Year-Old Man with Unilateral Flank Pain.mp3	5.1 MB
3-07 - Metabolic Acidosis.mp3	4.7 MB
1-21 - Clinical Evaluation of Hematuria.mp3	4.7 MB
2-17 Evaluation.mp3	4.6 MB
2-09 Item 008 A 55-Year-Old Woman Wi.mp3	4.6 MB
5-30 - Session Key Points.mp3	4.5 MB
3-06 - Presentation and Compensation in Acid-Base Disorders.mp3	4.4 MB
9-33 - Session Key Points.mp3	4.3 MB
1-07 - Item 001 A 41-Year-Old Woman with Hypertension.mp3	4.1 MB
9-23 - Kidney Transplantation and Graft Survival.mp3	4.1 MB
9-16 - Osteoporosis.mp3	4.0 MB
2-23 Session Key Points.mp3	4.0 MB
2-04 Causes.mp3	4.0 MB
8-27 - Pathophysiology and Epidemiology of Chronic Kidney Di.mp3	3.9 MB
7-32 - Pigment Nephropathy.mp3	3.9 MB
7-16 - Management.mp3	3.9 MB
7-31 - Contrast-Induced Nephropathy.mp3	3.8 MB
2-06 Causes Of The Syndrome Of Inapp.mp3	3.8 MB
5-07 - Combination Therapy.mp3	3.8 MB
1-08 - Interpretation of the Urinalysis.mp3	3.8 MB
2-11 Hypernatremia.mp3	3.7 MB
1-05 - Methods for Estimating Glomerular Filtration Rate.mp3	3.7 MB
1-06 - Test Validity.mp3	3.7 MB
2-10 Management.mp3	3.7 MB
1-22 - Imaging Used in the Evaluation of Hematuria.mp3	3.7 MB
5-06 - Choosing an Antihypertensive Agent.mp3	3.6 MB
2-19 Treatment.mp3	3.6 MB
7-26 - Urine Microscopy and Urine Chemistry Findings.mp3	3.6 MB
3-22 - Renal Tubular Acidosis.mp3	3.5 MB
5-20 - Clinical Manifestations.mp3	3.5 MB
2-07 Clinical Presentation.mp3	3.5 MB
1-17 - Measurement of Albumin and Protein Excretion.mp3	3.5 MB
7-09 - Small and Medium-Vessel Vasculitis.mp3	3.5 MB
8-20 - Management of Hypertension During Pregnancy.mp3	3.5 MB
3-10 - Lactic Acidosis.mp3	3.4 MB
7-27 - Additional Causes of Intrinsic Renal Disease.mp3	3.4 MB
3-04 - Treatment.mp3	3.4 MB
1-16 - Item 002 A 52-Year-Old Woman with Right Flank Pain, N.mp3	3.4 MB
2-12 Causes Of Diabetes Insipidus.mp3	3.4 MB
2-08 Symptomatic Hyponatremia And Os.mp3	3.4 MB
2-20 Evaluation Of Hyperkalemia.mp3	3.3 MB
5-03 - Essential Hypertension.mp3	3.2 MB
9-17 - Treatment.mp3	3.2 MB
6-32 - Session Key Points.mp3	3.2 MB
5-17 - Older Patients.mp3	3.2 MB
8-06 - Liver Disease.mp3	3.1 MB
6-25 - Diagnosis and Management.mp3	3.1 MB
1-10 - Albumin, Glucose, Ketones and Blood.mp3	3.1 MB
8-02 - Postrenal Disease.mp3	3.1 MB
1-27 - Session Key Points.mp3	3.1 MB
2-13 Assessment Of Polyuria.mp3	3.0 MB
8-16 - Prevention of New Kidney Stone Formation.mp3	3.0 MB
8-05 - Atheroembolic Disease.mp3	3.0 MB
3-12 - Diabetic Ketoacidosis.mp3	3.0 MB
6-09 - Minimal Change Glomerulopathy.mp3	3.0 MB
6-10 - Primary Membranous Glomerulopathy.mp3	3.0 MB
5-10 - Kidney Disease.mp3	3.0 MB
4-06 Respiratory Alkalosis.mp3	3.0 MB
2-14 Treatment.mp3	3.0 MB
3-14 - Ethylene Glycol and Methanol Toxicity.mp3	2.9 MB
4-21 Session Key Points.mp3	2.9 MB
1-13 - Erythrocytes.mp3	2.9 MB
8-14 - Acute Management.mp3	2.9 MB
7-11 - Thrombotic Microangiopathy.mp3	2.9 MB
8-07 - Tumor Lysis Syndrome.mp3	2.8 MB
6-02 - Glomerular Diseases.mp3	2.8 MB
3-09 - Mixed Metabolic Disorders.mp3	2.8 MB
1-01 - Introduction to Nephrology Section.mp3	2.8 MB
1-03 - Recommended Medications.mp3	2.8 MB
2-02 Osmolality And Tonicity.mp3	2.8 MB
7-23 - Acute Kidney Injury.mp3	2.8 MB
3-27 - Session Key Points.mp3	2.7 MB
9-15 - Adynamic Bone Disease.mp3	2.7 MB
1-02 - Glomerular Filtration Rate.mp3	2.7 MB
2-18 Other Considerations Concerning.mp3	2.6 MB
8-26 - Management of End-Stage Kidney Disease During Pregnan.mp3	2.6 MB
5-27 - Hyperuricemia.mp3	2.6 MB
7-04 - Lupus Nephritis.mp3	2.6 MB
4-16 Ambulatory Blood Pressure Monit.mp3	2.6 MB
4-11 Evaluation.mp3	2.5 MB
4-08 Associated Complications.mp3	2.5 MB
5-11 - Renovascular Hypertension.mp3	2.5 MB
1-23 - Urologic Follow-Up.mp3	2.5 MB
8-12 - Uric Acid Stones and Cystine Stones.mp3	2.5 MB
2-22 Treatment.mp3	2.5 MB
7-30 - Clinical Features That Put Patients at Greater Risk.mp3	2.5 MB
6-28 - Hepatitis C Virus-Associated Glomerulonephritis.mp3	2.5 MB
7-08 - Presentation, Diagnosis and Management.mp3	2.5 MB
1-04 - Blood Urea Nitrogen.mp3	2.5 MB
7-13 - Management.mp3	2.5 MB
9-19 - Special Considerations and Imaging.mp3	2.4 MB
8-13 - Clinical Manifestations and Diagnosis.mp3	2.4 MB
6-24 - IgA Nephropathy.mp3	2.4 MB
8-23 - Prevention and Treatment.mp3	2.4 MB
7-10 - Presentation, Diagnosis and Management of PICG.mp3	2.4 MB
7-20 - Alport Syndrome.mp3	2.3 MB
9-10 - Calcium and Phosphorus Homeostasis.mp3	2.3 MB
6-05 - The Nephritic Syndrome.mp3	2.3 MB
2-21 Hyporeninemic Hypoaldosteronism.mp3	2.3 MB
8-18 - Changes in the Urinary Tract and in Water Homeostasis.mp3	2.3 MB
4-15 Blood Pressure Management.mp3	2.3 MB
1-11 - Leukocytes.mp3	2.3 MB
4-04 Treatment.mp3	2.3 MB
9-02 - Nephrotoxins.mp3	2.3 MB
9-21 - Hospitalization.mp3	2.2 MB
3-03 - Causes of Hypophosphatemia.mp3	2.2 MB
6-12 - Diabetic Nephropathy.mp3	2.2 MB
3-23 - Proximal Renal Tubular Acidosis.mp3	2.2 MB
1-24 - Imaging Studies.mp3	2.2 MB
7-02 - Postinfectious Glomerulonephritis.mp3	2.2 MB
1-18 - Albuminuria.mp3	2.2 MB
7-22 - Fabry Disease.mp3	2.2 MB
4-18 Home Blood Pressure Monitoring.mp3	2.1 MB
4-13 Laboratory Studies.mp3	2.1 MB
4-20 Classification.mp3	2.1 MB
6-27 - Diagnosis and Management.mp3	2.1 MB
8-28 - Clinical Manifestations.mp3	2.1 MB
1-26 - Kidney Biopsy.mp3	2.1 MB
9-28 - Kidney Transplantation and Immunosuppresive Therapy.mp3	2.1 MB
6-15 - Amyloidosis.mp3	2.0 MB
9-04 - Protein Restriction.mp3	2.0 MB
5-12 - Management.mp3	2.0 MB
6-06 - Conditions that Cause the Nephrotic Syndrome.mp3	2.0 MB
7-33 - Acute Interstitial Nephritis.mp3	2.0 MB
2-05 Thiazide Diuretics.mp3	2.0 MB
5-24 - Analgesics.mp3	2.0 MB
4-03 Genetic Disorders.mp3	2.0 MB
7-25 - Clinical Manifestations and Diagnosis.mp3	2.0 MB
6-30 - Hepatitis B Virus-Associated Kidney Disease.mp3	2.0 MB
9-27 - Complications of Dialysis.mp3	2.0 MB
8-15 - Risk Factor Evaluation and Subsequent Treatment.mp3	2.0 MB
7-14 - Kidney Cystic Disorders.mp3	2.0 MB
8-03 - Acute Kidney Injury in Specific Clinical Settings.mp3	1.9 MB
8-09 - Calcium Stones.mp3	1.9 MB
9-24 - Hemodialysis.mp3	1.9 MB
5-15 - Special Populations.mp3	1.9 MB
7-07 - Anti-Glomerular Basement Membrane Antibody Disease.mp3	1.9 MB
7-06 - Management.mp3	1.9 MB
6-22 - Diagnosis and Management.mp3	1.9 MB
6-14 - Management.mp3	1.8 MB
9-13 - Renal Osteodystrophy.mp3	1.8 MB
6-07 - Focal Segmental Glomerulosclerosis.mp3	1.8 MB
6-26 - Membranoproliferative Glomerulonephritis.mp3	1.8 MB
9-29 - Risks of Transplantation.mp3	1.8 MB
2-03 Hyponatremia.mp3	1.8 MB
8-21 - Gestational Hypertension and Preeclampsia.mp3	1.8 MB
8-31 - Metabolic Acidosis.mp3	1.8 MB
9-08 - Coronary Artery Disease.mp3	1.8 MB
8-04 - Cardiorenal Syndrome.mp3	1.7 MB
5-21 - Sjogren Syndrome.mp3	1.7 MB
7-18 - Tuberous Sclerosis Complex.mp3	1.7 MB
4-12 Physical Examination.mp3	1.7 MB
5-23 - Malignancy.mp3	1.7 MB
9-12 - Vascular Calcification.mp3	1.7 MB
6-03 - Clinical Manifestations.mp3	1.7 MB
4-05 Respiratory Acidosis.mp3	1.7 MB
5-16 - Black Patients.mp3	1.7 MB
7-28 - Prerenal Azotemia.mp3	1.7 MB
3-17 - Salicylate Toxicity.mp3	1.7 MB
3-20 - Acidosis in Acute and Chronic Kidney Disease.mp3	1.7 MB
6-23 - Conditions that Cause the Nephritic Syndrome.mp3	1.7 MB
8-29 - Management.mp3	1.6 MB
4-17 Electronic Blood Pressure Monit.mp3	1.6 MB
6-04 - The Nephrotic Syndrome.mp3	1.6 MB
6-13 - Diagnosis.mp3	1.6 MB
8-19 - Chronic Hypertension in Pregnancy.mp3	1.6 MB
9-03 - Proteinuria.mp3	1.6 MB
6-16 - Diagnosis and Management.mp3	1.6 MB
9-05 - Complications.mp3	1.6 MB
4-19 Other Settings For Electronic B.mp3	1.6 MB
9-32 - Bone Disease, Vaccinations and Nonadherence.mp3	1.6 MB
8-10 - Hyperoxaluria.mp3	1.6 MB
8-11 - Hypocitraturia and Struvite Stones.mp3	1.5 MB
5-14 - Resistant Hypertension.mp3	1.5 MB
7-15 - Clinical Manifestations.mp3	1.5 MB
5-13 - Aldosterone Excess and Pheochromocytoma.mp3	1.5 MB
1-15 - Crystals.mp3	1.5 MB
1-14 - Casts.mp3	1.5 MB
9-11 - Laboratory Abnormalities.mp3	1.5 MB
9-31 - Special Considerations in Transplant Recipients.mp3	1.5 MB
8-17 - Normal Physiologic Changes in Pregnancy.mp3	1.5 MB
5-22 - Systemic Lupus Erythematosus and Infectious Diseases.mp3	1.5 MB
9-25 - Peritoneal Dialysis.mp3	1.5 MB
4-10 Cardiovascular Risk.mp3	1.5 MB
6-08 - Membranous Glomerulopathy.mp3	1.5 MB
3-19 - Pyroglutamic Acidosis.mp3	1.4 MB
5-04 - Blood Pressure Goals.mp3	1.4 MB
6-19 - HIV-Associated Nephropathy.mp3	1.4 MB
2-16 Hypokalemia.mp3	1.4 MB
6-17 - Multiple Myeloma.mp3	1.4 MB
3-21 - Normal Anion Gap Metabolic Acidosis.mp3	1.4 MB
9-07 - Dyslipidemia.mp3	1.4 MB
1-20 - Orthostatic Proteinuria.mp3	1.4 MB
7-03 - Diagnosis and Management.mp3	1.4 MB
8-22 - Pathophysiology.mp3	1.4 MB
5-19 - Chronic Tubulointerstitial Disorders.mp3	1.4 MB
5-28 - Obstruction.mp3	1.4 MB
7-19 - Medullary Cystic Kidney Disease.mp3	1.4 MB
6-21 - Hepatitis B Virus-Associated Kidney Disease.mp3	1.4 MB
5-25 - Calcineurin Inhibitors and Lithium.mp3	1.3 MB
3-18 - Treatment of Slacylate Poisoning.mp3	1.3 MB
9-34 - Close to Section.mp3	1.3 MB
3-11 - D-Lactic Acidosis.mp3	1.3 MB
9-22 - Treatment of End-Stage Kidney Disease.mp3	1.3 MB
7-29 - Acute Tubular Necrosis.mp3	1.3 MB
6-20 - Diagnosis and Management.mp3	1.3 MB
5-09 - Secondary Hypertension.mp3	1.3 MB
7-05 - Clinical Manifestations and Diagnosis.mp3	1.2 MB
1-25 - Radionuclide Kidney Clearance Scanning.mp3	1.2 MB
7-24 - Definition and Classification.mp3	1.2 MB
3-24 - Hypokalemic Distal Renal Tubular Acidosis.mp3	1.2 MB
5-05 - Lifestyle Modifications.mp3	1.2 MB
6-29 - Diagnosis and Management.mp3	1.1 MB
3-13 - Alcoholic Ketoacidosis.mp3	1.1 MB
5-02 - Prehypertension.mp3	1.1 MB
8-24 - Kidney Disease and Diabetes in the Pregnant Patient.mp3	1.1 MB
3-25 - Causes of Hypokalemic Distal Renal Tubular Acidosis.mp3	1.1 MB
1-09 - Urine pH.mp3	1.1 MB
6-31 - Diagnosis.mp3	1.1 MB
7-17 - Autosomal Recessive Polycystic Kidney Disease.mp3	1.1 MB
3-02 - Hypophosphatemia.mp3	1.0 MB
9-14 - Osteomalacia.mp3	1.0 MB
9-20 - Vaccination.mp3	1.0 MB
7-12 - Clinical Manifestations and Diagnosis.mp3	1.0 MB
9-26 - Management Without Dialysis.mp3	969.5 KB
3-15 - Propylene Glycol Toxicity.mp3	960.3 KB
5-26 - Lead.mp3	941.9 KB
5-29 - Management.mp3	933.6 KB
8-08 - Kidney Stones.mp3	932.3 KB
1-19 - Monoclonal and Transient Proteinuria.mp3	931.1 KB
4-07 Epidemiology Of Hypertension.mp3	928.1 KB
9-06 - Hypertension.mp3	896.8 KB
8-25 - Systemic Lupus Erythematosus.mp3	892.2 KB
9-09 - Chronic Kidney Disease-Mineral Bone Disorder.mp3	881.8 KB
3-05 - Acid-Base Disorders.mp3	868.0 KB
1-12 - Eosinophils.mp3	862.1 KB
2-24 Close To Session.mp3	850.3 KB
7-21 - Thin Glomerular Basement Membrane Disease.mp3	836.7 KB
2-01 Intro To Session 2.mp3	798.9 KB
8-33 - Close to Session.mp3	766.0 KB
3-28 - Close to Session.mp3	751.8 KB
9-30 - Cancer Risk.mp3	715.8 KB
1-28 - Close to Session.mp3	703.2 KB
3-26 - Mixed Forms of Renal Tubular Acidosis.mp3	692.9 KB
3-01 - Intro to Session 3.mp3	686.6 KB
9-01 - Intro to Session 9.mp3	642.7 KB
8-01 - Intro to Session 8.mp3	637.7 KB
5-31 - Close to Session.mp3	635.2 KB
5-01 - Intro to Session 5.mp3	626.4 KB
7-01 - Intro to Session 7.mp3	606.4 KB
7-35 - Close to Session.mp3	568.8 KB
6-33 - Close to Session.mp3	548.3 KB
6-01 - Intro to Session 6.mp3	463.8 KB
4-22 Close To Session.mp3	431.5 KB
4-01 Intro To Session 4.mp3	394.8 KB
/Part A/Neurology/05 Neurology/
6-24 Item 038 A Woman With Low Back.mp3	9.2 MB
4-28 Item 018 A 78-Year-Old Woman Wi.mp3	7.7 MB
5-11 Item 023 A Woman With Drooping.mp3	7.7 MB
6-17 Item 029 A Woman With Partial V.mp3	7.3 MB
5-21 Item 025 A 76-Year-Old Woman Is.mp3	7.2 MB
3-23 Item 013 Recommendations Regard.mp3	7.0 MB
2-07 Item 009 A Woman With A 2-Week.mp3	6.4 MB
4-15 Item 017 Treating A Man With Ri.mp3	6.2 MB
2-02 Primary Headache And Clinical F.mp3	5.5 MB
1-13 Item 005 A Man With Left Hemipl.mp3	5.5 MB
2-04 Migraine With Aura.mp3	5.4 MB
1-06 Item 003 Diagnosing Atypical Pa.mp3	5.4 MB
2-13 Item 011 A High School Student.mp3	5.4 MB
8-24 Pathophysiology And Epidemiolog.mp3	5.4 MB
1-01 Introduction To Neurology Secti.mp3	5.3 MB
10-38 Session Key Points.mp3	5.3 MB
1-15 Lumbar Puncture.mp3	4.9 MB
3-29 Partial Seizures.mp3	4.7 MB
7-25 Drugs For Parkinsons Disease.mp3	4.6 MB
2-19 Migraine And Menstruation.mp3	4.6 MB
2-08 Acute Migraine Treatment.mp3	4.5 MB
4-13 Clinical Evaluation And Video E.mp3	4.5 MB
7-31 Types Of Parkinsons-Plus Syndro.mp3	4.5 MB
10-10 Myasthenia Gravis.mp3	4.3 MB
1-08 Subarachnoid Hemorrhage.mp3	4.3 MB
2-17 Pharmacologic Prophylaxis Of Mi.mp3	4.3 MB
9-02 Medications.mp3	4.2 MB
1-12 Idiopathic Intracranial Hyperte.mp3	4.1 MB
3-16 Postconcussion Syndrome.mp3	4.0 MB
4-37 Hemorrhagic Stroke.mp3	4.0 MB
3-15 Item 012 A Woman Is Seen After.mp3	4.0 MB
6-20 Evaluation Of The Patient With.mp3	4.0 MB
1-03 Common Features And Evaluation.mp3	3.9 MB
2-11 Contraindications And Adverse E.mp3	3.8 MB
8-14 Tic Disorders And Tourette Synd.mp3	3.8 MB
8-09 Chorea.mp3	3.8 MB
9-09 Presenting Symptoms And Signs O.mp3	3.7 MB
3-03 Tension Origination.mp3	3.7 MB
6-29 Clinical Features.mp3	3.7 MB
9-32 Guillain-Barre Syndrome.mp3	3.7 MB
9-05 Symptomatic Management.mp3	3.7 MB
3-06 Treatment.mp3	3.7 MB
2-20 Migraine And Pregnancy.mp3	3.6 MB
5-24 Subarachnoid Hemorrhage.mp3	3.6 MB
1-02 Approach To The Patient With He.mp3	3.6 MB
7-20 Clinical Signs.mp3	3.6 MB
10-08 Amyotrophic Lateral Sclerosis.mp3	3.6 MB
7-18 Parkinsons Disease.mp3	3.6 MB
2-06 Risk Factors.mp3	3.6 MB
2-15 Migraine Prevention.mp3	3.5 MB
8-33 Clinical Course Of Multiple Scl.mp3	3.5 MB
3-24 Characteristics Of Seizures.mp3	3.5 MB
4-20 Antiepileptic Drugs And Pregnan.mp3	3.4 MB
8-38 Session Key Points.mp3	3.4 MB
9-34 Session Key Points.mp3	3.4 MB
7-02 Therapeutic Approach.mp3	3.4 MB
3-12 Management Of Concussions In At.mp3	3.4 MB
5-33 Session Key Points.mp3	3.4 MB
9-15 Noncompressive Myelopathies.mp3	3.4 MB
6-09 Medical Complications.mp3	3.4 MB
8-28 Diagnosis Of Multiple Sclerosis.mp3	3.3 MB
8-30 Differential Diagnosis Of Multi.mp3	3.3 MB
9-13 Treatment.mp3	3.3 MB
6-03 Antithrombotic Treatment.mp3	3.3 MB
1-04 Cerebrospinal Fluid Examination.mp3	3.3 MB
8-25 Presenting Signs And Symptoms O.mp3	3.3 MB
8-22 Restless Legs Syndrome.mp3	3.2 MB
10-15 Myopathies.mp3	3.2 MB
4-33 Nonconvulsive Seizure.mp3	3.2 MB
7-35 Ataxia.mp3	3.2 MB
1-19 ADJunctive Agents For Trigemina.mp3	3.2 MB
5-26 Dural Sinus Venous Thrombosis.mp3	3.2 MB
9-03 Glatiramer And Natalizumab.mp3	3.1 MB
8-35 Treatment Of Multiple Sclerosis.mp3	3.0 MB
3-02 Tension-Type Headache.mp3	3.0 MB
5-07 Small Subcortical Infarcts.mp3	3.0 MB
6-32 Treatment.mp3	3.0 MB
1-16 Trigeminal Neuralgia.mp3	3.0 MB
8-02 Essential Tremor.mp3	3.0 MB
7-15 Dementia And Driving.mp3	2.9 MB
10-21 Inherited Myopathies.mp3	2.9 MB
2-18 Episodic Migraine Prevention.mp3	2.9 MB
3-05 Cluster Headache.mp3	2.9 MB
10-29 Primary Central Nervous System.mp3	2.9 MB
7-34 Gait Types.mp3	2.9 MB
6-15 Stroke Recovery And Long-Term P.mp3	2.9 MB
5-12 Clinical Diagnosis Of Acute Isc.mp3	2.9 MB
5-22 Intracerebral Hemorrhage.mp3	2.9 MB
7-36 Session Key Points.mp3	2.8 MB
4-17 Adverse Effects Of Antiepilepti.mp3	2.8 MB
9-22 Common Symptoms And Signs Of Ne.mp3	2.8 MB
9-16 Mycobacterium Tuberculosis.mp3	2.8 MB
5-14 Thrombolysis.mp3	2.8 MB
10-13 Lambert-Eaton Myasthenic Syndr.mp3	2.8 MB
9-24 Carpal Tunnel Syndrome.mp3	2.8 MB
10-11 Pyridostigmine.mp3	2.7 MB
9-19 Peripheral Neuropathies.mp3	2.7 MB
2-12 Drug Interactions.mp3	2.7 MB
7-27 Dyskinesias.mp3	2.7 MB
8-17 Wilsons Disease.mp3	2.7 MB
2-10 Triptans.mp3	2.7 MB
7-19 Clinical Features Of Parkinsons.mp3	2.7 MB
7-13 Diagnosis And Treatment.mp3	2.7 MB
6-25 Diagnosis Of Alzheimers Disease.mp3	2.7 MB
8-20 Neuroleptic Malignant Syndrome.mp3	2.7 MB
6-28 Prevalence And Pathogenesis Of.mp3	2.6 MB
6-23 Differential Diagnosis Of Demen.mp3	2.6 MB
6-19 Age-Related Cognitive Decline.mp3	2.6 MB
1-07 Thunderclap Headache.mp3	2.6 MB
10-27 Clinical And Radiologic Featur.mp3	2.5 MB
2-14 Status Migrainosus.mp3	2.5 MB
8-36 Treatment Of Acute Exacerbation.mp3	2.5 MB
7-23 Differential Diagnosis Of Parki.mp3	2.5 MB
9-29 Neuropathies Of Diabetes And Im.mp3	2.5 MB
3-32 Session Key Points.mp3	2.5 MB
5-16 Exclusion Criteria.mp3	2.4 MB
7-26 Late-Stage Parkinsons Disease.mp3	2.4 MB
4-30 Management.mp3	2.4 MB
1-18 Medical Management.mp3	2.3 MB
9-04 Fingolimod And Mitoxantrone.mp3	2.3 MB
10-02 Chronic Inflammatory Demyelina.mp3	2.3 MB
7-12 Normal Pressure Hydrocephalus.mp3	2.3 MB
6-31 Pathologic Features.mp3	2.3 MB
4-18 Selection Of Antiepileptic Drug.mp3	2.3 MB
9-33 Treatment.mp3	2.3 MB
4-36 Diagnosis Of Stroke.mp3	2.3 MB
8-12 Myoclonus.mp3	2.2 MB
4-40 Session Key Points.mp3	2.2 MB
6-21 Behavioral And Motor Signs.mp3	2.2 MB
7-17 Overview Of Movement Disorders.mp3	2.2 MB
6-18 Definition And Description Of D.mp3	2.2 MB
5-02 Transient Ischemic Attack.mp3	2.2 MB
8-03 Benign Essential Tremor.mp3	2.2 MB
7-05 Dementia With Lewy Bodies.mp3	2.2 MB
3-17 Epidural And Subdural Hematomas.mp3	2.2 MB
10-33 Diagnosis And Treatment.mp3	2.2 MB
4-07 Cognitive Problems.mp3	2.1 MB
3-11 Concussive Head Injury.mp3	2.1 MB
5-06 Large Artery Atheroscerosis.mp3	2.1 MB
5-18 Blood Pressure Treatment In Acu.mp3	2.1 MB
10-06 Treatment Of Neuropthic Pain.mp3	2.1 MB
4-26 Alternative Therapies.mp3	2.1 MB
4-04 Idiopathic Generalized Epilepsy.mp3	2.0 MB
1-09 Reversible Cerebral Vasoconstri.mp3	2.0 MB
7-28 Patient Selection For Deep Brai.mp3	2.0 MB
5-23 Oral Anticoagulant-Associated I.mp3	2.0 MB
8-11 Movement Disorders And Symptoms.mp3	2.0 MB
5-09 Intracerebral And Subarachnoid.mp3	2.0 MB
5-03 Hospital Admission Guidelines.mp3	2.0 MB
9-25 Bells Palsy.mp3	1.9 MB
7-22 Diagnosis Of Parkinsons Disease.mp3	1.9 MB
2-16 Natural Remedies And Behavioral.mp3	1.9 MB
8-29 Other Diagnostic Elements.mp3	1.9 MB
6-04 Surgery For Secondary Stroke.mp3	1.9 MB
6-34 Session Key Points.mp3	1.9 MB
9-30 Diabetic Amyotrophy.mp3	1.9 MB
1-17 Triggering Factors.mp3	1.9 MB
3-30 Secondarily Generalized Tonic-C.mp3	1.9 MB
8-34 Benign MS.mp3	1.9 MB
10-30 Management Of Intracranial Tum.mp3	1.8 MB
9-07 Maintenance Of Mobility.mp3	1.8 MB
3-13 The ImPACT Test.mp3	1.8 MB
7-06 Lewy Bodies.mp3	1.8 MB
5-32 Admission To Stroke Units And S.mp3	1.8 MB
8-15 Management.mp3	1.8 MB
10-32 Paraneoplastic Syndromes.mp3	1.8 MB
4-31 Treatment.mp3	1.8 MB
1-10 Spontaneous Headache Attacks.mp3	1.8 MB
10-03 Critical Illness Polyneuropath.mp3	1.8 MB
2-03 Criteria For Migraine Diagnosis.mp3	1.8 MB
7-24 Treatment Of Parkinsons Disease.mp3	1.8 MB
4-38 Dopller-Flow Ultrasonography.mp3	1.8 MB
8-06 Dystonia.mp3	1.8 MB
9-31 Hereditary Neuropathies.mp3	1.8 MB
10-19 Corticosteroid-Induced Myopath.mp3	1.8 MB
3-31 Generalized Seizures.mp3	1.8 MB
7-08 Frontotemporal Dementia.mp3	1.8 MB
10-24 Drugs Potentially Causing Myop.mp3	1.7 MB
10-35 Brain Death.mp3	1.7 MB
6-10 Other Considerations.mp3	1.7 MB
3-08 Related Primary Headache Syndro.mp3	1.7 MB
5-17 Catheter-Based Approaches.mp3	1.7 MB
3-19 Head Injury In A Military Popul.mp3	1.7 MB
3-25 Epilepsy Risk Factors.mp3	1.7 MB
9-11 Compressive Myelopathies.mp3	1.7 MB
7-30 Parkinsons-Plus Syndromes.mp3	1.7 MB
5-05 Cardioembolic Stroke.mp3	1.7 MB
10-37 Apnea Test.mp3	1.7 MB
1-14 Possible Causes Of Intracranial.mp3	1.6 MB
5-15 Treatment Of Acute Ischemic Str.mp3	1.6 MB
9-21 Classification, Findings And Di.mp3	1.6 MB
2-09 Antiemetics.mp3	1.6 MB
5-29 Treatment.mp3	1.6 MB
7-33 Gait Disturbance.mp3	1.6 MB
4-29 Generalized Convulsive Status E.mp3	1.6 MB
10-39 Close To Section.mp3	1.6 MB
5-28 Carotid And Vertebral Artery Di.mp3	1.6 MB
7-10 Vascular Dementia.mp3	1.6 MB
8-31 Zinc Toxicity And Other Finding.mp3	1.6 MB
10-26 Intracranial Tumors.mp3	1.6 MB
6-08 Neurologic Worsening.mp3	1.5 MB
6-26 Primary Basis For Diagnosis.mp3	1.5 MB
4-24 Discontinuing Antiepileptic Dru.mp3	1.5 MB
3-21 Features And Epidemiology Of Ep.mp3	1.5 MB
4-22 Antiepileptic Drugs And Contrac.mp3	1.5 MB
6-02 Secondary Stroke Prevention, Hy.mp3	1.5 MB
6-13 Primary Prevention Of Stroke.mp3	1.5 MB
10-23 Toxic Myopathies.mp3	1.5 MB
3-22 Initial Approach To The Patient.mp3	1.4 MB
8-07 Dopamine-Responsive Dystonia.mp3	1.4 MB
2-05 Migraine Classification.mp3	1.4 MB
4-11 Imaging Studies.mp3	1.4 MB
3-26 Immunocompromised Patients.mp3	1.4 MB
10-20 Thyrotoxic Myopathy And Myopat.mp3	1.4 MB
5-19 Acute Antithrombotic Agents.mp3	1.4 MB
4-32 Nonconvulsive Status Epilepticu.mp3	1.4 MB
10-16 Elevated CK Levels And Associa.mp3	1.4 MB
4-12 Electroencephalography.mp3	1.4 MB
10-22 Critical Illness Myopathy.mp3	1.4 MB
6-14 Asymptomatic Carotid Stenosis.mp3	1.4 MB
9-28 Polyneuropathies.mp3	1.4 MB
9-06 Depression With MS.mp3	1.3 MB
4-09 Sudden Unexplained Death In Epi.mp3	1.3 MB
5-30 Asymptomatic Aneurysm.mp3	1.3 MB
10-05 Key Points.mp3	1.3 MB
3-09 Traumatic Brain Injury.mp3	1.3 MB
4-25 Intractable Epilepsy And Epilep.mp3	1.3 MB
4-03 Partial Epilepsy.mp3	1.3 MB
6-30 CSF Biologic Markers.mp3	1.3 MB
9-26 Brachial And Lumbosacral Plexop.mp3	1.2 MB
4-16 Antiepileptic Drug Therapy.mp3	1.2 MB
5-27 Treatment.mp3	1.2 MB
2-22 Key Points.mp3	1.2 MB
4-06 Mood Disorders.mp3	1.2 MB
6-07 Key Points.mp3	1.2 MB
6-05 Hemicraniectomy.mp3	1.1 MB
9-08 Key Points.mp3	1.1 MB
10-17 EMG Findings.mp3	1.1 MB
8-10 Tardive Dyskinesia.mp3	1.1 MB
4-08 Osteoporosis.mp3	1.1 MB
4-19 Antiepileptic Drugs In Women.mp3	1.1 MB
5-20 Key Points.mp3	1.1 MB
4-23 Dosing And Monitoring Of Antiep.mp3	1.1 MB
4-35 Epidemiology And Definition Of.mp3	1.1 MB
8-04 Deep Brain Stimulation.mp3	1.1 MB
6-06 Patent Foramen Ovale Closure.mp3	1.1 MB
10-04 Treatment.mp3	1.0 MB
8-13 Differential Diagnosis Of Myocl.mp3	1.0 MB
6-33 Medications For Treating Alzhei.mp3	1.0 MB
1-20 Session Key Points.mp3	997.2 KB
7-21 Nonmotor Complications Of Parki.mp3	980.9 KB
8-26 Uhthoffs Phenomenon.mp3	951.6 KB
6-11 Perioperative Stroke.mp3	950.8 KB
3-28 Clinical Presentation.mp3	946.6 KB
5-31 Key Points.mp3	946.6 KB
6-22 Clinical Manifestations Of Deme.mp3	937.0 KB
5-04 Ischemic Stroke.mp3	923.2 KB
8-27 Key Points.mp3	921.5 KB
10-25 Key Point.mp3	888.9 KB
8-37 Disease-Modifying Therapies.mp3	879.7 KB
5-25 Key Points.mp3	872.2 KB
5-10 Key Points.mp3	867.6 KB
5-08 Cryptogenic And Hemorrhagic Str.mp3	852.2 KB
7-29 Key Points.mp3	847.5 KB
8-39 Close To Session.mp3	840.9 KB
7-03 End-Stage Dementia.mp3	828.7 KB
2-23 Close To Sessio.mp3	804.5 KB
9-10 Key Points.mp3	795.7 KB
2-21 Migraine And Perimenopause.mp3	788.2 KB
5-13 Imaging Techniques.mp3	785.7 KB
4-39 Vascular Imaging Techniques.mp3	782.4 KB
3-33 Close To Session.mp3	776.1 KB
8-32 Key Points.mp3	770.2 KB
9-35 Close To Session.mp3	766.9 KB
9-17 Genetic Disorders.mp3	743.5 KB
9-01 Introduction To Session.mp3	728.8 KB
5-01 Introduction To Session.mp3	723.8 KB
3-07 Key Point.mp3	711.7 KB
3-01 Introduction To Session.mp3	700.8 KB
9-12 Diagnosis.mp3	700.0 KB
7-01 Introduction To Session.mp3	687.9 KB
6-35 Close To Session.mp3	687.9 KB
8-01 Introduction To Session.mp3	681.6 KB
9-27 Key Points.mp3	675.7 KB
10-01 Introduction To Session.mp3	669.9 KB
7-37 Close To Session.mp3	654.9 KB
2-01 Introduction To Session.mp3	651.5 KB
6-01 Introduction To Session.mp3	618.5 KB
4-01 Introduction To Session.mp3	616.4 KB
4-14 Key Points.mp3	612.2 KB
4-27 Key Points.mp3	605.5 KB
8-16 Key Points.mp3	605.5 KB
4-41 Close To Session.mp3	603.9 KB
4-34 Key Points.mp3	601.8 KB
7-04 Key Points.mp3	590.9 KB
9-23 Key Points.mp3	584.6 KB
4-02 Epilepsy Syndromes.mp3	574.6 KB
6-27 Key Points.mp3	566.7 KB
8-18 Treatment.mp3	544.1 KB
5-34 Close To Session.mp3	543.3 KB
10-09 Key Points.mp3	542.0 KB
1-21 Close To Session.mp3	517.4 KB
10-18 Key Points.mp3	511.9 KB
10-12 Key Point.mp3	500.2 KB
10-28 Key Points.mp3	494.8 KB
4-05 Key Points.mp3	484.3 KB
4-21 Antiepileptic Drugs And Breastf.mp3	478.5 KB
10-34 Key Points.mp3	473.9 KB
3-04 Key Points.mp3	464.7 KB
1-11 Key Points.mp3	463.4 KB
9-18 Key Point.mp3	460.1 KB
10-36 Key Point.mp3	426.6 KB
3-20 Key Point.mp3	425.4 KB
6-12 Key Point.mp3	423.3 KB
10-31 Key Point.mp3	422.9 KB
4-10 Key Points.mp3	406.2 KB
7-07 Key Point.mp3	401.6 KB
7-09 Key Point.mp3	396.1 KB
10-07 Key Point.mp3	395.3 KB
1-05 Key Point.mp3	379.4 KB
7-16 Key Point.mp3	376.9 KB
3-10 Key Points.mp3	364.4 KB
10-14 Key Point.mp3	357.3 KB
3-27 Key Point.mp3	353.9 KB
8-19 Key Point.mp3	348.1 KB
8-05 Key Points.mp3	335.5 KB
8-08 Key Point.mp3	322.6 KB
7-14 Key Point.mp3	321.7 KB
8-21 Key Point.mp3	314.6 KB
8-23 Key Point.mp3	305.4 KB
3-14 Key Point.mp3	293.7 KB
7-32 Key Point.mp3	292.9 KB
7-11 Key Point.mp3	279.5 KB
3-18 Key Point.mp3	277.8 KB
9-20 Key Point.mp3	273.3 KB
6-16 Key Point.mp3	262.4 KB
9-14 Key Point.mp3	237.3 KB
/.../09 Infectious Disease/
9-30 - Session Key Points.mp3	9.1 MB
7-29 - Session Key Points.mp3	8.5 MB
6-27 - Session Key Points.mp3	7.3 MB
5-28 - Session Key Points.mp3	7.3 MB
10-34 - Session Key Points.mp3	7.0 MB
4-27 - Session Key Points.mp3	5.6 MB
2-15 Item 017 A Kidney Transplant Pa.mp3	5.6 MB
6-20 - Evaluation and Management of Vertebral Osteomyelitis.mp3	5.4 MB
8-11 - Escherichia Coli Infection.mp3	5.3 MB
8-32 - Session Key Points.mp3	5.3 MB
4-04 - Diagnosis.mp3	5.0 MB
2-12 Community-Acquired Mrsa.mp3	4.9 MB
1-15 - Item 007 An 82-Year-Old Woman with a MRSA Infection.mp3	4.9 MB
2-23 Session Key Points.mp3	4.8 MB
3-25 - Session Key Points.mp3	4.8 MB
3-09 - Item 026 A Woman with Yellow Vaginal Discharge.mp3	4.6 MB
10-10 - Antiretroviral Regimens.mp3	4.5 MB
1-08 - Item 005 A Woman with Painful Genital Lesions and Dys.mp3	4.5 MB
5-10 - Item 039 A Woman with Increasing Pain of the Right Fo.mp3	4.5 MB
4-25 - Multidrug-Resistant and Extensively Drug-Resistant Tu.mp3	4.4 MB
4-14 - Item 033 A 29-Year-Old Man is Evaluated for Newly Dia.mp3	4.4 MB
6-19 - Item 045 A 52-Year-Old Man is Admitted to the ICU wit.mp3	4.4 MB
2-21 Diabetic Foot Infections.mp3	4.4 MB
6-22 - Causes.mp3	4.3 MB
1-07 - Epidemiology of Bacterial Meningitis.mp3	4.3 MB
4-07 - Item 031 A Man with a Ruptured Gallbladder Requiring .mp3	4.2 MB
5-16 - Item 043 A Woman with Mild Fever, Headache, Myalgia, .mp3	4.2 MB
8-16 - Treatment Recommendations.mp3	4.2 MB
3-15 - Item 028 A 22-Year-Old Man is Evaluated for a Painles.mp3	4.2 MB
8-22 - Antirejection Drugs in Transplant Recipients.mp3	4.1 MB
7-21 - Diagnosis of Falciparum Malaria.mp3	4.0 MB
3-07 - Management.mp3	4.0 MB
8-23 - Post-Transplantation Infections.mp3	4.0 MB
9-18 - Treatment.mp3	3.9 MB
1-11 - Clinical Signs of Impending Herniation.mp3	3.9 MB
7-17 - Viral Hemorrhagic Fever.mp3	3.8 MB
2-13 Necrotizing Fasciitis.mp3	3.8 MB
2-14 Evaluation And Treatment.mp3	3.8 MB
1-03 - Diagnosis and Treatment.mp3	3.8 MB
10-19 - Management.mp3	3.8 MB
3-10 - Antibiotic Therapy.mp3	3.8 MB
5-19 - Coccidioidomycosis.mp3	3.7 MB
7-23 - Travelers Diarrhea.mp3	3.7 MB
6-03 Treatment.mp3	3.7 MB
5-09 Treatment.mp3	3.7 MB
1-20 - Spinal Epidural Abscess.mp3	3.7 MB
5-04 Mycobacterium Avium Complex Infection.mp3	3.7 MB
2-11 Item 012 A 63-Year-Old Physicia.mp3	3.7 MB
1-25 - Session Key Points.mp3	3.7 MB
10-08 Cytomegalovirus Infection.mp3	3.7 MB
9-11 - Prevention.mp3	3.6 MB
3-03 - Possible Microbial Causes of CAP.mp3	3.6 MB
7-22 - Typhoid Fever.mp3	3.5 MB
6-10 - Item 044 A 53-Year-Old Man is Evaluated for Swelling .mp3	3.5 MB
7-14 - Botulism.mp3	3.5 MB
5-03 Diagnosis.mp3	3.5 MB
1-24 - Imaging Studies.mp3	3.5 MB
5-15 - Diagnosis and Treatment.mp3	3.5 MB
7-13 - Plague.mp3	3.4 MB
10-03 Metabolic Disorders.mp3	3.4 MB
6-11 - Pathophysiology and Classification of Osteomyelitis.mp3	3.4 MB
2-16 Toxic Shock Syndrome.mp3	3.4 MB
2-17 Diagnosis And Treatment.mp3	3.4 MB
9-21 - Recommended Prophylactic Regimens.mp3	3.4 MB
6-24 - Medications as a Cause of FUO.mp3	3.4 MB
10-15 - Management.mp3	3.3 MB
2-19 Management.mp3	3.3 MB
5-24 - Pelvic Inflammatory Disease.mp3	3.3 MB
1-14 - Outpatient Intravenous Antimicrobial Therapy.mp3	3.3 MB
9-20 - Rationale for Infective Endocarditis Prevention.mp3	3.3 MB
3-02 - Microbiology.mp3	3.3 MB
6-17 - Evaluation and Management of Diabetes-Associated Oste.mp3	3.2 MB
9-05 Surgical Site Infections.mp3	3.2 MB
4-03 Epidemiology and Microbiology of Urinary Tract Infectio.mp3	3.2 MB
7-04 Abnormalities in the Complement System.mp3	3.2 MB
1-16 - Brain Abscess.mp3	3.2 MB
4-23 - Antituberculous Drugs.mp3	3.2 MB
1-19 - Cranial Subdural Empyema.mp3	3.2 MB
2-22 Epidemiology Of Community-Acqui.mp3	3.2 MB
4-06 - Recurrent UTIs in Women.mp3	3.2 MB
1-09 - Diagnosis.mp3	3.2 MB
8-29 - Immunization Recommendations for Transplant Recipient.mp3	3.2 MB
3-24 - Ehrlichiosis and Anaplasmosis.mp3	3.1 MB
3-12 - Timing of Therapy.mp3	3.1 MB
7-03 Common Variable Immunodeficiency.mp3	3.1 MB
10-13 - Influenza Virus Infections.mp3	3.1 MB
1-01 - Introduction to Infectious Disease Section.mp3	3.1 MB
3-14 - Follow-Up.mp3	3.0 MB
6-05 Tertiary Syphilis.mp3	3.0 MB
8-21 - Amebiasis.mp3	3.0 MB
4-02 Rocky Mountain Spotted Fever.mp3	3.0 MB
5-13 - Mucormycosis.mp3	3.0 MB
5-17 - Blastomycosis.mp3	3.0 MB
2-03 Testing.mp3	3.0 MB
6-13 - Imaging Studies.mp3	3.0 MB
5-02 Nontuberculous Mycobacterial Infections.mp3	3.0 MB
6-09 - Genital Warts.mp3	2.9 MB
10-30 - Rifamycins.mp3	2.9 MB
1-12 - Recommended Antimicrobial Therapy.mp3	2.9 MB
10-07 Pneumocystis Jirovecii Pneumonia.mp3	2.9 MB
5-12 - Presentation and Treatment.mp3	2.9 MB
1-18 - Management.mp3	2.9 MB
2-07 Variant Creutzfeldt-Jakob Disea.mp3	2.9 MB
3-21 - Babesiosis.mp3	2.9 MB
5-26 - Treatment.mp3	2.9 MB
3-04 - Diagnosis.mp3	2.9 MB
7-20 - Diagnosis.mp3	2.9 MB
3-18 - Clinical Manifestations of Lyme Disease.mp3	2.9 MB
8-14 - Clostridium Difficile Infection.mp3	2.8 MB
7-24 - Dengue Fever.mp3	2.8 MB
9-26 - Diagnosis.mp3	2.8 MB
1-10 - Management.mp3	2.8 MB
4-22 - Treatment.mp3	2.8 MB
6-02 Herpes Simplex Virus Infection.mp3	2.8 MB
3-11 - Pathogen-Specific Therapy for CAP.mp3	2.8 MB
5-21 - Cervicitis and Urethritis.mp3	2.7 MB
10-25 - Glycylcyclines.mp3	2.7 MB
2-18 Animal Bites.mp3	2.7 MB
4-16 - Tuberculin Skin Test.mp3	2.7 MB
6-23 - Tuberculosis as a Cause of FUO.mp3	2.7 MB
1-04 - Causes of Bacterial Meningitis.mp3	2.6 MB
3-20 - Treatment Recommendations.mp3	2.6 MB
4-18 - Interferon-Gamma Release Assays.mp3	2.6 MB
4-13 - Clinical Manifestations.mp3	2.6 MB
10-14 - Clinical Features and Evaluation.mp3	2.6 MB
9-04 Prevention.mp3	2.6 MB
2-20 Human Bites.mp3	2.6 MB
4-11 - Mycobacterium Tuberculosis Infection.mp3	2.6 MB
8-04 Specific Pathogens in Patients with Diarrhea.mp3	2.6 MB
9-13 - Hospital-Acquired Pneumonia and Ventilator-Associated.mp3	2.6 MB
9-28 - Initiation of Care.mp3	2.5 MB
8-26 - Fungal Infections.mp3	2.5 MB
9-22 - Epidemiology and Prevention of HIV-AIDS.mp3	2.5 MB
3-19 - Diagnosis.mp3	2.5 MB
9-07 Treatment and Prevention.mp3	2.5 MB
9-29 - Immunizations and Prophylaxis for Opportunistic Infec.mp3	2.5 MB
7-16 - Diagnosis and Treatment.mp3	2.5 MB
3-05 - Testing.mp3	2.5 MB
5-23 - Neisseria Gonorrhoeae Infection.mp3	2.5 MB
4-19 - Culture and Other Microbiologic Tests.mp3	2.5 MB
1-21 - Encephalitis.mp3	2.5 MB
9-23 - Pathophysiology and Natural History.mp3	2.4 MB
10-18 - Varicella-Zoster Virus.mp3	2.4 MB
10-06 Opportunistic Infections.mp3	2.4 MB
10-17 - Management.mp3	2.4 MB
8-17 - Viral Gastroenteritis.mp3	2.4 MB
9-27 - Indications for HIV Testing.mp3	2.4 MB
6-21 - Fever of Unknown Origin.mp3	2.4 MB
9-16 - Prevention.mp3	2.4 MB
1-02 - Epidemiology and Cause of Viral Meningitis.mp3	2.4 MB
4-21 - Radiographic Imaging.mp3	2.3 MB
4-08 - Acute Pyelonephritis.mp3	2.3 MB
9-25 - Screening.mp3	2.3 MB
2-06 Diagnosis.mp3	2.3 MB
7-12 - Differentiating Smallpox from Chickenpox.mp3	2.3 MB
7-26 - Rickettsial Infection.mp3	2.3 MB
9-09 - Diagnosis.mp3	2.3 MB
4-12 - Pathophysiology.mp3	2.3 MB
9-24 - Chronic HIV Infection.mp3	2.3 MB
8-25 - Bacterial Infections.mp3	2.3 MB
8-15 - Diagnosis.mp3	2.2 MB
10-32 - Outpatient Antimicrobial Therapy.mp3	2.2 MB
8-10 - Treatment.mp3	2.2 MB
7-15 - Tularemia.mp3	2.2 MB
3-16 - Lyme Disease.mp3	2.2 MB
5-07 Systemic Candidiasis.mp3	2.2 MB
2-02 West Nile Virus Encephalitis.mp3	2.1 MB
8-19 - Giardia Infection.mp3	2.1 MB
8-05 The Physical Examination.mp3	2.1 MB
10-21 - Lipopeptides and Glycolipopeptides.mp3	2.1 MB
2-04 Prion Diseases Of The Central N.mp3	2.1 MB
6-18 - Antibiotic Therapy.mp3	2.1 MB
8-06 Campylobacter Infection.mp3	2.1 MB
9-14 - Diagnosis.mp3	2.1 MB
5-18 - Histoplasmosis.mp3	2.1 MB
2-10 Diagnosis.mp3	2.1 MB
3-17 - Clinical Presentation and Treatment.mp3	2.1 MB
8-07 Shigella Infection.mp3	2.1 MB
6-04 Syphilis.mp3	2.1 MB
1-13 - Adjunctive Corticosteroids.mp3	2.0 MB
8-27 - Protozoa and Helminths.mp3	2.0 MB
9-12 - Evidence-Based Interventions for Reducing CLABSI.mp3	2.0 MB
8-08 - Salmonella Infection.mp3	2.0 MB
7-02 Selective IgA Deficiency.mp3	2.0 MB
8-30 - Hospital-Acquired Infections.mp3	2.0 MB
9-06 Diagnosis.mp3	2.0 MB
7-28 - Travel-Associated Fungal Infections.mp3	2.0 MB
8-12 - Yersinia Infection.mp3	2.0 MB
5-11 - Aspergillosis and Aspergilloma.mp3	2.0 MB
2-09 Risk Factors.mp3	2.0 MB
7-09 - Treatment.mp3	2.0 MB
9-03 Diagnosis and Treatment.mp3	2.0 MB
7-06 - Class B and Class C Agents.mp3	2.0 MB
1-23 - Herpes Simplex Encephalitis.mp3	2.0 MB
7-27 - Brucellosis.mp3	2.0 MB
8-28 - Prevention of Infections in Transplant Recipients.mp3	2.0 MB
8-13 - Vibrio Infection.mp3	2.0 MB
4-05 - Management of Cystitis in Women.mp3	2.0 MB
7-11 - Smallpox.mp3	1.9 MB
5-25 - Epididymitis.mp3	1.9 MB
6-16 - Treatment.mp3	1.9 MB
10-04 Cardiovascular Disease.mp3	1.9 MB
10-16 - Herpes Simplex Viruses.mp3	1.9 MB
4-17 - False Positive and False Negative Results.mp3	1.9 MB
5-06 Rapidly Growing Mycobacteria.mp3	1.9 MB
6-25 - Evaluation.mp3	1.9 MB
3-22 - Treatment.mp3	1.9 MB
1-05 - Other Causes of Bacterial Meningitis.mp3	1.9 MB
8-24 - Viral Infections.mp3	1.8 MB
7-10 - Gastrointestinal Anthrax.mp3	1.8 MB
10-20 - New Topics in Anti-Infective Therapy.mp3	1.8 MB
5-08 Clinical Manifestations and Diagnosis.mp3	1.8 MB
10-09 Management of HIV Infection.mp3	1.8 MB
10-24 - Beta-Lactam Antibiotics.mp3	1.8 MB
3-23 - Southern Tick-Associated Rash Illness.mp3	1.7 MB
9-08 Central Line-Associated Bloodstream Infections.mp3	1.7 MB
4-24 - Treatment Recommendations.mp3	1.7 MB
9-17 - Hospital-Acquired Infections Caused by Multidrug-Resi.mp3	1.7 MB
9-15 - Treatment.mp3	1.7 MB
1-22 - Clinical Definition.mp3	1.7 MB
8-20 - Cryptosporidium Infection.mp3	1.7 MB
7-19 - Malaria.mp3	1.7 MB
6-08 - Lymphogranuloma Venereum.mp3	1.7 MB
2-08 Skin And Soft Tissue Infections.mp3	1.7 MB
10-05 Immune Reconstitution Inflammatory Syndrome.mp3	1.7 MB
4-20 - Bronchoscopy.mp3	1.7 MB
5-22 - Chlamydia Trachomatis Infection.mp3	1.6 MB
7-05 Bioterrorism.mp3	1.6 MB
5-27 - Antibiotic Recommendations.mp3	1.6 MB
6-26 - Imaging.mp3	1.6 MB
10-27 - Polymixins.mp3	1.6 MB
8-03 Diagnostic Yield of Bacterial Stool Culture.mp3	1.5 MB
10-31 - Antimicrobial Stewardship.mp3	1.5 MB
3-06 - Treatment.mp3	1.5 MB
10-33 - Hyperbaric Oxygen.mp3	1.5 MB
7-07 - Anthrax.mp3	1.5 MB
9-19 - Infective Endocarditis Prevention.mp3	1.5 MB
10-12 - Management of Pregnant Patients with HIV Infection.mp3	1.5 MB
2-05 Creutzfeldt-Jakob Disease.mp3	1.5 MB
4-10 - Acute Prostatitis.mp3	1.4 MB
6-12 - Clinical Manifestations.mp3	1.4 MB
3-08 - Minor Criteria for Severe CAP.mp3	1.4 MB
1-17 - Presentation.mp3	1.4 MB
5-14 - Cryptococcosis.mp3	1.4 MB
6-15 - Bone Biopsy.mp3	1.4 MB
7-08 - Spores.mp3	1.4 MB
10-35 - Close to Section.mp3	1.4 MB
10-11 - Resistance Testing.mp3	1.3 MB
1-06 - Recurrent Bacterial Meningitis.mp3	1.3 MB
6-07 - Treatment.mp3	1.3 MB
6-06 - Chancroid.mp3	1.2 MB
8-18 - Parasitic Infections.mp3	1.2 MB
9-02 Catheter-Associated Urinary Tract Infections.mp3	1.2 MB
8-02 Infectious Gastrointestinal Syndromes.mp3	1.2 MB
7-25 - Hepatitis A Virus Infection.mp3	1.2 MB
10-02 Complications of HIV Infection in the Antiretroviral T.mp3	1.2 MB
8-09 - Bacteremia.mp3	1.2 MB
5-05 Mycobacterium Kansasii.mp3	1.2 MB
3-13 - Complications.mp3	1.1 MB
10-26 - New Uses for Older Antimicrobial Agents.mp3	1.1 MB
10-23 - Oxazolidinones.mp3	1.1 MB
8-31 - Prevention.mp3	1.1 MB
4-15 - Diagnostic Testing.mp3	1.0 MB
4-09 - Asymptomatic Bacteriuria.mp3	1.0 MB
7-18 - Travel Medicine.mp3	1.0 MB
10-29 - Aminoglycosides.mp3	995.1 KB
6-14 - Laboratory Studies.mp3	978.7 KB
2-24 Close To Session.mp3	853.3 KB
2-01 Intro To Session 2.mp3	806.5 KB
10-28 - Fosfomycin.mp3	789.9 KB
5-20 - Sporotrichosis.mp3	771.8 KB
8-33 - Close to Session.mp3	761.4 KB
9-10 - Treatment.mp3	754.7 KB
3-26 - Close to Session.mp3	752.6 KB
1-26 - Close to Session.mp3	701.6 KB
9-31 - Close to Session.mp3	700.0 KB
3-01 Intro to Session 3.mp3	670.7 KB
5-01 Intro to Session 5.mp3	654.8 KB
10-22 - Telavancin.mp3	647.4 KB
8-01 Intro to Session 8.mp3	641.1 KB
9-01 Intro to Session 9.mp3	632.7 KB
5-29 - Close to Session.mp3	631.4 KB
4-26 - Prevention.mp3	623.4 KB
10-01 Intro to Session 10.mp3	597.6 KB
7-30 - Close to Session.mp3	595.9 KB
6-28 - Close to Session.mp3	544.5 KB
7-01 Intro to Session 7.mp3	543.7 KB
6-01 Intro to Session 6.mp3	448.8 KB
4-28 - Close to Session.mp3	432.0 KB
4-01 Intro to Session 4.mp3	420.3 KB
/Part A/Cardiology/01 Cardiology/
4-20 Item 026 A Man Is Evaluated For.mp3	8.7 MB
4-08 Item 025 A 72-Year-Old Woman Wi.mp3	8.4 MB
3-22 Item 024 A 64-year-old Woman wi.mp3	8.3 MB
2-15 Item 017 A 70-Year-Old Man With.mp3	8.1 MB
2-23 Item 018 Cardiac Risk Assessmen.mp3	7.7 MB
5-21 Item 035 A 72-Year-Old Man Is E.mp3	7.3 MB
3-14 Item 023 A 75-year-old Man with.mp3	6.3 MB
1-20 Item 011 A Man with Nonischemic.mp3	6.3 MB
4-03 Reperfusion Therapy.mp3	5.9 MB
6-11 Item 037 A 60-Year-Old Man With.mp3	5.8 MB
8-23 Types Of Prosthetic Valves.mp3	5.7 MB
5-14 Item 031 A 46-Year-Old Man Is E.mp3	5.7 MB
9-38 Session Key Points.mp3	5.4 MB
7-37 Aortic Stenosis.mp3	5.1 MB
1-10 A Man with Worsening Exertional.mp3	5.1 MB
6-20 Item 042 A 67-Year-Old Man With.mp3	5.0 MB
1-02 Epidemiology of Cardiovascular.mp3	5.0 MB
6-34 Antiarrhythmic Medications.mp3	4.9 MB
2-08 Testing.mp3	4.7 MB
2-26 Chronic Stable Angina.mp3	4.7 MB
8-42 Session Key Points.mp3	4.7 MB
9-37 Diagnostic Testing.mp3	4.6 MB
1-08 Systemic Inflammatory Condition.mp3	4.6 MB
9-27 Treatment.mp3	4.5 MB
2-19 Risk Factors For Coronary Arter.mp3	4.3 MB
1-12 The Joint Commission Core Measu.mp3	4.2 MB
8-04 Bicuspid Aortic Valve.mp3	4.1 MB
5-26 Heart Failure With Preserved Ej.mp3	4.1 MB
7-16 Inherited Arrhythmia Syndromes.mp3	4.0 MB
1-14 Diagnostic Testing for Atherosc.mp3	4.0 MB
4-14 Complications Following Stemi.mp3	3.9 MB
7-27 Pathophysiology Of Valvular Hea.mp3	3.9 MB
2-24 Emerging Risk Factors.mp3	3.9 MB
10-31 Session Key Points.mp3	3.9 MB
8-34 Treatment.mp3	3.8 MB
4-02 ST-Elevation Myocardial Infarct.mp3	3.7 MB
9-17 Adults With Cyanotic Congenital.mp3	3.7 MB
10-07 Interventional Therapy.mp3	3.7 MB
9-22 Thoracic Aortic Aneurysm.mp3	3.7 MB
5-27 Implantable Cardioverter-Defibr.mp3	3.6 MB
8-26 Patent Foramen Ovale.mp3	3.5 MB
2-04 Risks Of Coronary Diagnostic Te.mp3	3.5 MB
9-23 Timing Of Repair.mp3	3.4 MB
5-30 Inpatient Management Of Acute D.mp3	3.4 MB
6-12 Clinical Course And Risk Strati.mp3	3.4 MB
8-17 Diagnosis And Management.mp3	3.3 MB
8-33 Diagnostic Evaluation.mp3	3.3 MB
3-16 Duration of Clopidogrel Therapy.mp3	3.3 MB
1-01 Introduction to Cardiology Sect.mp3	3.3 MB
10-13 Cardiotoxicity Of Radiation Th.mp3	3.3 MB
10-21 Pregnancy And Cardiovascular D.mp3	3.3 MB
4-05 Contraindications To Thrombolyt.mp3	3.3 MB
3-27 Anticoagulants.mp3	3.2 MB
7-34 General Principles Of Managemen.mp3	3.2 MB
6-02 Strategies To Prevent Readmissi.mp3	3.2 MB
2-21 Psychosocial Stressors.mp3	3.2 MB
9-08 Aortic Coarctation.mp3	3.2 MB
2-28 Medical Therapy.mp3	3.2 MB
1-11 Quality Measures in Cardiovascu.mp3	3.1 MB
10-02 Cardiovascular Risk Reduction.mp3	3.1 MB
5-34 Session Key Points.mp3	3.1 MB
6-08 Electrocardiography Findings.mp3	3.0 MB
3-20 Other Causes of ACS.mp3	3.0 MB
1-25 Poor Prognostic Findings.mp3	3.0 MB
3-02 Nitrates.mp3	3.0 MB
8-02 Pathogenesis And Natural Histor.mp3	3.0 MB
9-06 Diagnostic Evaluation And Treat.mp3	3.0 MB
9-02 Patent Ductal Arteriosus.mp3	2.9 MB
9-13 Tetralogy Of Fallot.mp3	2.9 MB
2-29 Antianginal Medications.mp3	2.9 MB
5-08 Diagnosis And Evaluation Of Hea.mp3	2.9 MB
5-33 Intravenous Vasoactive Medicati.mp3	2.9 MB
1-04 The INTERHEART Study.mp3	2.9 MB
6-04 Takotsubo Cardiomyopathy And Ac.mp3	2.8 MB
7-18 Catecholaminergic Polymorphic V.mp3	2.8 MB
5-28 Cardiac Resynchronization Thera.mp3	2.8 MB
6-15 Lifestyle Modifications.mp3	2.8 MB
9-32 Treatment.mp3	2.8 MB
2-07 Diagnostic Testing For Structur.mp3	2.8 MB
7-02 Atrial Fibrillation And Atrial.mp3	2.8 MB
10-26 Peripartum Cardiomyopathy.mp3	2.8 MB
5-18 Initiating And Managing ACE Inh.mp3	2.8 MB
3-23 The TIMI Risk Score.mp3	2.8 MB
5-15 Medical Therapy For Systolic He.mp3	2.7 MB
7-31 Serial Evaluation Of Asymptomat.mp3	2.7 MB
8-10 Pathogenesis And Natural Histor.mp3	2.7 MB
3-11 Surgical Revascularization.mp3	2.7 MB
2-11 Complications Of Transesophagea.mp3	2.7 MB
9-36 History And Physical Examinatio.mp3	2.7 MB
7-32 Quantitative Measures In Report.mp3	2.7 MB
10-29 Anticoagulation Therapy During.mp3	2.7 MB
3-17 After Surgical Revascularizatio.mp3	2.7 MB
4-09 Initial Medical Therapy For Ste.mp3	2.7 MB
4-18 Papillary Muscle Rupture.mp3	2.7 MB
6-33 Approach To The Patient With Ta.mp3	2.7 MB
5-16 ACE Inhibitors And Angiotensin.mp3	2.6 MB
4-26 Pharmacologic Treatment And Sec.mp3	2.6 MB
9-24 Repair Of Ascending Aortic Aneu.mp3	2.6 MB
6-07 Clinical Presentation And Diagn.mp3	2.6 MB
7-10 Nonpharmacologic Strategies.mp3	2.6 MB
1-09 Other Considerations.mp3	2.6 MB
10-03 Hypertension Associated With P.mp3	2.6 MB
10-23 Predictors Of Maternal Cardiac.mp3	2.6 MB
10-28 Medication Use During Pregnanc.mp3	2.6 MB
7-28 Diagnostic Evaluation.mp3	2.5 MB
8-08 Management.mp3	2.5 MB
2-17 Rhythm Recorders.mp3	2.5 MB
4-25 Invasive Approaches In Patients.mp3	2.5 MB
8-37 Pathophysiology Of Ventricular.mp3	2.5 MB
9-29 Aortic Atheroma.mp3	2.5 MB
4-16 Cardiogenic Shock.mp3	2.5 MB
10-18 Algorithm For Monitoring.mp3	2.5 MB
2-20 Established Risk Factors.mp3	2.5 MB
6-26 Clinical Presentation, Evaluati.mp3	2.5 MB
1-22 Variables Associated with Worse.mp3	2.4 MB
9-03 Diagnostic Evaluation And Treat.mp3	2.4 MB
10-17 Risk Factors For Anthracycline.mp3	2.4 MB
3-30 Session Key Points.mp3	2.4 MB
9-31 Screening And Surveillance Of A.mp3	2.4 MB
1-21 Cardiac Stress Testing.mp3	2.4 MB
8-38 Clinical Presentation.mp3	2.4 MB
6-09 Exercise Echocardiography.mp3	2.4 MB
5-19 Diuretics.mp3	2.4 MB
3-05 ACE Inhibitors and Statins.mp3	2.4 MB
1-15 Nuclear SPECT Perfusion.mp3	2.4 MB
5-06 Risk Reduction.mp3	2.3 MB
7-06 Long-Term Management.mp3	2.3 MB
7-09 Rate Versus Rhythm Control.mp3	2.3 MB
4-13 Glucose Control.mp3	2.3 MB
7-14 Idiopathic Ventricular Tachycar.mp3	2.3 MB
7-08 Oral Factor Xa Inhibitors.mp3	2.3 MB
3-15 Follow-Up Care After Percutaneo.mp3	2.3 MB
9-20 Diseases Of The Aorta.mp3	2.3 MB
9-18 Eisenmengers Syndrome.mp3	2.3 MB
5-03 Clinical Presentation.mp3	2.3 MB
7-41 Session Key Points.mp3	2.3 MB
10-09 Acute Limb Ischemia.mp3	2.2 MB
5-31 Ultrafiltration.mp3	2.2 MB
1-17 Dobutamine and Vasodilator Nucl.mp3	2.2 MB
3-08 Coronary Revascularization.mp3	2.2 MB
7-21 Acute Management.mp3	2.2 MB
6-17 Interventional Treatment.mp3	2.2 MB
5-09 Diagnostic Testing.mp3	2.2 MB
2-05 Other Complications.mp3	2.2 MB
8-15 Tricuspid Valve Disease.mp3	2.2 MB
7-30 Laboratory And Imaging Tests.mp3	2.2 MB
3-03 Calcium Channel Blockers.mp3	2.2 MB
7-13 Ventricular Tachycardia With St.mp3	2.2 MB
2-16 Diagnostic Testing For Cardiac.mp3	2.2 MB
10-05 Symptom Relief.mp3	2.2 MB
1-19 Coronary CT Imaging and CMR Ima.mp3	2.2 MB
5-32 Cardiogenic Shock.mp3	2.2 MB
6-31 Pacemakers.mp3	2.2 MB
9-26 Diagnosis And Evaluation Of Acu.mp3	2.1 MB
6-37 Session Key Points.mp3	2.1 MB
9-05 Pathophysiology And Clinical Pr.mp3	2.1 MB
8-32 Clinical Presentation.mp3	2.1 MB
6-22 Clinical Presentation And Evalu.mp3	2.0 MB
8-40 Treatment.mp3	2.0 MB
6-24 Management.mp3	2.0 MB
1-28 Perfusion Scan.mp3	2.0 MB
4-22 Risk Stratification.mp3	2.0 MB
2-30 Session Key Points.mp3	2.0 MB
2-12 Three-Dimensional Echocardiogra.mp3	2.0 MB
6-05 Tachycardia-Mediated Cardiomyop.mp3	2.0 MB
6-16 Device Therapy.mp3	2.0 MB
5-20 Digoxin.mp3	1.9 MB
5-22 Aldosterone Antagonists.mp3	1.9 MB
3-24 Early Invasive Treatment Approa.mp3	1.9 MB
10-30 Mechanical Valve Prostheses.mp3	1.9 MB
7-35 Indications For Intervention.mp3	1.9 MB
8-20 Prophylaxis.mp3	1.9 MB
3-21 Non-ST-Elevation MI and Unstabl.mp3	1.9 MB
5-17 Beta Blockers.mp3	1.9 MB
8-18 Transthoracic Echocardiography.mp3	1.9 MB
2-02 Visualization Of The Coronary A.mp3	1.9 MB
6-23 Differentiating Restrictive Car.mp3	1.9 MB
3-09 Percutaneous Coronary Intervent.mp3	1.9 MB
9-34 Peripheral Arterial Disease.mp3	1.8 MB
5-02 Women And Cardiovascular Diseas.mp3	1.8 MB
4-10 Beta Blockers And ACE Inhibitor.mp3	1.8 MB
8-30 Defects By Location.mp3	1.8 MB
9-10 Treatment.mp3	1.8 MB
3-10 Current Guidelines.mp3	1.8 MB
5-05 Evaluation.mp3	1.8 MB
5-10 Cardiopulmonary Exercise Testin.mp3	1.8 MB
10-16 Cardiotoxicity Of Chemotherapy.mp3	1.8 MB
10-11 Bypass Surgery Vs Angiopathy.mp3	1.7 MB
1-30 Viability Testing.mp3	1.7 MB
4-04 Regionalized PCI Centers.mp3	1.7 MB
5-11 Laboratory Evaluation.mp3	1.7 MB
9-14 Diagnostic Evaluation After Rep.mp3	1.7 MB
7-22 Hands-Only CPR.mp3	1.7 MB
1-27 Interpretation of Nuclear Stres.mp3	1.7 MB
6-10 Other Conditions.mp3	1.7 MB
8-29 Atrial Septal Defect.mp3	1.7 MB
7-40 Balloon Valvuloplasty.mp3	1.7 MB
9-11 Follow-Up After Aortic Coarctat.mp3	1.7 MB
2-13 Pulmonary Artery Catheterizatio.mp3	1.7 MB
1-24 Imaging.mp3	1.7 MB
8-25 Adult Congenital Heart Disease.mp3	1.6 MB
4-23 Key Points.mp3	1.6 MB
1-18 Coronary Angiography and CAC Te.mp3	1.6 MB
4-27 Session Key Points.mp3	1.6 MB
7-07 Alternatives To Warfarin.mp3	1.6 MB
4-21 Long-Term Medical Therapy.mp3	1.6 MB
2-22 Metabolic Syndrome.mp3	1.6 MB
6-21 Restrictive Cardiomyopathy.mp3	1.6 MB
1-23 Contraindications to Exercise E.mp3	1.6 MB
2-03 Coronary Artery Calcium Scoring.mp3	1.6 MB
8-07 Pathogenesis And Natural Histor.mp3	1.6 MB
1-29 Vasodilator Agents.mp3	1.6 MB
7-29 Other Findings.mp3	1.5 MB
3-26 Other Agents.mp3	1.5 MB
4-17 Ventricular Septal Defect.mp3	1.5 MB
1-26 Diagnostic Accuracy of Cardiac.mp3	1.5 MB
4-07 Thrombolytic Therapy.mp3	1.5 MB
5-23 Hydralazine And Isosorbide Dini.mp3	1.5 MB
8-11 Mitral Valve Prolapse.mp3	1.5 MB
7-04 Acute Anticoagulation.mp3	1.5 MB
9-21 Comparison Of Thoracic Aortic I.mp3	1.5 MB
2-09 Echocontrast.mp3	1.5 MB
8-05 Balloon Valvotomy.mp3	1.5 MB
9-09 Diagnostic Evaluation.mp3	1.5 MB
6-36 Other Drugs.mp3	1.4 MB
4-15 Mechanical Complications.mp3	1.4 MB
6-29 Sinus Bradycardia.mp3	1.4 MB
8-35 Reproductive Considerations And.mp3	1.4 MB
8-03 Management Of Aortic Regurgitat.mp3	1.4 MB
6-14 Management Of Hypertrophic Card.mp3	1.4 MB
8-13 Mitral Valve Repair.mp3	1.4 MB
7-05 Cardioversion And Acute Rate Co.mp3	1.4 MB
5-29 Key Points.mp3	1.4 MB
4-19 Left Ventricular Thrombus.mp3	1.4 MB
3-28 Lipid-Lowering Medications.mp3	1.3 MB
10-32 Close To Section And Disclaimer.mp3	1.3 MB
7-33 B-Type Natriuretic Peptide Leve.mp3	1.3 MB
3-19 Acute Coronary Syndromes.mp3	1.3 MB
7-23 Device Therapy For Prevention O.mp3	1.3 MB
8-16 Infective Endocarditis.mp3	1.3 MB
8-31 Genetic Syndromes.mp3	1.2 MB
9-15 Treatment Of Tetralogy Of Fallo.mp3	1.2 MB
3-12 Hybrid Coronary Revascularizati.mp3	1.2 MB
3-04 Cardiovascular-Protective Medic.mp3	1.2 MB
7-25 Device Infections.mp3	1.2 MB
7-38 Management.mp3	1.2 MB
8-22 Prosthetic Valves.mp3	1.2 MB
6-35 Dronedarone.mp3	1.2 MB
9-25 Key Points.mp3	1.2 MB
1-13 Clinical History and Exam for D.mp3	1.2 MB
8-12 Management.mp3	1.2 MB
7-39 Early And Cardinal Symptoms.mp3	1.2 MB
6-18 Role Of Genetic Testing And Scr.mp3	1.2 MB
10-10 Therapy.mp3	1.2 MB
6-28 Approach To The Patient With Br.mp3	1.1 MB
7-20 Epidemiology Of Sudden Cardiac.mp3	1.1 MB
7-12 Premature Ventricular Contracti.mp3	1.1 MB
4-24 Diagnostic Issues In Patients W.mp3	1.1 MB
6-03 Key Points.mp3	1.1 MB
8-39 Diagnostic Evaluation.mp3	1.1 MB
10-04 Antiplatelet Therapy.mp3	1.1 MB
1-03 Ethnicity and Cardiovascular Di.mp3	1.1 MB
10-22 Prepregnancy Evaluation.mp3	1.0 MB
9-07 Key Points.mp3	1.0 MB
7-17 Brugada Syndrome.mp3	1.0 MB
8-24 Key Points.mp3	1.0 MB
2-10 Hand-Held Echocardiography.mp3	991.8 KB
1-16 Dobutamine Echocardiography.mp3	983.0 KB
10-14 Management Of Radiation-Induce.mp3	960.9 KB
6-25 Types Of Cardiac Tumors.mp3	953.3 KB
8-06 Key Points.mp3	949.9 KB
3-29 Timing of Coronary Angiography.mp3	949.1 KB
1-06 Chronic Kidney Disease and Card.mp3	940.4 KB
6-06 Hypertrophic Cardiomyopathy.mp3	934.1 KB
8-19 Indications For Surgery.mp3	922.0 KB
5-04 The Womens Ischemia Syndrome Ev.mp3	921.2 KB
7-03 Acute Management.mp3	919.9 KB
5-25 Key Points.mp3	894.3 KB
2-06 Key Points.mp3	883.5 KB
10-27 Subsequent Pregnancies.mp3	878.9 KB
5-24 Calcium Channel Blockers.mp3	878.1 KB
3-13 Key Points.mp3	867.2 KB
2-31 Close To Session.mp3	859.7 KB
4-11 Antithrombolytic Therapy.mp3	842.5 KB
8-43 Close To Session.mp3	827.9 KB
3-25 Antiplatelet Medications.mp3	825.8 KB
10-25 Management Of Cardiovascular D.mp3	822.1 KB
6-30 Atrioventricular Block.mp3	799.9 KB
10-20 Key Points.mp3	794.9 KB
8-21 Key Points.mp3	792.0 KB
7-19 Idiopathic VF.mp3	782.8 KB
4-12 Antiplatelet Therapy.mp3	771.1 KB
8-41 Reproductive Considerations And.mp3	766.5 KB
3-07 Key Points.mp3	765.6 KB
9-39 Close To Session.mp3	757.3 KB
9-33 Key Points.mp3	755.6 KB
5-12 Evaluation For Ischemia.mp3	753.9 KB
8-14 Key Points.mp3	751.8 KB
3-31 Close to Session.mp3	734.7 KB
10-19 Management Of Chemotherapy-Ind.mp3	733.5 KB
9-12 Key Points.mp3	725.1 KB
5-01 Intro To Session 5.mp3	715.9 KB
4-06 Facilitated PCI.mp3	711.3 KB
9-01 Intro To Session 9.mp3	704.2 KB
8-09 Key Points.mp3	702.5 KB
10-06 Key Points.mp3	695.8 KB
8-01 Intro To Session 8.mp3	693.7 KB
3-06 Additional Treatments.mp3	692.9 KB
7-36 Key Points.mp3	691.6 KB
8-27 Migraines As Related To PFOs.mp3	690.0 KB
8-28 Key Points.mp3	689.1 KB
6-38 Close To Session.mp3	687.9 KB
10-01 Intro To Session 10.mp3	682.0 KB
3-01 Intro to Session 3.mp3	679.5 KB
7-01 Intro To Session 7.mp3	675.4 KB
2-01 Intro To Session 2.mp3	659.0 KB
7-42 Close To Session.mp3	652.4 KB
9-19 Key Points.mp3	643.6 KB
10-08 Key Points.mp3	638.6 KB
4-28 Close To Session.mp3	616.8 KB
2-25 Key Points.mp3	611.4 KB
4-01 Intro To Session 4.mp3	608.5 KB
6-01 Intro To Session 6.mp3	595.9 KB
9-28 Key Points.mp3	583.0 KB
5-13 Key Points.mp3	576.7 KB
5-07 Key Points.mp3	566.2 KB
8-36 Key Points.mp3	554.1 KB
10-12 Key Points.mp3	547.4 KB
5-35 Close To Session.mp3	546.2 KB
10-24 Key Points.mp3	543.3 KB
1-32 Close to Session.mp3	534.1 KB
1-31 Session Key Points.mp3	502.7 KB
9-30 Key Points.mp3	487.3 KB
7-11 Key Points.mp3	480.2 KB
2-27 Key Points.mp3	466.4 KB
10-15 Key Points.mp3	451.7 KB
7-24 Key Point.mp3	450.9 KB
9-16 Key Points.mp3	430.0 KB
6-19 Key Points.mp3	428.7 KB
2-18 Key Points.mp3	424.1 KB
3-18 Key Point.mp3	422.1 KB
7-26 Key Points.mp3	396.6 KB
2-14 Key Points.mp3	395.3 KB
6-13 Key Point.mp3	386.9 KB
6-32 Key Points.mp3	374.0 KB
9-04 Key Point.mp3	365.2 KB
1-05 Key Point.mp3	320.9 KB
7-15 Key Point.mp3	320.5 KB
9-35 Key Point.mp3	297.5 KB
1-07 Key Point.mp3	292.5 KB
6-27 Key Point.mp3	290.4 KB
/Part A/Rheumatology/06 Rheumatology/
2-18 Item 007 A Woman with Stiffness and Swelling of the Fin.mp3	8.1 MB
5-13 Item 029 A Woman with Fatigue, a Photosensitive Malar R.mp3	7.8 MB
6-21 Item 042 A Man is Hospitalized for Acute Kidney Injury .mp3	7.5 MB
6-15 Item 038 A Woman with Fever and Right Knee Pain.mp3	6.9 MB
1-10 Item 002 A Woman with Recurring Pain and Swelling of th.mp3	6.6 MB
1-17 Item 005 A Woman is Seen with Progressively Worsening W.mp3	6.5 MB
4-37 Session Key Points.mp3	6.4 MB
4-18 Item 019 A Man with Hand Pain and Morning Stiffness.mp3	6.3 MB
3-27 Item 017 A Man with Acute Swelling and Pain of the Righ.mp3	6.2 MB
2-10 Item 006 A Man with Progressive Pain and Swelling of Bo.mp3	6.1 MB
4-24 Item 026 A Woman with Progressive Fatigue and Dyspnea o.mp3	6.1 MB
5-35 Session Key Points.mp3	6.0 MB
5-23 Item 033 A Man Has an Evaluation Before Total Joint Art.mp3	5.8 MB
9-32 Session Key Points.mp3	5.7 MB
6-38 Session Key Points.mp3	5.6 MB
7-35 Session Key Points.mp3	5.0 MB
1-07 Common Overuse Syndromes.mp3	5.0 MB
8-38 Session Key Points.mp3	4.8 MB
7-08 Management.mp3	4.7 MB
3-15 Item 009 A Woman Presents with Fatigue and Tingling in .mp3	4.7 MB
1-18 Dermatologic Manifestations.mp3	4.4 MB
1-15 Inflammatory Chronic Polyarthritis.mp3	4.4 MB
3-41 Session Key Points.mp3	4.3 MB
5-10 Clinical Manifestations.mp3	4.2 MB
2-03 Ankylosing Spondylitis.mp3	4.1 MB
6-36 Urate Excretion and Underexcretion.mp3	3.8 MB
5-04 Peripheral Involvement.mp3	3.8 MB
4-36 Imaging.mp3	3.7 MB
4-30 Psoriatic Arthritis.mp3	3.7 MB
5-11 Musculoskeletal Manifestations.mp3	3.7 MB
1-26 Erythrocyte Sedimentation Rate.mp3	3.7 MB
3-37 Surgical Therapy.mp3	3.7 MB
5-29 Reproductive Issues.mp3	3.7 MB
3-02 Tumor Necrosis Factor-a Inhibitors.mp3	3.6 MB
7-06 Classification.mp3	3.6 MB
2-28 Biologic Disease-Modifying Antirheumatic Drugs.mp3	3.6 MB
6-12 Pulmonary Arterial Hypertension.mp3	3.6 MB
4-16 Surgical Intervention.mp3	3.4 MB
6-35 Pathophysiology of Hyperuricemia.mp3	3.4 MB
2-05 Joint Aspiration.mp3	3.4 MB
1-23 Lung Disease.mp3	3.4 MB
3-10 Allopurinol.mp3	3.3 MB
1-02 Inflammatory versus Noninflammatory Pain.mp3	3.3 MB
2-07 Evaluation of Disease Progression.mp3	3.3 MB
8-36 Granulomatosis with Polyangiitis.mp3	3.2 MB
8-11 Autoantibodies.mp3	3.2 MB
4-14 Pharmacologic Therapy.mp3	3.2 MB
6-24 Clinical Manifestations.mp3	3.1 MB
2-11 Anti-Inflammatory Agents.mp3	3.1 MB
7-07 Treatment.mp3	3.0 MB
4-34 Diagnosis.mp3	3.0 MB
4-13 Nonpharmacologic Interventions.mp3	3.0 MB
4-28 Classification.mp3	2.9 MB
1-29 Antibody Tests.mp3	2.9 MB
1-05 The Musculoskeletal Examination.mp3	2.8 MB
3-28 Complications and Extra-Articular Manifestations.mp3	2.8 MB
1-01 Introduction to Rheumatology Section.mp3	2.8 MB
6-02 Diagnosis.mp3	2.8 MB
6-07 Gastrointestinal Manifestations.mp3	2.7 MB
8-25 Clinical Manifestations and Diagnosis.mp3	2.7 MB
6-04 Clinical Manifestations and Management.mp3	2.7 MB
2-19 Disease-Modifying Antirheumatic Drugs.mp3	2.7 MB
7-21 Disseminated Gonococcal Infection.mp3	2.7 MB
2-31 Session Key Points.mp3	2.7 MB
3-23 Musculoskeletal Manifestations of Rheumatoid Arthritis.mp3	2.7 MB
3-34 Biologic DMARDs.mp3	2.7 MB
7-18 Laboratory and Radiographic Studies.mp3	2.6 MB
4-29 Ankylosing Spondylitis.mp3	2.6 MB
1-08 Subacromial Bursitis.mp3	2.6 MB
4-20 Evaluation and Diagnosis.mp3	2.6 MB
8-26 Management.mp3	2.6 MB
4-08 Diffuse Idiopathic Skeletal Hyperostosis.mp3	2.6 MB
2-16 Corticosteroids.mp3	2.6 MB
5-07 Systemic Lupus Erythematosus.mp3	2.5 MB
5-27 Treatment.mp3	2.5 MB
3-40 Rheumatoid Arthritis and Pregnancy.mp3	2.5 MB
6-25 Diagnosis.mp3	2.5 MB
1-12 Monoarticular Arthritis.mp3	2.5 MB
8-28 Takayasu Arteritis.mp3	2.5 MB
6-37 Drugs that Alter Serum Levels.mp3	2.5 MB
2-02 Radiography.mp3	2.5 MB
4-05 Clinical Features and Classification.mp3	2.4 MB
1-30 Autoantibodies in Rheumatic Conditions.mp3	2.4 MB
3-30 Management.mp3	2.4 MB
6-06 Vascular Manifestations.mp3	2.4 MB
4-10 Diagnosis.mp3	2.4 MB
1-31 ANCA Testing.mp3	2.4 MB
1-21 Inflammatory Eye Disease.mp3	2.4 MB
3-24 Laboratory Studies.mp3	2.4 MB
7-17 Infectious Arthritis.mp3	2.3 MB
8-19 Association with Malignancy.mp3	2.3 MB
5-22 Autoantibodies.mp3	2.3 MB
8-31 Polyarteritis Nodosa.mp3	2.3 MB
3-25 Imaging Studies.mp3	2.3 MB
5-12 Kidney Manifestations.mp3	2.3 MB
8-05 Cutaneous Manifestations.mp3	2.3 MB
5-14 Neurologic Manifestations.mp3	2.2 MB
9-02 Microscopic Polyangiitis.mp3	2.2 MB
9-20 Adult-Onset Stills Disease.mp3	2.2 MB
1-19 Other Dermatologic Manifestations.mp3	2.2 MB
5-15 Cardiovascular Manifestations.mp3	2.2 MB
8-07 Extramuscular and Cardiopulmonary Manifestations.mp3	2.2 MB
7-05 Chronic Gouty Arthritis.mp3	2.2 MB
2-30 Biologic Agents and Traditional DMARDs.mp3	2.2 MB
6-11 Pulmonary Manifestations.mp3	2.2 MB
9-30 Sarcoidosis.mp3	2.1 MB
4-25 Genetic Predisposition to Spondyloarthritis.mp3	2.1 MB
2-15 Colchicine.mp3	2.1 MB
8-16 Differential Diagnosis.mp3	2.1 MB
9-28 Marfans Syndrome.mp3	2.1 MB
6-30 Clinical Manifestations.mp3	2.0 MB
7-24 Mycobacterium Tuberculosis.mp3	2.0 MB
9-07 Diagnosis and Management.mp3	2.0 MB
3-03 Abatacept.mp3	2.0 MB
5-25 Drug-Induced Lupus Erythematosus.mp3	2.0 MB
9-24 Familial Autoinflammatory Diseases.mp3	2.0 MB
7-33 Antibiotic Initiation.mp3	2.0 MB
9-06 Cryoglobulinemic Vasculitis.mp3	2.0 MB
4-15 Corticosteroids and Hyaluronic Acid.mp3	2.0 MB
8-22 Systemic Vasculitis.mp3	2.0 MB
5-03 Axial Involvement.mp3	1.9 MB
7-34 Surgical Management.mp3	1.9 MB
9-16 Relapsing Polychondritis.mp3	1.9 MB
7-11 Clinical Manifestations.mp3	1.9 MB
9-21 Diagnosis.mp3	1.9 MB
2-20 Hydroxychloroquine.mp3	1.9 MB
5-21 Diagnosis.mp3	1.9 MB
4-32 Reactive Arthritis.mp3	1.9 MB
7-12 Diagnosis.mp3	1.9 MB
9-27 Ehlers-Danlos Syndrome.mp3	1.9 MB
9-08 Henoch-Schonlein Purpura.mp3	1.9 MB
7-32 Pharmacologic Therapy.mp3	1.9 MB
1-22 Uveitis.mp3	1.9 MB
5-05 Reactive Arthritis.mp3	1.9 MB
8-18 Treatment.mp3	1.8 MB
3-17 Environmental and Genetic Risk Factors.mp3	1.8 MB
2-22 Leflunomide.mp3	1.8 MB
7-27 Parvovirus B19.mp3	1.8 MB
1-25 Musculoskeletal and Rheumatic Manifestations.mp3	1.8 MB
6-16 Scleroderma Spectrum Disorders.mp3	1.8 MB
7-10 Epidemiology and Pathophysiology of Calcium Pyrophospha.mp3	1.8 MB
3-04 Rituximab.mp3	1.8 MB
9-17 Diagnosis.mp3	1.8 MB
8-27 Polymyalgia Rheumatica.mp3	1.7 MB
8-37 Management.mp3	1.7 MB
5-17 The Antiphospholipid Syndrome.mp3	1.7 MB
8-03 Epidemiology.mp3	1.7 MB
9-26 Osteogenesis Imperfecta.mp3	1.7 MB
6-05 Musculoskeletal Manifestations.mp3	1.7 MB
9-13 Clinical Manifestations and Diagnosis.mp3	1.7 MB
3-16 Rheumatoid Arthritis.mp3	1.7 MB
9-31 Diagnosis and Treatment.mp3	1.7 MB
7-26 Fungal Infections.mp3	1.7 MB
7-15 Basic Calcium Phosphate Deposition Disease.mp3	1.6 MB
9-22 Treatment.mp3	1.6 MB
2-08 The Health Assessment Questionnaire.mp3	1.6 MB
3-20 Environmental Factors.mp3	1.6 MB
9-03 Churg-Strauss Syndrome.mp3	1.6 MB
9-33 Close to Section.mp3	1.6 MB
6-09 Treatment.mp3	1.6 MB
2-14 Analgesics.mp3	1.6 MB
7-29 Prosthetic Joint Infections.mp3	1.6 MB
2-29 Cryopyrin-Associated Syndromes.mp3	1.6 MB
3-33 Disease-Modifying Antirheumatic Drugs.mp3	1.6 MB
3-19 Antibodies.mp3	1.6 MB
1-28 Complement.mp3	1.6 MB
3-13 Uricase.mp3	1.5 MB
8-23 Causes of Secondary Vasculitis.mp3	1.5 MB
8-33 Kawasaki Disease.mp3	1.5 MB
4-21 Treatment.mp3	1.5 MB
9-05 Key Points.mp3	1.5 MB
3-35 Other Agents.mp3	1.5 MB
9-12 Behcets Disease.mp3	1.5 MB
4-19 Epidemiology of Fibromyalgia.mp3	1.5 MB
4-35 Laboratory Testing.mp3	1.5 MB
5-16 Pulmonary and Hematologic Manifestations.mp3	1.4 MB
8-15 Muscle Biopsy.mp3	1.4 MB
4-31 Inflammatory Bowel Disease-Associated Arthritis.mp3	1.4 MB
2-21 Sulfasalazine.mp3	1.4 MB
6-22 Epidemiology and Pathophysiology of Sjogrens Syndrome.mp3	1.4 MB
6-34 Epidemiology of Gout.mp3	1.4 MB
8-29 Management.mp3	1.4 MB
5-34 Classification.mp3	1.3 MB
4-22 Pharmacologic Therapy.mp3	1.3 MB
2-23 Azathioprine.mp3	1.3 MB
6-26 Treatment.mp3	1.3 MB
8-02 Pathophysiology of Idiopathic Inflammatory Myopathies.mp3	1.3 MB
5-26 Key Points.mp3	1.3 MB
7-03 Acute and Intercritical Gout.mp3	1.3 MB
4-06 Primary and Secondary Osteoarthritis.mp3	1.3 MB
7-02 Acute Gouty Inflammation.mp3	1.3 MB
8-10 Diagnosis and Muscle-Related Enzymes.mp3	1.3 MB
3-07 Belimumab and Interleukin-1beta Inhibitors.mp3	1.3 MB
5-30 Key Points.mp3	1.3 MB
8-35 Antineutrophil Cytoplasmic Antibodies and Associated Va.mp3	1.3 MB
8-34 Key Points.mp3	1.3 MB
4-26 Environmental Triggers.mp3	1.3 MB
2-12 Proton Pump Inhibitors.mp3	1.3 MB
3-38 Nonpharmacologic Management.mp3	1.3 MB
9-14 Treatment.mp3	1.3 MB
7-23 Lyme Arthritis.mp3	1.2 MB
9-11 Key Points.mp3	1.2 MB
1-27 C-Reactive Protein.mp3	1.2 MB
7-14 Key Points.mp3	1.2 MB
3-22 Diagnosis.mp3	1.2 MB
6-08 Kidney Manifestations.mp3	1.2 MB
3-08 Key Points.mp3	1.2 MB
7-13 Treatment.mp3	1.2 MB
4-33 Key Points.mp3	1.2 MB
5-20 Key Points.mp3	1.2 MB
6-32 Treatment and Prognosis.mp3	1.2 MB
3-05 Tocilizumab.mp3	1.2 MB
9-10 Management.mp3	1.2 MB
3-06 Ustekinumab.mp3	1.2 MB
7-22 Nongonococcal Gram-Negative Organisms.mp3	1.2 MB
8-32 Management.mp3	1.2 MB
9-09 Cutaneous Leukocytoclastic Vasculitis.mp3	1.1 MB
8-20 Prognosis.mp3	1.1 MB
1-14 Acute Polyarthritis.mp3	1.1 MB
8-24 Giant Cell Arteritis.mp3	1.1 MB
6-10 Key Points.mp3	1.1 MB
7-09 Key Points.mp3	1.1 MB
4-09 Key Points.mp3	1.1 MB
5-31 Prognosis.mp3	1.1 MB
7-28 Other Forms of Viral Arthritis.mp3	1.1 MB
1-20 Fever.mp3	1.1 MB
1-32 Session Key Points.mp3	1.1 MB
7-25 Mycobacterium Marinum.mp3	1.1 MB
9-29 Key Points.mp3	1.1 MB
1-03 Noninflammatory Pain Sources.mp3	1.1 MB
7-04 Tophaceous Gout.mp3	1.1 MB
8-13 Imaging Studies.mp3	1.1 MB
3-11 Febuxostat.mp3	1.0 MB
6-27 Prognosis.mp3	1.0 MB
7-20 Infection with Gram-Positive Organisms.mp3	1.0 MB
6-14 Key Points.mp3	974.0 KB
6-31 Diagnosis.mp3	972.3 KB
6-17 Nephrogenic Systemic Fibrosis.mp3	966.9 KB
8-17 Key Points.mp3	960.2 KB
4-02 Pathophysiology of Osteoarthritis.mp3	958.1 KB
2-25 Mycophenolate Mofetil.mp3	954.7 KB
6-19 Pregnancy and Systemic Sclerosis.mp3	951.4 KB
5-24 Differential Diagnosis.mp3	949.3 KB
4-23 Key Points.mp3	939.2 KB
1-11 Overview of Arthritis.mp3	938.0 KB
7-19 Key Points.mp3	935.9 KB
7-31 Key Points.mp3	930.4 KB
1-13 Oligoarthritis.mp3	919.6 KB
2-27 Key Points.mp3	918.3 KB
2-32 Close to Session.mp3	917.0 KB
1-06 Pain with Range of Motion.mp3	916.6 KB
2-24 Cyclophosphamide.mp3	903.7 KB
8-30 Key Points.mp3	902.9 KB
6-18 Key Points.mp3	890.8 KB
2-17 Key Points.mp3	887.8 KB
5-28 Key Points.mp3	887.4 KB
2-06 Key Points.mp3	887.3 KB
8-04 Clinical Manifestations.mp3	870.3 KB
2-01 INTRO TO SESSION 2.mp3	860.2 KB
2-04 Ultrasonography.mp3	852.7 KB
8-06 Key Points.mp3	849.4 KB
8-39 Close to Session.mp3	842.7 KB
6-03 Key Points.mp3	840.6 KB
8-21 Key Points.mp3	840.6 KB
4-03 Risk Factors.mp3	838.5 KB
3-09 Urate-Lowering Therapy.mp3	827.4 KB
4-12 Key Points.mp3	826.0 KB
5-19 Malignancy.mp3	823.4 KB
3-42 Close to Session.mp3	819.4 KB
8-12 Anti-Mi-2 and Other Autoantibodies.mp3	818.1 KB
3-12 Probenecid.mp3	813.5 KB
3-18 Hormones.mp3	801.0 KB
5-08 Epidemiology.mp3	799.2 KB
5-06 Key Points.mp3	799.2 KB
1-24 Diarrhea.mp3	799.2 KB
6-33 Key Points.mp3	782.1 KB
1-33 Close to Session.mp3	769.0 KB
2-13 Common Risks for NSAID Adverse Events.mp3	766.2 KB
7-30 Infections in Previously Damaged Joints.mp3	764.6 KB
5-02 Treatment.mp3	754.9 KB
6-28 Key Points.mp3	754.1 KB
5-33 Pathophysiology and Epidemiology of Systemic Sclerosis.mp3	752.5 KB
3-01 Intro to session.mp3	749.1 KB
4-27 Key Points.mp3	744.5 KB
5-32 Key Points.mp3	731.5 KB
8-14 Electromyography.mp3	728.2 KB
5-01 INTRO TO SESSION 5.mp3	727.3 KB
6-13 Cardiac Manifestations.mp3	717.8 KB
4-11 Imaging Studies.mp3	713.7 KB
2-26 Cyclosporin.mp3	713.1 KB
9-01 INTRO TO SESSION 9.mp3	712.2 KB
5-36 Close to Session.mp3	703.9 KB
3-32 NSAIDs and Corticosteroids.mp3	698.2 KB
3-21 Key Points.mp3	690.2 KB
8-01 INTRO TO SESSION 8.mp3	683.5 KB
4-17 Key Points.mp3	677.6 KB
9-25 Key Points.mp3	669.2 KB
4-07 Erosive Osteoarthritis.mp3	664.7 KB
7-36 Close to Session.mp3	664.2 KB
3-36 Key Points.mp3	658.9 KB
9-18 Treatment.mp3	631.1 KB
6-29 Mixed Connective Tissue Disease.mp3	619.2 KB
6-39 Close to Session.mp3	615.8 KB
7-01 INTRO TO SESSION 7.mp3	614.9 KB
6-20 Key Points.mp3	603.6 KB
8-09 Key Points.mp3	602.0 KB
8-08 Gastrointestinal Manifestations.mp3	582.8 KB
3-31 Key Points.mp3	572.3 KB
3-26 Key Points.mp3	555.2 KB
4-04 Key Points.mp3	542.6 KB
6-01 INTRO TO SESSION 6.mp3	531.8 KB
5-09 Key Points.mp3	524.2 KB
5-18 Gastrointestinal Manifestations.mp3	523.8 KB
9-04 Management.mp3	518.3 KB
9-19 Key Point.mp3	506.6 KB
4-38 Close to Session.mp3	503.3 KB
3-29 Key Points.mp3	490.8 KB
1-16 Key Points.mp3	489.9 KB
4-01 INTRO TO SESSION 4.mp3	486.2 KB
1-09 Key Points.mp3	481.9 KB
9-23 Key Point.mp3	475.7 KB
6-23 Key Points.mp3	458.2 KB
7-16 Key Points.mp3	458.2 KB
3-39 Key Points.mp3	433.2 KB
9-15 Key Point.mp3	430.5 KB
1-04 Key Points.mp3	364.1 KB
2-09 Key Point.mp3	363.2 KB
3-14 Key Points.mp3	337.0 KB
/.../11 Pulmonary Medicine/
5-09 - Item 016 A 78 Year-Old Man with Increasing Dry Cough .mp3	7.9 MB
5-18 - Item 020 A 45 Year-Old Woman with Worsening Asthma Sy.mp3	7.6 MB
4-17 - Item 014 A 46 Year-Old Man with a New Pleural Effusio.mp3	7.2 MB
6-09 - Item 021 A 58 Year-Old Man with Loud Snoring and Gasp.mp3	7.1 MB
3-19 - Item 010 A 74 Year-Old Woman with a UTI and Hypotensi.mp3	7.1 MB
6-16 - Item 022 A 30 Year-Old Woman with Progressive Dyspnea.mp3	6.7 MB
3-11 - Item 007 A 55 Year-Old Man is in the ED After Being F.mp3	6.3 MB
4-10 - Item 013 A 56 Year-Old Man with COPD.mp3	6.3 MB
10-15 - Therapeutic Drug Overdoses.mp3	5.8 MB
2-12 - Item 004 A 67 Year-Old Man with Pauses in Breathing D.mp3	5.7 MB
2-20 - Item 005 A 70 Year-Old Woman with Severe COPD.mp3	5.4 MB
8-35 - Session Key Points.mp3	5.1 MB
9-04 - Vasopressor Agents.mp3	5.0 MB
1-20 - Item 003 A 78 Year-Old Man with a History of Severe S.mp3	5.0 MB
4-20 - Hypersensitivity Pneumonitis.mp3	4.8 MB
9-28 - Session Key Points.mp3	4.8 MB
1-24 - Bronchoscopy as a Diagnostic Tool.mp3	4.7 MB
2-14 - Classification of Asthma Severity.mp3	4.6 MB
7-32 - Session Key Points.mp3	4.6 MB
7-06 - Further Evaluation.mp3	4.6 MB
1-03 - Spirometry.mp3	4.5 MB
1-09 - Item 002 A 66 Year-Old Man is in the ICU for Possible.mp3	4.4 MB
6-08 - VQ Scanning.mp3	4.4 MB
7-05 - Management.mp3	4.4 MB
6-13 - Hemodynamically Unstable Patients.mp3	4.4 MB
7-16 - Other Treatment Options.mp3	4.3 MB
3-32 - Session Key Points.mp3	4.2 MB
9-12 - Acute Respiratory Distress Syndrome.mp3	4.1 MB
6-26 - Session Key Points.mp3	4.1 MB
8-28 - Respiratory Complications of Neuromuscular Weakness.mp3	4.0 MB
4-07 - Pattern and Distribution.mp3	3.9 MB
6-17 - Classification of Pulmonary Hypertension.mp3	3.9 MB
8-19 - Acute Respiratory Distress Syndrome.mp3	3.9 MB
2-29 - Pathophysiology.mp3	3.9 MB
3-26 - Lung Volume Reduction Surgery.mp3	3.8 MB
5-02 - Sarcoidosis.mp3	3.8 MB
10-08 - Hypothermic Emergencies.mp3	3.8 MB
2-25 - Management of Asthma Exacerbations.mp3	3.7 MB
1-05 - Bronchial Challenge Testing.mp3	3.7 MB
7-12 - Evaluating Patients with Confirmed Non-Small Cell Lun.mp3	3.7 MB
4-05 - Diagnostic Approach and Evaluation.mp3	3.7 MB
3-23 - Noninvasive Mechanical Ventilation.mp3	3.7 MB
5-34 - Session Key Points.mp3	3.7 MB
9-03 - Types of Shock.mp3	3.6 MB
8-16 - Air Travel in Pulmonary Disease.mp3	3.6 MB
9-20 - Management of Septic Shock.mp3	3.5 MB
2-27 - Asthma and Pregnancy.mp3	3.5 MB
9-15 - Ventilator-Associated Pneumonia.mp3	3.5 MB
4-19 - Connective Tissue Disease.mp3	3.4 MB
4-25 - Session Key Points.mp3	3.4 MB
8-21 - Non-Ventilator-Related Management.mp3	3.4 MB
9-11 - Invasive Mechanical Ventilation.mp3	3.4 MB
2-26 - Difficult-To-Manage Asthma.mp3	3.3 MB
8-29 - Generalized Muscle Weakness.mp3	3.3 MB
7-09 - Screening and Primary Prevention.mp3	3.3 MB
7-02 - Pulmonary Arterial Hypertension.mp3	3.3 MB
1-23 - Bronchoscopy.mp3	3.3 MB
7-30 - Risk Factors and Diagnosis.mp3	3.2 MB
3-18 - Antibiotic Agents.mp3	3.2 MB
5-16 - Silicosis.mp3	3.2 MB
4-21 - Drug-Induced and Radiation-Induced Parenchymal Lung D.mp3	3.2 MB
2-22 - Anti-IgE Antibody.mp3	3.1 MB
6-12 - Fondaparinux.mp3	3.1 MB
10-28 - Session Key Points.mp3	3.1 MB
7-24 - Excessive Daytime Sleepiness.mp3	3.1 MB
1-04 - Flow Volume Loop.mp3	3.1 MB
4-04 - Classification by Histopathologic Features.mp3	3.0 MB
5-32 - Management.mp3	3.0 MB
6-06 - Chest Radiography and Electrocardiography.mp3	3.0 MB
9-26 - Anaphylaxis.mp3	3.0 MB
3-27 - Managing Exacerbations of COPD.mp3	3.0 MB
9-23 - Mechanical Ventilation and Miscellaneous Issues.mp3	3.0 MB
10-17 - Acute Abdominal Surgical Emergencies.mp3	2.9 MB
1-14 - Pulse Oximetry.mp3	2.9 MB
5-11 - Asbestos-Related Lung Diseases.mp3	2.8 MB
8-08 - Treatment.mp3	2.8 MB
2-15 - Pharmacotherapy.mp3	2.8 MB
6-11 - Contraindications to Anticoagulation.mp3	2.8 MB
5-22 - Transudate or Exudate Characterization.mp3	2.8 MB
3-06 - Assessment and Monitoring of Disease Progression.mp3	2.7 MB
3-28 - Home Management.mp3	2.7 MB
3-02 - Risk Factors.mp3	2.7 MB
9-24 - Acute Inhalational Injuries.mp3	2.7 MB
2-18 - Inhaled Corticosteroids.mp3	2.7 MB
3-03 - Diagnosis and Treatment.mp3	2.7 MB
3-13 - Pharmacologic Therapy.mp3	2.7 MB
1-01 - Introduction to Pulmonary Section.mp3	2.7 MB
1-11 - Common Causes of Reduced DLCO.mp3	2.7 MB
6-10 - Acute Treatment of Pulmonary Embolism.mp3	2.7 MB
8-26 - Decreased Respiratory Drive.mp3	2.7 MB
7-15 - Treatment.mp3	2.7 MB
5-06 - Occupational Lung Disease.mp3	2.7 MB
4-15 - Cryptogenic Organizing Pneumonia.mp3	2.6 MB
9-13 - Obstructive Lung Disease.mp3	2.6 MB
6-15 - Inferior Vena Cava Interruption.mp3	2.6 MB
6-14 - Anticoagulation.mp3	2.6 MB
8-02 - Positive Airway Pressure.mp3	2.6 MB
7-14 - Staging of SCLC.mp3	2.6 MB
8-33 - Management.mp3	2.5 MB
8-32 - Obstructive Lung Disease.mp3	2.5 MB
10-12 - Carbon Monoxide.mp3	2.5 MB
4-03 - Classification.mp3	2.5 MB
2-11 - Aspirin-Sensitive Asthmas.mp3	2.5 MB
2-16 - Beta 2-Agonists.mp3	2.5 MB
10-14 - Toxicity of Drugs of Abuse.mp3	2.5 MB
6-18 - Epidemiology.mp3	2.5 MB
6-02 - Pathophysiology and Epidemiology of Acute Pulmonary T.mp3	2.5 MB
10-07 - Neuroleptic Malignant Syndrome.mp3	2.5 MB
9-19 - Source Control and Antibiotic Therapy.mp3	2.4 MB
1-16 - Common Clinical Indications for Imaging Tests.mp3	2.4 MB
5-25 - Chemistries.mp3	2.4 MB
9-14 - Weaning.mp3	2.4 MB
7-29 - Pathophysiology.mp3	2.4 MB
2-10 - Vocal Cord Dysfunction.mp3	2.4 MB
5-24 - Causes of Inflammation.mp3	2.4 MB
3-16 - Other Agents.mp3	2.4 MB
8-17 - Recognizing the Critically Ill Patient.mp3	2.4 MB
6-21 - Evaluation.mp3	2.4 MB
10-10 - Alcohols.mp3	2.3 MB
9-09 - Patient Selection.mp3	2.3 MB
8-25 - Ventilatory Respiratory Failure.mp3	2.3 MB
1-08 - Diffusing Capacity for Carbon Monoxide.mp3	2.3 MB
3-07 - Classification of Severity of Airflow.mp3	2.3 MB
4-18 - Smoking-Related Parenchymal Lung Disease.mp3	2.3 MB
10-18 - Supportive Care in Critical Illness.mp3	2.3 MB
4-14 - Nonspecific Interstitial Pneumonia.mp3	2.3 MB
10-09 - Toxicology.mp3	2.3 MB
4-12 - Prognosis.mp3	2.3 MB
2-09 - Exercise-Induced Bronchospasm.mp3	2.2 MB
5-07 - Key Elements of the Exposure History.mp3	2.2 MB
3-14 - Drug Combinations.mp3	2.2 MB
7-10 - Diagnosis.mp3	2.2 MB
1-31 - Comorbid Conditions.mp3	2.2 MB
7-19 - Mesothelioma.mp3	2.2 MB
5-21 - Pleural Fluid Analysis.mp3	2.2 MB
6-05 - Biomarker Assays.mp3	2.1 MB
10-21 - Nutrition.mp3	2.1 MB
1-28 - Pathogenesis.mp3	2.1 MB
4-09 - Surgical Lung Biopsy.mp3	2.1 MB
3-04 - Genetic Predisposition.mp3	2.1 MB
7-03 - Pulmonary Nodule Evaluation.mp3	2.1 MB
2-08 - Treatment.mp3	2.1 MB
7-04 - Assessment of Risk for Malignancy.mp3	2.1 MB
5-05 - Diagnosis and Treatment.mp3	2.1 MB
6-24 - Diagnosis.mp3	2.1 MB
10-05 - Hyperthermic Emergencies.mp3	2.1 MB
2-02 - Occupational Asthma.mp3	2.1 MB
6-07 - Other Imaging Studies.mp3	2.1 MB
5-20 - History and Physical Examination.mp3	2.1 MB
6-03 - Risk Factors and Clinical Assessment.mp3	2.1 MB
3-22 - Pulmonary Rehabilitation.mp3	2.1 MB
2-21 - Theophylline.mp3	2.1 MB
3-10 - Referral.mp3	2.1 MB
6-19 - Diagnosis.mp3	2.1 MB
2-19 - Leukotriene-Modifying Drugs.mp3	2.0 MB
4-11 - Idiopathic Pulmonary Fibrosis.mp3	2.0 MB
1-22 - PET-CT.mp3	2.0 MB
3-15 - Phosphodiesterase-4 Inhibitors.mp3	2.0 MB
4-23 - Nitrofurantoin.mp3	2.0 MB
1-21 - Positron Emission Tomography.mp3	2.0 MB
10-22 - Special Nutrition Situations in Critical Care.mp3	2.0 MB
10-11 - Clinical Manifestations.mp3	2.0 MB
7-08 - Risk Factors.mp3	2.0 MB
1-33 - Session Key Points.mp3	2.0 MB
9-10 - Application.mp3	2.0 MB
6-22 - Treatment.mp3	2.0 MB
6-04 - The Wells Prediction Score.mp3	2.0 MB
5-13 - Pleural Diseases.mp3	1.9 MB
2-07 - Allergic Bronchopulmonary Aspergillopsis.mp3	1.9 MB
10-25 - Process Measures.mp3	1.9 MB
4-06 - High-Resolution CT.mp3	1.9 MB
10-04 - Antihypertensive Agents for Hypertensive Crises.mp3	1.9 MB
1-32 - Allergy Skin Testing.mp3	1.9 MB
9-05 - Non-Invasive Mechanical Ventilation.mp3	1.9 MB
5-29 - Parapneumonic Effusions and Empyema.mp3	1.9 MB
7-18 - Carcinoid Tumors.mp3	1.8 MB
10-16 - Other Considerations.mp3	1.8 MB
8-05 - Central Sleep Apnea Syndromes.mp3	1.8 MB
8-11 - Obesity Hypoventilation Syndrome.mp3	1.8 MB
7-13 - Staging.mp3	1.8 MB
8-12 - Neuromuscular Diseases.mp3	1.8 MB
1-17 - Upper-Lobe Distribution of Opacities.mp3	1.8 MB
8-34 - Initial Management of Life-Threatening Asthma Exacerb.mp3	1.8 MB
10-13 - Cyanide.mp3	1.8 MB
1-26 - Epidemiology and Natural History.mp3	1.8 MB
9-25 - Supportive Care.mp3	1.8 MB
8-04 - Oral Appliances and Other Therapies.mp3	1.7 MB
2-30 - Session Key Points.mp3	1.7 MB
9-18 - Classification and Management.mp3	1.7 MB
1-25 - Asthma.mp3	1.7 MB
5-31 - Pneumothorax.mp3	1.7 MB
9-06 - Obstructive Lung Disease.mp3	1.7 MB
9-02 - Shock.mp3	1.7 MB
4-16 - Acute Interstitial Pneumonia.mp3	1.7 MB
5-23 - Cell Counts and Differential.mp3	1.7 MB
8-14 - Acute Mountain Sickness and High-Altitude Cerebral Ed.mp3	1.7 MB
1-07 - Lung Volumes.mp3	1.7 MB
7-22 - Anterior Mediastinal Masses.mp3	1.6 MB
5-28 - Tests for Pleural Malignancy.mp3	1.6 MB
8-13 - Sleep Disturbances and Periodic Breathing.mp3	1.6 MB
8-24 - Pneumonia.mp3	1.6 MB
7-27 - Shift Work Sleep Disorder.mp3	1.6 MB
7-07 - Epidemiology of Lung Cancer.mp3	1.6 MB
1-19 - Contrast-Enhanced CT.mp3	1.6 MB
7-23 - Middle and Posterior Mediastinal Masses.mp3	1.6 MB
3-21 - Oxygen Therapy.mp3	1.6 MB
6-25 - Management.mp3	1.6 MB
1-18 - Computed Tomography.mp3	1.6 MB
4-22 - Methotrexate.mp3	1.6 MB
8-03 - Surgery.mp3	1.6 MB
4-13 - Treatment.mp3	1.6 MB
3-25 - Preoperative Patient Management.mp3	1.6 MB
5-27 - Pleural Biopsy.mp3	1.5 MB
2-28 - Epidemiology of Chronic Obstructive Pulmonary Disease.mp3	1.5 MB
8-31 - Pulmonary.mp3	1.5 MB
8-22 - Heart Failure.mp3	1.5 MB
5-33 - Tension Pneumothorax.mp3	1.5 MB
3-29 - Hospital Management.mp3	1.5 MB
8-18 - Respiratory Failure.mp3	1.5 MB
1-15 - Chest Radiography.mp3	1.5 MB
8-30 - Restrictive Lung Disease.mp3	1.5 MB
10-06 - Malignant Hyperthermia.mp3	1.5 MB
7-21 - Mediastinal Masses.mp3	1.5 MB
2-05 - Cough-Variant Asthma.mp3	1.5 MB
10-02 - Hypertensive Emergencies.mp3	1.5 MB
7-17 - Prognosis and Follow-Up.mp3	1.5 MB
5-30 - Malignant Pleural Effusion.mp3	1.5 MB
10-29 - Close to Section.mp3	1.4 MB
9-22 - Hyperglycemia.mp3	1.4 MB
7-25 - Sleep Laboratory-Based Studies.mp3	1.4 MB
9-07 - Following Extubation.mp3	1.4 MB
4-24 - Radiation Pneumonitis.mp3	1.4 MB
2-04 - Virus-Induced Asthma.mp3	1.4 MB
1-02 - Pulmonary Function Testing.mp3	1.4 MB
10-03 - Laboratory Studies.mp3	1.4 MB
3-24 - Endotracheal Intubation with Mechanical Ventilation.mp3	1.4 MB
3-08 - GOLD Classification System and BODE Index for COPD.mp3	1.4 MB
9-27 - Management.mp3	1.4 MB
3-17 - The Role of Morphine.mp3	1.4 MB
2-24 - Alternative and Complementary Therapies.mp3	1.4 MB
7-11 - Evaluation.mp3	1.3 MB
5-17 - Radiologic Findings Associated with Silicosis.mp3	1.3 MB
3-05 - Extrapulmonary Effects and Comorbid Conditions.mp3	1.3 MB
5-26 - Tests for Tuberculous Effusions.mp3	1.3 MB
1-30 - Differential Diagnosis.mp3	1.3 MB
8-09 - Sleep-Related Hypoventilation Syndromes.mp3	1.3 MB
7-20 - Neoplasms Metastatic to the Lung.mp3	1.3 MB
2-17 - Anticholinergic Agents.mp3	1.3 MB
8-06 - Risk Factors.mp3	1.3 MB
9-17 - Pathophysiology.mp3	1.3 MB
2-03 - Reactive Airways Dysfunction Syndrome.mp3	1.3 MB
8-15 - High-Altitude Pulmonary Edema.mp3	1.3 MB
3-20 - Smoking Cessation.mp3	1.3 MB
10-20 - Persistent Neuropsychiatric Disorders After Critical.mp3	1.2 MB
1-10 - DLCO Testing.mp3	1.2 MB
10-27 - Intensive Care Unit Prognosis.mp3	1.2 MB
5-15 - Lung Cancer Risk.mp3	1.2 MB
10-23 - Approaches to Providing Best Practice.mp3	1.2 MB
7-26 - Jet Lag.mp3	1.2 MB
6-23 - Chronic Thromboembolic Pulmonary Hypertension.mp3	1.2 MB
1-27 - Genetic Predisposition.mp3	1.2 MB
5-03 - Treatment.mp3	1.2 MB
5-12 - Pathophysiology.mp3	1.2 MB
2-06 - Gastroesophageal Reflux Disease and Asthma.mp3	1.2 MB
7-31 - Treatment.mp3	1.2 MB
3-12 - Management.mp3	1.2 MB
9-16 - Epidemiology of Sepsis.mp3	1.1 MB
10-24 - Structural Measures.mp3	1.1 MB
3-31 - Hospital Discharge and Follow-Up.mp3	1.1 MB
1-12 - Pulmonary Hemorrhage Syndrome.mp3	1.1 MB
3-09 - Ongoing Monitoring.mp3	1.1 MB
1-06 - Mannitol.mp3	1.1 MB
8-27 - Neuromuscular Disease.mp3	1.1 MB
5-04 - Lymphangioleiomyomatosis.mp3	1.1 MB
4-08 - Associated Findings.mp3	1.1 MB
2-23 - Allergen Immunotherapy and Allergen Avoidance.mp3	1.1 MB
8-20 - Common Causes of Acute Respiratory Distress Syndrome.mp3	1.1 MB
4-02 - Diffuse Parenchymal Lung Disease.mp3	1.1 MB
6-20 - Screening.mp3	1.1 MB
2-13 - Management.mp3	1.1 MB
1-29 - Clinical Evaluation.mp3	1.0 MB
5-19 - Pleural Effusion.mp3	1.0 MB
10-26 - Rapid Response Team.mp3	1.0 MB
8-23 - Atelectasis.mp3	1.0 MB
5-14 - Benign Asbestosis Pleural Effusion.mp3	947.9 KB
7-28 - Obstructive Sleep Apnea.mp3	890.2 KB
8-07 - Symptoms and Diagnosis.mp3	881.9 KB
10-19 - Intensive Care Unit-Acquired Weakness.mp3	881.0 KB
1-13 - The 6-Minute Walk Test.mp3	863.9 KB
5-08 - Management.mp3	861.4 KB
3-30 - Indications for Immediate Admission to the ICU.mp3	843.8 KB
9-08 - Other Populations with Hypoxemic Respiratory Failure.mp3	793.6 KB
9-21 - Corticosteroids.mp3	786.9 KB
2-31 - Close to Session.mp3	780.6 KB
8-36 - Close to Session.mp3	761.1 KB
8-10 - Chronic Obstructive Pulmonary Disease.mp3	734.8 KB
3-33 - Close to Session.mp3	709.6 KB
9-29 - Close to Session.mp3	706.6 KB
5-01 - Intro to Session 5.mp3	669.1 KB
5-10 - Surveillance.mp3	665.3 KB
9-01 - Intro to Session 9.mp3	652.3 KB
8-01 - Intro to Session 8.mp3	641.1 KB
3-01 - Intro to Session 3.mp3	630.6 KB
6-27 - Close to Session.mp3	618.8 KB
2-01 - Intro to Session 2.mp3	616.4 KB
10-01 - Intro to Session 10.mp3	607.6 KB
7-01 - Intro to Session 7.mp3	598.0 KB
7-33 - Close to Session.mp3	577.6 KB
6-01 - Intro to Session 6.mp3	550.7 KB
4-26 - Close to Session.mp3	533.6 KB
4-01 - Intro to Session 4.mp3	529.0 KB
5-35 - Close to Session.mp3	470.2 KB
1-34 - Close to Session.mp3	444.2 KB
/Part A/Dermatology/02 Dermatology/
8-07 Erythema Multiforme, Stevens-Jo.mp3	7.9 MB
4-24 Item 037 A Woman Is Evaluated F.mp3	7.8 MB
3-08 Item 030 A Man Is Evaluated In.mp3	7.0 MB
4-17 Item 035 A Woman With Epilepsy.mp3	6.8 MB
2-13 Item 027 A Woman Is Evaluated I.mp3	6.8 MB
6-17 Item 052 A Man Presents with Sm.mp3	6.7 MB
2-06 Item 022 A Woman With Peeling S.mp3	6.6 MB
3-17 Item 034 A Woman With An Asympt.mp3	6.6 MB
6-32 Dermatomyositis.mp3	6.5 MB
7-29 Hematology-Oncology.mp3	6.4 MB
1-18 Contact Dermatitis.mp3	6.3 MB
2-10 Therapies.mp3	6.1 MB
7-28 Item 067 A Man Is Evaluated For.mp3	6.1 MB
3-03 Common Cutaneous Drug Reaction.mp3	6.0 MB
5-14 Item 045 A Woman With Recurrent.mp3	6.0 MB
1-05 Topical Corticosteroids.mp3	5.9 MB
3-10 Acne.mp3	5.8 MB
8-45 Key Points.mp3	5.7 MB
2-08 Clinical Features.mp3	5.5 MB
2-03 Treatment.mp3	5.5 MB
7-35 Key Points.mp3	5.2 MB
5-22 Item 047 A Man Whose Skin Is Ve.mp3	5.2 MB
4-05 Abscesses Furuncles And Carbunc.mp3	5.2 MB
2-02 Atopic Dermatitis.mp3	5.1 MB
4-18 Herpes Simplex Virus.mp3	5.1 MB
1-27 Stasis Dermatitis.mp3	4.6 MB
1-21 Hand Dermatitis.mp3	4.5 MB
5-29 Melanocytic And Dysplastic Nevi.mp3	4.5 MB
4-19 Evaluation Diagnosis And Treatm.mp3	4.4 MB
1-10 Item 009 A Woman Presents With.mp3	4.4 MB
8-05 HIV Infection.mp3	4.4 MB
5-33 Session Key Points.mp3	4.4 MB
1-17 Item 013 A Patient With A Sunbu.mp3	4.4 MB
2-15 Common Areas Of Involvement.mp3	4.3 MB
4-13 Tinea.mp3	4.2 MB
5-23 Malignant Melanoma.mp3	4.2 MB
5-15 Basal Cell Carcinoma.mp3	4.1 MB
6-30 Treatment.mp3	4.0 MB
1-11 Treatment Of Dermatologic Condi.mp3	4.0 MB
1-03 Emergent Skin Conditions.mp3	4.0 MB
3-06 Pigmented Purpuric Dermatoses.mp3	3.9 MB
7-32 Sweet Syndrome.mp3	3.9 MB
7-11 Calciphylaxis.mp3	3.9 MB
3-18 Rosacea.mp3	3.9 MB
4-14 Diagnosis And Treatment.mp3	3.8 MB
3-02 Drug Reactions.mp3	3.8 MB
7-03 Purpura And Cutaneous Vasculiti.mp3	3.8 MB
2-07 Psoriasis.mp3	3.8 MB
5-18 Squamous Cell Carcinoma.mp3	3.7 MB
6-09 Treatment.mp3	3.6 MB
8-26 Onychomycosis.mp3	3.5 MB
6-08 Evaluation of Patients with Itc.mp3	3.5 MB
7-30 Treatment Issues.mp3	3.5 MB
6-34 Session Key Points.mp3	3.5 MB
6-07 Pruritus.mp3	3.5 MB
1-01 Introduction To Dermatology Sec.mp3	3.5 MB
8-11 Erythroderma.mp3	3.5 MB
7-02 Livedo Reticularis.mp3	3.5 MB
3-14 Treatment Of Acne.mp3	3.4 MB
8-09 Treatment.mp3	3.4 MB
2-19 Seborrheic Dermatitis.mp3	3.4 MB
2-09 Diagnosis And Treatment.mp3	3.4 MB
1-23 Treatment.mp3	3.3 MB
4-30 Session Key Points.mp3	3.3 MB
7-25 Porphyria Cutanea Tarda.mp3	3.3 MB
5-04 Diagnosis And Treatment.mp3	3.3 MB
6-15 Treatment.mp3	3.3 MB
1-26 Diagnosis And Treatment.mp3	3.3 MB
2-14 Lichen Planus.mp3	3.3 MB
1-02 Approach To The Patient With De.mp3	3.2 MB
2-11 Common Systemic Therapies.mp3	3.2 MB
2-18 Pityriasis Rosea.mp3	3.2 MB
3-13 Common Therapies.mp3	3.2 MB
5-12 Burns.mp3	3.2 MB
4-06 Impetigo.mp3	3.1 MB
8-02 Diabetes Mellitus.mp3	3.1 MB
7-04 Causes Of Cutaneous Small Vesse.mp3	3.0 MB
3-21 Hidradenitis Suppurativa.mp3	2.9 MB
7-17 Erythema Nodosum.mp3	2.9 MB
1-07 Other Issues With Corticosteroi.mp3	2.8 MB
6-14 Chronic Urticaria.mp3	2.8 MB
2-16 Treatment.mp3	2.8 MB
4-08 Cellulitis And Erysipelas.mp3	2.8 MB
1-20 Treatment.mp3	2.7 MB
7-26 Cryoglobulinemia.mp3	2.7 MB
6-19 Recognizing an Autoimmune Bullo.mp3	2.7 MB
3-07 Miliaria.mp3	2.7 MB
7-21 Pyoderma Gangrenosum.mp3	2.6 MB
7-07 Rheumatoid Arthritis.mp3	2.6 MB
3-04 Drug-Induced Systemic Reactions.mp3	2.6 MB
6-05 Pyogenic Granulomas and Epiderm.mp3	2.6 MB
5-25 Diagnosis.mp3	2.6 MB
5-24 Other Melanomas.mp3	2.6 MB
6-20 Diagnosing an Autoimmune Bliste.mp3	2.6 MB
4-29 Molluscum Contagiosum.mp3	2.6 MB
7-18 Diagnosis And Treatment.mp3	2.6 MB
6-04 Solar Lentigines Hypertrophic S.mp3	2.5 MB
8-22 Psoriatic Nail Changes.mp3	2.5 MB
6-29 Diagnosis of Lupus Erythematosu.mp3	2.4 MB
5-17 Actinic Keratoses.mp3	2.4 MB
7-09 Pruritis.mp3	2.4 MB
5-03 Scabies Infestation.mp3	2.3 MB
8-36 Common Clinical Problems In Old.mp3	2.3 MB
3-15 Other Treatment Options.mp3	2.3 MB
4-21 Herpes Zoster.mp3	2.3 MB
1-12 Category X Drugs.mp3	2.2 MB
5-08 Spider Bites.mp3	2.2 MB
4-27 Treatment.mp3	2.2 MB
8-04 Thyroid Disease.mp3	2.2 MB
4-03 Folliculitis.mp3	2.2 MB
8-29 Oral Melanotic Macules And Lich.mp3	2.2 MB
6-12 Clinical Manifestations and Dia.mp3	2.2 MB
4-22 Treatment.mp3	2.2 MB
5-07 Bedbugs.mp3	2.1 MB
1-24 Xerotic Eczema.mp3	2.1 MB
3-09 Acantholytic Dermatosis.mp3	2.1 MB
1-15 Common Rashes.mp3	2.1 MB
7-05 Henoch-Schonlein Purpura.mp3	2.1 MB
5-10 Cuts And Scrapes.mp3	2.1 MB
2-20 Session Key Points.mp3	2.1 MB
2-04 Eczema Herpeticum.mp3	2.1 MB
3-22 Session Key Points.mp3	2.1 MB
5-06 Lice.mp3	2.0 MB
6-27 Subacute Cutaneous Lupus Erythe.mp3	2.0 MB
7-13 Nephrogenic Systemic Fibrosis.mp3	2.0 MB
4-09 Noninfectious Conditions That R.mp3	2.0 MB
3-20 Vascular Rosacea.mp3	2.0 MB
6-24 Disease Associations.mp3	2.0 MB
7-34 Endocrinology.mp3	2.0 MB
4-11 Erythrasma.mp3	2.0 MB
5-26 Treatment.mp3	1.9 MB
6-02 Neurofibromas and Acrochordons.mp3	1.9 MB
4-25 Warts.mp3	1.9 MB
6-18 Autoimmune Bullous Diseases.mp3	1.9 MB
4-26 CDC Guidelines.mp3	1.9 MB
8-20 Lichen Planopilaris And Lupus.mp3	1.9 MB
8-17 Alopecia Areata.mp3	1.8 MB
7-15 Sarcoidosis.mp3	1.8 MB
8-35 Skin In Aging Populations.mp3	1.8 MB
3-11 Testing.mp3	1.8 MB
8-08 Diagnosis.mp3	1.8 MB
6-13 Classification of Urticaria.mp3	1.7 MB
8-15 Metabolic Imbalance And Medicat.mp3	1.7 MB
1-19 Epicutaneous Patch Testing.mp3	1.7 MB
8-24 Melanonychia And Subungual Mela.mp3	1.7 MB
6-28 Chronic Cutaneous Lupus Erythem.mp3	1.7 MB
8-40 Postinflammatory Hypo- Or Hyper.mp3	1.7 MB
7-14 Cutaneous Malignancies Followin.mp3	1.6 MB
8-25 Beau Lines And Median Nail Dyst.mp3	1.6 MB
1-06 Dosing Corticosteroids.mp3	1.6 MB
1-16 Eczematous Dermatoses.mp3	1.6 MB
6-03 Cherry Hemangiomas and Dermatof.mp3	1.6 MB
1-25 Nummular Dermatitis.mp3	1.5 MB
5-31 Halo Nevi.mp3	1.5 MB
8-18 Telogen Effluvium.mp3	1.5 MB
1-28 Session Key Points.mp3	1.4 MB
8-33 Squamous Cell Carcinoma And Ora.mp3	1.4 MB
4-16 Candidiasis.mp3	1.4 MB
8-19 Traction Alopecia And Central C.mp3	1.4 MB
8-31 Leukoplakia And Erythroplakia.mp3	1.4 MB
3-12 Acne Fulminans.mp3	1.4 MB
7-22 Treatment.mp3	1.4 MB
7-24 End-Stage Liver Disease.mp3	1.4 MB
6-33 Treatment.mp3	1.4 MB
8-12 Diagnosis.mp3	1.4 MB
5-28 Seborrheic Keratoses.mp3	1.3 MB
5-32 Sebaceous Hyperplasia.mp3	1.3 MB
6-22 Treatment of Autoimmune Blister.mp3	1.3 MB
4-12 Keratolysis.mp3	1.3 MB
5-02 Stings And Bites.mp3	1.2 MB
8-43 Dermatosis Papulosa Nigra And S.mp3	1.2 MB
1-08 Combination Products.mp3	1.2 MB
1-13 Antihistamines And Other Drugs.mp3	1.2 MB
6-25 Lupus Erythematosus.mp3	1.2 MB
8-32 Actinic Cheilitis And Black Hai.mp3	1.2 MB
8-46 Close To Section.mp3	1.2 MB
8-13 Treatment.mp3	1.2 MB
6-26 Acute Lupus.mp3	1.2 MB
5-20 Keratoacanthoma.mp3	1.2 MB
8-42 Pseudofollicular Barbae And Acn.mp3	1.2 MB
8-30 Aphthous Ulcers.mp3	1.1 MB
3-19 Periorificial Dermatitis.mp3	1.1 MB
7-06 Key Points.mp3	1.1 MB
6-11 Causes of Urticaria.mp3	1.1 MB
1-22 Autoeczematization.mp3	1.1 MB
5-05 Key Points.mp3	1.1 MB
7-27 Key Points.mp3	1.1 MB
8-10 Key Points.mp3	1.0 MB
8-16 Androgenetic Alopecia.mp3	1.0 MB
8-44 Vitiligo.mp3	980.0 KB
8-41 Keloids.mp3	974.2 KB
5-16 Key Points.mp3	928.2 KB
2-21 Untitled.mp3	921.5 KB
8-23 Lichen Planus.mp3	895.6 KB
7-19 Inflammatory Bowel Disease.mp3	891.4 KB
6-16 Key Points.mp3	891.4 KB
2-01 Intro To Session.mp3	868.0 KB
4-20 Key Points.mp3	867.2 KB
8-38 Key Points.mp3	866.8 KB
8-14 Key Points.mp3	851.3 KB
8-06 Key Points.mp3	837.5 KB
3-23 Close To Session.mp3	822.5 KB
2-12 Key Points.mp3	822.0 KB
8-39 Dermatologic Diseases Of Skin O.mp3	813.3 KB
3-16 Key Points.mp3	796.1 KB
8-37 Care Of Aged Skin.mp3	789.4 KB
6-06 Lipomas.mp3	783.2 KB
2-17 Key Points.mp3	778.2 KB
6-31 Key Points.mp3	773.6 KB
1-29 Untitled.mp3	773.2 KB
3-01 Intro To Session.mp3	746.0 KB
5-34 Close To Session.mp3	722.6 KB
5-01 Intro To Session.mp3	705.0 KB
8-27 Onychomycosis.mp3	702.5 KB
2-05 Key Points.mp3	700.0 KB
3-05 Key Points.mp3	696.2 KB
7-33 Key Points.mp3	693.3 KB
6-10 Key Points.mp3	684.9 KB
8-28 Key Points.mp3	681.6 KB
7-36 Close To Session.mp3	660.3 KB
7-23 Key Points.mp3	646.9 KB
4-15 Key Points.mp3	646.5 KB
5-19 Key Points.mp3	645.2 KB
4-23 Key Points.mp3	640.6 KB
7-01 Intro To Session.mp3	628.1 KB
4-02 Bacterial Skin Infections.mp3	624.0 KB
6-35 Close to Session.mp3	609.3 KB
6-21 Key Points.mp3	607.6 KB
8-21 Key Points.mp3	607.2 KB
4-10 Key Points.mp3	588.4 KB
8-01 Intro To Session.mp3	584.2 KB
1-09 Key Points.mp3	570.5 KB
1-14 Key Points.mp3	565.5 KB
8-34 Key Points.mp3	565.0 KB
1-04 Key Points.mp3	553.0 KB
5-09 Key Points.mp3	528.2 KB
7-31 Key Points.mp3	523.6 KB
6-23 Key Points.mp3	518.6 KB
7-16 Key Points.mp3	515.3 KB
6-01 Intro to Session.mp3	505.2 KB
7-20 Key Points.mp3	497.3 KB
4-31 Close To Session.mp3	496.9 KB
4-04 Key Points.mp3	495.6 KB
5-27 Key Points.mp3	490.6 KB
4-01 Intro To Session.mp3	485.2 KB
8-03 Key Points.mp3	485.2 KB
5-21 Key Points.mp3	476.0 KB
4-28 Key Points.mp3	459.2 KB
7-12 Key Points.mp3	448.0 KB
5-13 Key Points.mp3	438.3 KB
7-08 Key Points.mp3	431.7 KB
5-30 Key Point.mp3	380.3 KB
5-11 Key Points.mp3	373.6 KB
4-07 Key Points.mp3	335.9 KB
7-10 Key Point.mp3	304.6 KB
/Part B/Endocrinology/07 Endocrinology/
2-09 Evaluation And Management.mp3	7.6 MB
6-09 - Item 029 A Man with Recurrent Palpitations, Sweating,.mp3	6.0 MB
1-22 Pharmacologic Agents.mp3	6.0 MB
1-11 Item 004 A Woman With Nonpainfu.mp3	5.8 MB
2-19 Diabetic Nephropathy.mp3	5.6 MB
2-10 Item 008 A Woman With Graves Di.mp3	5.5 MB
8-04 Evaluation.mp3	5.4 MB
7-09 - Evaluation and Treatment of Parathyroid Hormone-Media.mp3	5.3 MB
5-04 - Thyroid Cancer.mp3	5.3 MB
4-08 - Item 019 A Woman with Three Episodes of Severe Hypogl.mp3	5.2 MB
4-15 - Item 021 A Man is Evaluated for Loss of Strength and .mp3	5.2 MB
4-19 - Diagnosing Hypothyroidism.mp3	5.2 MB
6-15 - Item 036 A Man is Evaluated for Perioral Paresthesias.mp3	5.1 MB
4-03 - Evaluation of Thyroid Function.mp3	4.9 MB
3-18 - Item 016 A Woman is Evaluated for Muscle Cramps and D.mp3	4.9 MB
1-15 Item 007 A Woman With Irregular.mp3	4.8 MB
7-02 - Hirsutism and Polycystic Ovary Syndrome.mp3	4.8 MB
5-18 - Clinical Features.mp3	4.7 MB
1-10 Prediction And Prevention Of Ty.mp3	4.7 MB
2-15 Item 011 A 15-Year-Old Girl Is.mp3	4.7 MB
6-05 - Treatment.mp3	4.6 MB
5-14 - Item 025 A Woman with a History of Hypertension and C.mp3	4.6 MB
6-16 - Testosterone Replacement Therapy.mp3	4.6 MB
4-13 - Toxic Multinodular Goiter and Toxic Adenoma.mp3	4.5 MB
6-14 - Diagnosis and Evaluation of Male Hypogonadism.mp3	4.5 MB
5-06 - Thyroid Function and Disease in Pregnancy.mp3	4.5 MB
6-24 - Session Key Points.mp3	4.5 MB
8-11 Teriparatide.mp3	4.5 MB
5-09 - Myxedema Coma.mp3	4.5 MB
6-04 - Diagnosis.mp3	4.3 MB
3-10 - Item 015 A Woman with Fatigue, Lethargy, Constipation.mp3	4.3 MB
3-17 - Diagnosis and Management.mp3	4.3 MB
8-02 Epidemiology And Physiology Of.mp3	4.3 MB
2-13 Four Hypoglycemic Situations.mp3	4.3 MB
5-08 - Item 022 Managing a Woman with Osteoporosis Discovere.mp3	4.2 MB
4-14 - Destructive Thyroiditis.mp3	4.1 MB
2-06 Oral Agents.mp3	3.9 MB
2-21 Acute Mononeuropathies And Diab.mp3	3.8 MB
1-09 Overview Of Type 2 Diabetes.mp3	3.8 MB
3-03 Fasting Hypoglycemia.mp3	3.7 MB
1-05 Diagnostic Criteria For Diabete.mp3	3.7 MB
5-16 - Adrenal Function During Critical Illness.mp3	3.6 MB
5-07 - Thyroid Storm.mp3	3.6 MB
8-07 Antiosteoporosis Pharmacologic.mp3	3.6 MB
6-08 - Goals of Therapy.mp3	3.6 MB
7-06 - Calcium Homeostasis.mp3	3.6 MB
2-17 Management Of Diabetic Retinopa.mp3	3.6 MB
2-07 Diabetic Ketoacidosis And Hyper.mp3	3.5 MB
5-20 - Treatment.mp3	3.4 MB
6-19 - Gynecomastia.mp3	3.4 MB
3-28 - Causes and Diagnosis of Acromegaly.mp3	3.4 MB
7-12 - Malignancy-Associated Hypercalcemia.mp3	3.4 MB
3-23 - Causes of Hyperprolactinemia and Prolactinomas.mp3	3.4 MB
2-03 Pharmacokinetic Properties Of I.mp3	3.3 MB
1-01 Introduction To Endocrinology S.mp3	3.3 MB
7-08 - Causes and Diagnosis of Hypercalcemia.mp3	3.3 MB
6-06 - Primary Hyperaldosteronism.mp3	3.3 MB
5-24 - Session Key Points.mp3	3.3 MB
7-17 - Treatment of Hypocalcemia.mp3	3.2 MB
1-19 Cardiovascular Risk.mp3	3.2 MB
2-20 Diabetic Neuropathy.mp3	3.2 MB
1-17 The Hemoglobin A1c Test.mp3	3.2 MB
7-18 - Session Key Points.mp3	3.2 MB
4-21 - Thyroid Nodules.mp3	3.2 MB
7-13 - Treatment of Acute Hypercalcemia.mp3	3.2 MB
5-21 - Adrenal Incidentaloma.mp3	3.2 MB
3-33 - Session Key Points.mp3	3.1 MB
2-18 Treatment Of Advanced Diabetic.mp3	3.1 MB
3-29 - Treatment.mp3	3.1 MB
1-18 Hemoglobin A1c Target.mp3	3.1 MB
6-22 - Secondary Amenorrhea.mp3	3.1 MB
6-10 - Adrenocortical Cancer.mp3	3.1 MB
7-03 - Treatment.mp3	3.0 MB
1-16 Glycemic Monitoring.mp3	3.0 MB
5-13 - Diagnosis.mp3	3.0 MB
4-22 - Thyroid Ultrasonography.mp3	3.0 MB
2-04 Insulin Dosing.mp3	2.9 MB
1-20 Other Considerations For Loweri.mp3	2.9 MB
5-17 - Cushing Syndrome.mp3	2.9 MB
6-07 - Diagnosis.mp3	2.9 MB
2-02 Insulin Therapy For Diabetes.mp3	2.9 MB
8-12 Osteomalacia.mp3	2.9 MB
4-16 - Drug-Induced Thyrotoxicosis.mp3	2.8 MB
5-19 - Imaging Studies.mp3	2.8 MB
6-23 - Diagnosis and Evaluation of Amenorrhea.mp3	2.8 MB
4-02 - Thyroid Physiology.mp3	2.8 MB
2-22 Session Key Points.mp3	2.7 MB
2-11 Hypoglycemia.mp3	2.7 MB
5-23 - Management.mp3	2.7 MB
4-10 - Treatment.mp3	2.7 MB
4-11 - Antithyroid Drug Adverse Effects.mp3	2.6 MB
5-15 - Treatment of Adrenal Insufficiency.mp3	2.6 MB
7-07 - Clinical Manifestations of Hypercalcemia.mp3	2.6 MB
3-26 - Adverse Effects of Dopamine Agonists.mp3	2.6 MB
3-15 - Thyroid-Stimulating Hormone Deficiency.mp3	2.6 MB
3-22 - Treatment of Pituitary Tumors.mp3	2.6 MB
3-25 - Medical Therapies for Pituitary Adenomas.mp3	2.6 MB
6-20 - Physiology of Female Reproduction.mp3	2.6 MB
4-09 - Graves Disease.mp3	2.6 MB
4-23 - The Bethesda Classification System.mp3	2.5 MB
4-24 - Session Key Points.mp3	2.5 MB
6-13 - Primary and Secondary Hypogonadism.mp3	2.5 MB
7-14 - Diagnosis of Hypocalcemia.mp3	2.5 MB
1-02 Classification And Diagnosis Of.mp3	2.4 MB
7-16 - Causes of Hypocalcemia.mp3	2.4 MB
4-04 - Thyroglobulin.mp3	2.4 MB
2-05 Inpatient Management Of Hypergl.mp3	2.3 MB
7-10 - Familial Forms of Hyperparathyroidism.mp3	2.3 MB
1-06 Presentation Of Type 1 Diabetes.mp3	2.3 MB
1-23 Session Key Points.mp3	2.3 MB
5-05 - Effects of Nonthyroidal Illness on Thyroid Function T.mp3	2.3 MB
8-13 Vitamin D Deficiency.mp3	2.3 MB
8-14 Clinical Features And Evaluatio.mp3	2.3 MB
4-20 - Subclinical Hypothyroidism.mp3	2.2 MB
3-16 - Diabetes Insipidus.mp3	2.2 MB
1-04 Screening For Diabetes.mp3	2.2 MB
3-08 - Pituitary Tumor Apoplexy.mp3	2.2 MB
5-10 - Physiologic Regulation of Adrenal Function.mp3	2.2 MB
2-12 Situations In Which Hypoglycemi.mp3	2.2 MB
5-22 - Testing.mp3	2.2 MB
8-08 Complications.mp3	2.2 MB
4-07 - Classic Test Result Patterns in Thyrotoxicosis.mp3	2.1 MB
3-14 - Adrenocorticotropic Hormone Deficiency.mp3	2.1 MB
3-31 - Incidentalomas.mp3	2.1 MB
1-21 Nonpharmacologic Approaches.mp3	2.1 MB
1-13 Treatment Of Gestational Diabet.mp3	2.0 MB
1-12 Gestational Diabetes.mp3	2.0 MB
6-12 - Physiology of Male Reproduction.mp3	2.0 MB
3-30 - Clinically Nonfunctioning and Gonadotropin-Producing .mp3	2.0 MB
7-15 - Differential Diagnosis of Hypocalcemia.mp3	2.0 MB
8-10 Denosumab.mp3	2.0 MB
3-05 - Hypothalamic Disease.mp3	1.9 MB
1-07 Onset Of Beta Cell Destruction.mp3	1.9 MB
3-27 - Pregnancy in a Patient with a Prolactinoma.mp3	1.9 MB
3-24 - Clinical Features of Hyperprolactinemia and Prolactin.mp3	1.9 MB
3-02 Hypoglycemia in Patients Without Diabetes.mp3	1.9 MB
6-03 - Clinical Manifestations.mp3	1.8 MB
5-11 - Adrenal Insufficiency.mp3	1.8 MB
8-09 Raloxifene.mp3	1.8 MB
5-12 - Causes of Adrenal Insufficiency.mp3	1.8 MB
8-06 Prevention Of Osteoporosis And.mp3	1.7 MB
5-02 - Multinodular Goiter.mp3	1.7 MB
7-05 - Female Infertility.mp3	1.7 MB
4-18 - Hypothyroidism.mp3	1.7 MB
4-17 - Subclinical Hyperthyroidism.mp3	1.7 MB
3-20 - Approach to a Sellar Mass.mp3	1.7 MB
2-14 Barriers To Achieving Tight Glu.mp3	1.6 MB
3-12 - Growth Hormone Replacement Therapy.mp3	1.6 MB
3-19 - Pituitary Tumors.mp3	1.6 MB
6-02 - Pheochromocytoma.mp3	1.6 MB
4-05 - The Radioactive Iodine Uptake Test.mp3	1.6 MB
3-06 - Causes of Acquired Hypothalamic Disease.mp3	1.6 MB
3-07 - Causes and General Management of Hypopituitarism.mp3	1.5 MB
2-08 Symptoms of Severe Hyperglycemia.mp3	1.5 MB
4-06 - Thyrotoxicosis.mp3	1.5 MB
8-03 Risk Factors For Low Bone Mass.mp3	1.5 MB
2-16 Diabetic Retinopathy.mp3	1.5 MB
6-17 - Anabolic Steroid Abuse in Men.mp3	1.5 MB
1-03 Insulin Resistance.mp3	1.4 MB
3-11 - Growth Hormone Deficiency.mp3	1.4 MB
3-04 - Postprandial Hypoglycemia.mp3	1.4 MB
5-03 - Simple Goiter.mp3	1.4 MB
6-21 - Primary Amenorrhea.mp3	1.3 MB
3-13 - Gonadotropin Deficiency.mp3	1.3 MB
3-09 - Management.mp3	1.3 MB
8-05 Prediction Of Fracture Risk.mp3	1.3 MB
4-12 - Management.mp3	1.3 MB
3-32 - Thyroid-Stimulating Hormone-Secreting Tumors.mp3	1.3 MB
1-14 Other Types Of Diabetes.mp3	1.2 MB
3-21 - Mass Effects of Pituitary Tumors.mp3	1.2 MB
8-15 Treatment.mp3	1.2 MB
6-11 - Basic Concepts and Common Features of Reproductive Di.mp3	1.2 MB
8-16 Session Key Points.mp3	1.2 MB
8-17 Close To Section.mp3	1.0 MB
1-08 Diabetic Ketoacidosis.mp3	958.6 KB
7-11 - Causes and Diagnosis of Nonparathyroid Hormone-Mediat.mp3	944.0 KB
2-23 Close To Session.mp3	807.3 KB
3-34 - Close to Session.mp3	702.5 KB
7-04 - Anabolic Steroid Abuse in Women.mp3	694.8 KB
6-18 - Male Infertility.mp3	679.4 KB
5-01 - Intro to Session 5.mp3	634.9 KB
6-25 - Close to Session.mp3	618.8 KB
3-01 Intro to Session 3.mp3	611.4 KB
2-01 Intro To Session 2.mp3	610.0 KB
7-01 - Intro to Session 7.mp3	603.3 KB
7-19 - Close to Session.mp3	571.9 KB
6-01 - Intro to Session 6.mp3	554.0 KB
4-01 - Intro to Session 4.mp3	539.6 KB
4-25 - Close to Session.mp3	532.5 KB
8-01 Intro To Session 8.mp3	528.9 KB
5-25 - Close to Session.mp3	464.4 KB
1-24 Close To Session.mp3	450.8 KB
Thumbs.db	16.4 KB
Folder.jpg	11.0 KB
AlbumArtSmall.jpg	2.8 KB
/Part A/Hematology/04a Hematology/
2-02 Polycythemia Vera.mp3	7.5 MB
7-33 Session Key Points.mp3	7.0 MB
2-03 Diagnosis And Treatment Of PV.mp3	6.6 MB
1-23 The International Prognostic Sc.mp3	6.5 MB
7-10 Normal Platelet Physiology.mp3	6.3 MB
2-22 Acute Lymphoblastic Leukemia.mp3	6.3 MB
1-03 Aplastic Anemia.mp3	6.2 MB
3-26 Approach To Anemia.mp3	6.1 MB
4-06 Cobalamin Deficiency.mp3	6.0 MB
4-23 Thalassemia.mp3	5.9 MB
3-04 Hematopoietic Stem Cell Transpl.mp3	5.9 MB
2-05 Essential Thrombocythemia.mp3	5.7 MB
4-25 Session Key Points.mp3	5.6 MB
4-02 Iron Deficiency.mp3	5.6 MB
7-12 Immune Thrombocytopenic Purpura.mp3	5.6 MB
8-21 Treatment.mp3	5.5 MB
2-15 Acute Myeloid Leukemia.mp3	5.5 MB
8-36 Session Key Points.mp3	5.4 MB
3-15 Side Effects.mp3	5.3 MB
6-38 Session Key Points.mp3	5.2 MB
6-37 Von Willebrand Disease.mp3	5.1 MB
8-04 Antiphospholipid Syndrome.mp3	5.0 MB
5-27 Paroxysmal Nocturnal Hemoglobin.mp3	4.9 MB
8-34 Thrombophilia and Venous.mp3	4.7 MB
3-27 Session Key Points.mp3	4.7 MB
6-10 Item 068 A 67-Year-Old Man With.mp3	4.6 MB
5-33 Session Key Points.mp3	4.5 MB
5-25 Microangiopathic Hemolytic Anem.mp3	4.4 MB
5-29 Hemochromatosis.mp3	4.3 MB
4-09 Item 037 Woman Is Evaluated In.mp3	4.3 MB
1-19 Item 013 Diagnosing Lenalidomid.mp3	4.3 MB
2-17 Item 015 Diagnosing All-Trans-R.mp3	4.3 MB
7-16 Heparin-Induced Thrombocytopeni.mp3	4.2 MB
2-23 Session Key Points.mp3	4.2 MB
5-24 Item 059 A Man Is Evaluated For.mp3	4.1 MB
4-19 Hereditary Spherocytosis.mp3	4.1 MB
6-02 Erythrocytes.mp3	4.0 MB
5-30 Evaluation For Hemochromatosis.mp3	4.0 MB
3-08 Clinical Manifestations And Fin.mp3	3.9 MB
2-18 Treating Patients With AML.mp3	3.9 MB
4-17 Hemolytic Anemias.mp3	3.9 MB
4-10 Folate Deficiency.mp3	3.8 MB
4-12 Inflammatory Anemia.mp3	3.8 MB
3-02 Hematopoietic Growth Factors.mp3	3.8 MB
2-12 Primary Myelofibrosis.mp3	3.8 MB
7-17 Diagnosing And Treatment.mp3	3.8 MB
4-21 Glucose-6-Phosphate Dehydrogena.mp3	3.7 MB
1-20 The Myelodysplastic Syndromes.mp3	3.7 MB
7-28 Factor V Leiden.mp3	3.7 MB
1-01 Introduction To Hematology Sect.mp3	3.7 MB
4-03 Mild Iron Deficiency Symptoms.mp3	3.7 MB
8-15 Fondaparinux and Warfarin.mp3	3.7 MB
2-08 Item 014 Diagnosing Transfusion.mp3	3.7 MB
6-24 Item 074 A 72-Year-Old Man Is E.mp3	3.6 MB
7-19 Thrombotic Thrombocytopenic Pur.mp3	3.5 MB
7-20 Treatment Of TTP.mp3	3.5 MB
6-28 Evaluation Of Patients With Sus.mp3	3.5 MB
2-09 Chronic Myeloid Leukemia.mp3	3.5 MB
3-12 Diagnosis And Prognosis.mp3	3.5 MB
5-02 Sickle Cell Syndrome.mp3	3.3 MB
3-18 Monoclonal Gammopathy Of Undete.mp3	3.3 MB
1-15 Other Neutropenia Concerns.mp3	3.3 MB
3-24 Waldenstroms Macroglobulinemia.mp3	3.2 MB
1-13 Neutropenia.mp3	3.2 MB
1-09 Item 004 Managing A Patient Wit.mp3	3.2 MB
4-04 Treatment For Iron Deficiency.mp3	3.2 MB
5-18 Warm Autoimmune Hemolytic Anemi.mp3	3.2 MB
2-19 Induction Chemotherapy.mp3	3.1 MB
4-14 Anemia Of Kidney Disease.mp3	3.1 MB
3-11 Item 016 Managing A Patient Wit.mp3	3.1 MB
8-28 Sickle Cell Disease.mp3	3.0 MB
3-22 Diagnosis And Treatment Of AL A.mp3	3.0 MB
4-24 Beta Thalassemia.mp3	3.0 MB
5-19 Cold Agglutinin Disease.mp3	3.0 MB
3-20 Item 020 Performing Thrombophil.mp3	2.9 MB
3-09 Other Causes Of Renal Impairmen.mp3	2.9 MB
8-08 Thrombophilia Testing.mp3	2.8 MB
1-11 Large Granular Lymphocytosis.mp3	2.8 MB
2-16 Classification Of AML.mp3	2.8 MB
1-10 Pure Red Cell Aplasia.mp3	2.7 MB
2-13 Treatment Of Primary Myelofibro.mp3	2.7 MB
8-31 Immune Thrombocytopenic Purpura.mp3	2.7 MB
2-10 Treatment Of CML.mp3	2.6 MB
3-16 Bisphosphonate-Induced Osteonec.mp3	2.6 MB
5-04 Management Of Sickle Cell Disea.mp3	2.6 MB
2-06 Treatment Of ET.mp3	2.6 MB
4-07 Pernicious Anemia.mp3	2.6 MB
4-16 Item 042 A Pregnant Woman Is In.mp3	2.5 MB
5-20 Treating Cold Agglutinin Diseas.mp3	2.5 MB
6-07 Clinical Transfusion Issues.mp3	2.5 MB
8-18 Prevention of DVT.mp3	2.5 MB
1-07 Appropriate Supportive Care.mp3	2.5 MB
8-32 Microangiopathy of Pregnancy.mp3	2.5 MB
5-05 Pain.mp3	2.5 MB
6-25 Therapeutic Apheresis.mp3	2.5 MB
8-02 Acquired Thrombophilic Conditions.mp3	2.5 MB
3-21 Immunoglobulin Light-Chain Amyl.mp3	2.4 MB
6-27 Overview Of Bleeding Disorders.mp3	2.4 MB
1-06 Treating Patients With Aplastic.mp3	2.4 MB
5-12 Erythrocyte Transfusion In Sick.mp3	2.4 MB
1-25 Session Key Points.mp3	2.4 MB
2-20 Acute Promyelocytic Leukemia.mp3	2.4 MB
7-02 Acquired Hemophilia.mp3	2.3 MB
8-24 Gestational Anemia.mp3	2.3 MB
6-05 Strategies To Minimize Allogene.mp3	2.3 MB
6-11 Fresh Frozen Plasma.mp3	2.2 MB
8-19 Mechanical Prophylaxis.mp3	2.2 MB
1-05 PNH Clones.mp3	2.2 MB
1-04 Other Causes Of Pancytopenia.mp3	2.2 MB
5-07 Acute Chest Syndrome.mp3	2.2 MB
7-30 Antithrombin Deficiency.mp3	2.2 MB
7-31 Protein C And Protein S Deficie.mp3	2.1 MB
6-35 Hemophilia A And B.mp3	2.1 MB
8-35 Diagnosis and Management.mp3	2.1 MB
7-04 Coagulopathy Of Liver Disease.mp3	2.1 MB
8-10 Diagnosis of DVT and Pulmonary Embolism.mp3	2.1 MB
8-16 Warfarin Management.mp3	2.1 MB
6-23 Key Points.mp3	2.0 MB
1-22 Classification Of Myelodysplast.mp3	2.0 MB
8-13 Unfractionated Heparin.mp3	2.0 MB
6-32 Mixing Studies.mp3	2.0 MB
8-25 Iron Deficiency.mp3	2.0 MB
7-23 Qualitative Platelet Disorders.mp3	2.0 MB
5-15 Item 053 A Woman Is Evaluated F.mp3	2.0 MB
1-14 Pharmacologic Causes Of Neutrop.mp3	1.9 MB
3-14 Treatment.mp3	1.9 MB
6-03 Clinical Transfusion Issues.mp3	1.9 MB
7-08 Vitamin K Deficiency.mp3	1.9 MB
6-30 The Prothrombin Time And The Ac.mp3	1.9 MB
6-18 Transfusion-Related Acute Lung.mp3	1.8 MB
8-37 Close to Section.mp3	1.8 MB
1-24 Chronic Myelomonocytic Leukemia.mp3	1.8 MB
5-03 Differentiating Among The Sickl.mp3	1.8 MB
8-03 Cancer as an Acquired Thrombophilic Condition.mp3	1.8 MB
5-13 Other Hemoglobinopathies.mp3	1.7 MB
6-16 Delayed Hemolytic Transfusion R.mp3	1.7 MB
5-06 Stroke.mp3	1.7 MB
7-25 Acquired Platelet Dysfunction.mp3	1.7 MB
1-02 Hematopoietic Stem Cells And Th.mp3	1.6 MB
7-06 Disseminated Intravascular Coag.mp3	1.6 MB
5-14 Key Points.mp3	1.5 MB
5-22 Drug-Induced Autoimmune Hemolyt.mp3	1.5 MB
6-15 Acute Hemolytic Transfusion Rea.mp3	1.5 MB
6-20 Allergic Reactions And Anaphyla.mp3	1.5 MB
5-08 Pulmonary Hypertension.mp3	1.4 MB
8-12 Use of Anticoagulants.mp3	1.4 MB
1-21 Sideroblastic Anemia.mp3	1.4 MB
3-01 Introduction To Session.mp3	1.3 MB
4-08 Key Points.mp3	1.2 MB
6-22 Infectious Complications.mp3	1.2 MB
7-27 Pathophysiology Of Thrombosis A.mp3	1.2 MB
6-12 Cryoprecipitate.mp3	1.2 MB
6-33 Other Assays.mp3	1.2 MB
8-22 Superficial Vein Thrombophlebitis.mp3	1.2 MB
8-07 Key Points.mp3	1.2 MB
7-29 Prothrombin G20210a Gene Mutati.mp3	1.2 MB
6-04 Preparation.mp3	1.2 MB
8-14 Low-Molecular-Weight Heparin.mp3	1.1 MB
5-17 Autoimmune Hemolytic Anemia.mp3	1.1 MB
7-18 Key Points.mp3	1.1 MB
7-11 Key Points.mp3	1.1 MB
6-21 Transfusion-Associated Graft-Ve.mp3	1.0 MB
6-19 Febrile Nonhemolytic Transfusio.mp3	1.0 MB
5-32 Secondary Iron Overload.mp3	1.0 MB
6-17 Nonhemolytic Reactions.mp3	992.6 KB
2-07 Key Points.mp3	988.8 KB
7-14 Drug-Induced Immune Thrombocyto.mp3	985.9 KB
5-11 Severe Acute Anemia.mp3	978.0 KB
7-13 Key Points.mp3	977.5 KB
6-34 Key Points.mp3	948.3 KB
8-06 Other Acquired Thrombophilic Disorders.mp3	947.2 KB
8-33 Key Points.mp3	944.6 KB
5-28 Key Points.mp3	926.9 KB
7-32 Dysfibrinogenemia.mp3	922.4 KB
2-04 Key Points.mp3	921.5 KB
5-09 Priapism.mp3	914.4 KB
3-06 Multiple Myeloma And Related Di.mp3	910.7 KB
8-29 Key Points.mp3	901.2 KB
7-22 Other Thrombocytopenias Due To.mp3	881.5 KB
7-24 Key Points.mp3	880.6 KB
3-17 Key Points.mp3	879.3 KB
2-21 Key Points.mp3	871.4 KB
6-29 Laboratory Evaluation.mp3	867.2 KB
3-25 Key Points.mp3	855.9 KB
4-22 Key Points.mp3	849.6 KB
2-11 Key Points.mp3	847.5 KB
6-13 Other Plasma-Derived Transfusio.mp3	843.8 KB
3-07 Multiple Myeloma.mp3	843.8 KB
1-08 Key Points.mp3	830.8 KB
1-17 Thrombocytopenia.mp3	827.1 KB
4-11 Key Points.mp3	821.6 KB
8-05 Catastrophic Antiphospholipid Syndrome.mp3	815.9 KB
6-09 Key Points.mp3	813.7 KB
8-30 Gestational Thrombocytopenia.mp3	799.6 KB
6-06 Platelet Transfusion.mp3	791.5 KB
7-21 Key Points.mp3	788.6 KB
4-05 Key Points.mp3	786.9 KB
3-19 Key Points.mp3	765.2 KB
8-23 Key Points.mp3	754.5 KB
5-26 Key Points.mp3	746.0 KB
8-27 Key Points.mp3	735.6 KB
3-05 Key Points.mp3	730.1 KB
6-31 The Thrombin Clotting Time.mp3	726.9 KB
6-08 Platelet Transfusion Refractori.mp3	726.8 KB
8-26 Folate Deficiency.mp3	721.0 KB
3-23 Key Points.mp3	698.3 KB
1-16 Key Points.mp3	674.9 KB
1-26 Close To Session.mp3	670.7 KB
3-03 Key Points.mp3	664.5 KB
5-10 Infection.mp3	661.5 KB
7-01 Introduction To Session.mp3	660.7 KB
8-01 Introduction to Session.mp3	660.4 KB
7-05 Key Points.mp3	656.9 KB
3-28 Close To Session.mp3	656.5 KB
5-34 Close To Session.mp3	651.9 KB
8-17 Key Points.mp3	650.8 KB
2-24 Close To Session.mp3	649.8 KB
4-26 Close To Session.mp3	649.4 KB
6-39 Close To Session.mp3	647.3 KB
7-34 Close To Session.mp3	647.3 KB
3-13 Key Points.mp3	641.9 KB
5-31 Key Points.mp3	636.0 KB
1-12 Key Points.mp3	623.9 KB
6-14 Key Points.mp3	621.4 KB
6-01 Introduction To Session.mp3	620.2 KB
3-10 Key Points.mp3	619.7 KB
7-26 Key Points.mp3	617.2 KB
4-01 Introduction To Session.mp3	613.1 KB
5-01 Introduction To Session.mp3	611.4 KB
2-14 Key Points.mp3	608.9 KB
4-18 Key Points.mp3	599.3 KB
7-03 Key Points.mp3	579.2 KB
5-16 Acquired Hemolytic Anemias Over.mp3	561.3 KB
8-09 Key Points.mp3	555.5 KB
4-20 Key Points.mp3	555.0 KB
4-15 Key Points.mp3	555.0 KB
6-26 Key Points.mp3	518.2 KB
8-20 Key Points.mp3	514.1 KB
4-13 Key Points.mp3	493.5 KB
6-36 Key Points.mp3	454.2 KB
2-01 Introduction To Session.mp3	438.4 KB
7-09 Key Point.mp3	400.3 KB
7-07 Key Point.mp3	364.4 KB
5-23 Key Point.mp3	323.8 KB
8-11 Key Point.mp3	304.7 KB
7-15 Key Point.mp3	273.3 KB
1-18 Key Points.mp3	257.0 KB
5-21 Key Point.mp3	220.2 KB
/.../08 General Internal_/
4-17 - Item 046 A 94-Year-Old Woman with Progressive Weaknes.mp3	7.3 MB
6-09 - Item 070 A 68-Year-Old Man is Evaluated for Continuin.mp3	6.5 MB
2-17 - Item 012 Identifying the Source of a Diagnostic Error.mp3	5.9 MB
5-09 - Item 052 A 75-Year-Old Woman with Recently Diagnosed .mp3	5.8 MB
3-20 - Nonopioid Medical Therapies.mp3	5.7 MB
10-15 Perioperative Management of Li.mp3	5.5 MB
3-10 - Item 022 A 56-Year-Old Woman with Symmetric Bilateral.mp3	5.5 MB
4-11 - Initiating Pharmacologic Treatment.mp3	5.4 MB
2-06 - Tobacco Use Disorder.mp3	5.2 MB
1-08 - Item 003 A 40 Year Old Nurse with Obsessive-Compulsiv.mp3	5.1 MB
5-19 - Item 053 A 42-Year-Old Woman with a 6-Month History o.mp3	5.1 MB
2-10 - Item 010 A 46-Year-Old Patient Asks You for Help with.mp3	5.0 MB
6-26 - Session Key Points.mp3	4.9 MB
8-21 - Management of Depression.mp3	4.8 MB
10-06 Pulmonary Perioperative Manage.mp3	4.7 MB
8-20 - Diagnosis of Depressive Disorders.mp3	4.7 MB
9-15 - Mild Cognitive Impairment.mp3	4.6 MB
6-14 - Item 079 A 38-Year-Old Woman is Evaluated for Left Kn.mp3	4.5 MB
6-10 - Definition and Pathophysiology of Obesity.mp3	4.4 MB
4-08 - Item 040 A 60-Year-Old Man with Generalized Fatigue a.mp3	4.3 MB
3-17 - Item 039 A 42-Year-Old Woman is Evaluated for Chest P.mp3	4.2 MB
1-16 - Item 006 An 88-Year-Old Man in Hospice Care is Evalua.mp3	4.2 MB
8-27 - Session Key Points.mp3	4.2 MB
4-15 - Diagnostic Evaluation of Syncope.mp3	4.1 MB
2-20 - Transitions of Care.mp3	4.1 MB
5-20 - Ankle Sprains.mp3	4.1 MB
7-13 - Emergency Contraception, Sterilization and Counseling.mp3	4.0 MB
2-14 - Principles of Patient Safety.mp3	4.0 MB
2-30 - Session Key Points.mp3	3.9 MB
8-10 - Otitis Externa.mp3	3.9 MB
3-19 - General Principles of Management.mp3	3.8 MB
4-29 - Session Key Points.mp3	3.8 MB
5-29 - Drug Therapy.mp3	3.8 MB
1-04 - Observational Studies.mp3	3.8 MB
6-20 - Treatment.mp3	3.7 MB
5-14 - Specific Causes of Hip Pain.mp3	3.7 MB
1-17 - Screening for Infectious Diseases.mp3	3.7 MB
3-09 - Managing Pain Symptoms.mp3	3.7 MB
6-13 - Pharmacologic Therapy.mp3	3.6 MB
1-14 - Specific Screening Tests.mp3	3.6 MB
7-19 - Clinical Presentation and Evaluation of Abnormal Uter.mp3	3.5 MB
7-22 - Chronic Pelvic Pain.mp3	3.5 MB
10-09 Perioperative Management of An.mp3	3.5 MB
1-02 - Interpretation of the Medical Literature.mp3	3.5 MB
3-11 - Constipation, Dyspnea and Nausea.mp3	3.5 MB
9-23 - Clinical Presentation and Management of Pressure Ulce.mp3	3.4 MB
10-17 Session Key Points.mp3	3.4 MB
4-19 - Cardiac Causes of Chest Pain.mp3	3.4 MB
7-25 - Vulvovaginal Candidiasis.mp3	3.4 MB
6-23 - Benign Prostatic Hyperplasia.mp3	3.4 MB
2-09 - Drug Abuse Issues.mp3	3.4 MB
9-24 - Session Key Points.mp3	3.3 MB
3-06 - Palliative Care.mp3	3.3 MB
9-13 - Fall Prevention.mp3	3.3 MB
2-04 - Behavioral Counseling.mp3	3.3 MB
2-27 - Withholding or Withdrawing Treatment.mp3	3.3 MB
1-10 - Important Health Care Initiatives and Trends.mp3	3.3 MB
8-25 - Clinical Presentation and Treatment of Posttraumatic .mp3	3.3 MB
3-23 - Patient Monitoring.mp3	3.2 MB
6-03 - Management of Hypertriglyceridemia.mp3	3.2 MB
5-30 - Major Adverse Events Associated with Statin Use.mp3	3.2 MB
4-16 - Risk Stratification and Management of Syncope.mp3	3.2 MB
4-23 - Chest Pain and Decision to Hospitalize.mp3	3.2 MB
4-21 - Pulmonary Causes of Chest Pain.mp3	3.1 MB
7-14 - Menopause.mp3	3.1 MB
3-02 - Conflicts of Interest.mp3	3.1 MB
6-04 - Management of Low HDL Cholesterol.mp3	3.1 MB
6-16 - Comparing Surgical and Non-Surgical Interventions.mp3	3.1 MB
7-33 - Session Key Points.mp3	3.1 MB
4-24 - Diagnosis and Management of Acute Low Back Pain.mp3	3.1 MB
7-04 - Hypoactive Sexual Desire Disorder.mp3	3.1 MB
9-05 - Types of Eating Disorders.mp3	3.1 MB
5-02 - Diagnosis and Evaluation of Neck Pain.mp3	3.1 MB
6-15 - Surgery for Obesity.mp3	3.0 MB
4-05 - Treatment.mp3	3.0 MB
3-14 - Overview of Common Symptoms.mp3	3.0 MB
7-05 - Orgasmic Disorder and Other Sexual Disorders.mp3	2.9 MB
10-04 Cardiovascular Perioperative M.mp3	2.9 MB
8-03 - Retinal Detachment.mp3	2.9 MB
3-25 - Subacute and Chronic Cough.mp3	2.8 MB
9-06 - Bulimia Nervosa.mp3	2.8 MB
1-26 - Influenza Vaccination Recommendations.mp3	2.8 MB
7-23 - Clinical Presentation and Evaluation of Vaginitis.mp3	2.8 MB
4-12 - Neurocardiogenic Syncope.mp3	2.8 MB
3-15 - Assessment of Chronic Noncancer Pain.mp3	2.8 MB
5-15 - Diagnosis and Evaluation of Knee Pain.mp3	2.8 MB
7-31 - Glaucoma.mp3	2.8 MB
10-07 Venous Thromboembolism Prophyl.mp3	2.8 MB
4-07 - Presyncope, Dysequilibrium and Nonspecific Dizziness.mp3	2.8 MB
9-18 - The Older Driver.mp3	2.8 MB
10-11 Perioperative Management of Di.mp3	2.8 MB
1-01 - Introduction to General Internal Medicine Section.mp3	2.8 MB
8-13 - Pharyngitis.mp3	2.8 MB
7-16 - Benefits and Risks of Systemic Hormone Therapy.mp3	2.8 MB
6-25 - Acute and Chronic Prostatitis and Pelvic Pain.mp3	2.7 MB
10-10 Perioperative Management of An.mp3	2.7 MB
4-03 - Vertigo.mp3	2.7 MB
1-11 - Screening.mp3	2.7 MB
1-05 - Other Study Designs.mp3	2.6 MB
5-11 - Carpal Tunnel Syndrome.mp3	2.6 MB
7-10 - Contraception.mp3	2.6 MB
9-14 - The Home Environment.mp3	2.6 MB
6-18 - Risk Factors for Erectile Dysfunction.mp3	2.6 MB
8-11 - Sinusitis.mp3	2.6 MB
1-25 - Immunization.mp3	2.6 MB
7-32 - Cataract.mp3	2.6 MB
5-12 - Other Causes of Wrist and Hand Pain.mp3	2.6 MB
2-24 - Professionalism and Ethics.mp3	2.6 MB
1-32 - Session Key Points.mp3	2.5 MB
9-03 - Somatoform Disorders.mp3	2.5 MB
1-18 - Breast Cancer Screening.mp3	2.5 MB
5-27 - HDL Cholesterol.mp3	2.5 MB
1-03 - Experimental Studies.mp3	2.5 MB
3-28 - Chronic Fatigue and Chronic Fatigue Syndrome.mp3	2.5 MB
10-16 Perioperative Management of Ne.mp3	2.5 MB
6-06 - Management of Metabolic Syndrome.mp3	2.4 MB
7-21 - Dysmenorrhea.mp3	2.4 MB
3-05 - The Impaired Physician and Colleague Responsibility.mp3	2.4 MB
8-17 - Temporalmandibular Disorders.mp3	2.4 MB
4-28 - Interventional and Surgical Treatment.mp3	2.4 MB
5-26 - Triglycerides.mp3	2.4 MB
7-27 - Bacterial Conjunctivitis.mp3	2.4 MB
2-15 - Quality Improvement Models.mp3	2.4 MB
7-29 - Uveitis and Blepharitis.mp3	2.3 MB
1-24 - Caveats to Genetic Testing.mp3	2.3 MB
5-06 - Rotator Cuff Disorders.mp3	2.3 MB
6-21 - Premature Ejaculation and Decreased Libid.mp3	2.3 MB
5-23 - Midfoot and Forefoot Pain.mp3	2.3 MB
8-14 - Lemierre's Syndrome.mp3	2.3 MB
3-24 - Acute Cough.mp3	2.3 MB
9-02 - Bipolar Disorder.mp3	2.3 MB
9-08 - Treatment of Eating Disorders.mp3	2.3 MB
10-14 Perioperative Management of Ki.mp3	2.3 MB
9-16 - Depression in Older Adults.mp3	2.3 MB
4-14 - Cardiac Causes of Syncope.mp3	2.3 MB
1-20 - Cervical and Anal Cancer Screening.mp3	2.2 MB
4-04 - Clinical Presentation of Peripheral Vertigo.mp3	2.2 MB
1-06 - Statistical Analysis.mp3	2.2 MB
10-02 Perioperative Testing.mp3	2.2 MB
7-09 - Clinical Presentation and Treatment of Breast Pain.mp3	2.2 MB
2-29 - Confidentiality.mp3	2.2 MB
6-24 - Indications for Surgical Intervention.mp3	2.2 MB
3-22 - Controlled Substance Agreements.mp3	2.2 MB
9-11 - Difficult Patient Encounters.mp3	2.2 MB
7-17 - Breast Cancer Risk and Nonhormonal Therapy.mp3	2.2 MB
2-05 - Diet and Physical Activity.mp3	2.2 MB
5-04 - Diagnosis and Evaluation of Shoulder Pain.mp3	2.2 MB
7-06 - Clinical Presentation of a Breast Mass.mp3	2.2 MB
5-16 - Trauma and Patellofemoral Pain Syndrome.mp3	2.1 MB
5-24 - Screening for Dyslipidemia.mp3	2.1 MB
2-18 - Diagnostic Errors.mp3	2.1 MB
10-05 Beta Blockers in Perioperative.mp3	2.1 MB
5-31 - Session Key Points.mp3	2.1 MB
10-13 Adrenal Insufficiency.mp3	2.1 MB
8-22 - Serotonin Syndrome.mp3	2.1 MB
3-31 - Session Key Points.mp3	2.1 MB
5-28 - Managing Dyslipidemia with Therapeutic Lifestyle Chan.mp3	2.1 MB
5-07 - Adhesive Capsulitis and Aeromioclaviclular Joint Dege.mp3	2.1 MB
7-20 - Management.mp3	2.1 MB
7-30 - Pathophysiology and Clinical Presentation of Macular .mp3	2.0 MB
8-23 - Anxiety Disorders.mp3	2.0 MB
9-10 - Autism Spectrum Disorders.mp3	2.0 MB
7-18 - Management of Urogenital Symptoms.mp3	2.0 MB
2-03 - Special Considerations for Health Care Workers.mp3	2.0 MB
3-21 - Opioid Therapy.mp3	2.0 MB
7-07 - Evaluation of a Breast Mass.mp3	2.0 MB
8-15 - Epistaxis.mp3	2.0 MB
10-08 Perioperative Management of Wa.mp3	2.0 MB
2-07 - Alcohol Use Issues.mp3	2.0 MB
2-26 - Advance Directives and Surrogate Decision-Making.mp3	2.0 MB
4-09 - Evaluation of Insomnia.mp3	2.0 MB
5-25 - Evaluation of Lipid Levels - LDL Cholesterol.mp3	2.0 MB
6-02 - Combination Drug Therapy.mp3	1.9 MB
5-22 - Achilles Tendinopathy.mp3	1.9 MB
3-07 - Deciding When Hospice Palliative Care Is Indicated.mp3	1.9 MB
3-18 - Classification of Chronic Pain Mechanisms.mp3	1.9 MB
1-29 - Pneumococcal Disease.mp3	1.9 MB
5-03 - Treatment.mp3	1.9 MB
6-12 - Lifestyle Modification and Behavioral Therapy.mp3	1.9 MB
2-21 - Medication Reconciliation.mp3	1.8 MB
7-24 - Trichomoniasis.mp3	1.8 MB
1-28 - Varicella and Herpes Zoster.mp3	1.8 MB
6-08 - Dyslipidemia Management and Stroke Prevention.mp3	1.8 MB
8-07 - Evaluation of Hearing Loss.mp3	1.8 MB
3-13 - Depression and Delirium.mp3	1.8 MB
9-20 - Evaluation and Treatment of Urinary Incontinence.mp3	1.8 MB
2-28 - Physician-Assisted Suicide and Euthanasia.mp3	1.8 MB
4-27 - Pharmacologic Treatment.mp3	1.8 MB
8-12 - Allergic and Nonallergic Rhinitis.mp3	1.8 MB
4-06 - Central Vertigo.mp3	1.7 MB
7-02 - Female Sexual Dysfunction.mp3	1.7 MB
4-10 - Management of Insomnia.mp3	1.7 MB
9-22 - Devices, Injectable Bulking Agents and Surgery.mp3	1.7 MB
5-05 - Test Used in Shoulder Evaluation.mp3	1.7 MB
2-22 - Health Information Technology and Patient Safety.mp3	1.7 MB
8-26 - Obsessive-Compulsive Disorder.mp3	1.7 MB
6-05 - Epidemiology and Pathophysiology of Metabolic Syndrom.mp3	1.7 MB
8-19 - Anal Fissure and Anorectal Abscess.mp3	1.7 MB
2-12 - Domestic Violence.mp3	1.7 MB
6-22 - Androgen Deficiency.mp3	1.7 MB
2-08 - The AUDIT Test.mp3	1.7 MB
2-13 - USPSTF Review of Domestic Violence.mp3	1.7 MB
6-27 - Close to Session.mp3	1.7 MB
4-26 - Treatment.mp3	1.6 MB
5-10 - Olecranon Bursitis and Ulnar Nerve Entrapment.mp3	1.6 MB
1-27 - Tetanus, Diphtheria and Pertussis.mp3	1.6 MB
5-18 - Iliotibial Band Syndrome and Baker Cyst.mp3	1.6 MB
1-22 - Additional Cancer Screening Tests.mp3	1.6 MB
1-19 - Genetic Considerations.mp3	1.6 MB
4-22 - Gastrointestinal and Musculoskeletal Causes of Chest .mp3	1.6 MB
9-21 - Behavioral and Pharmacologic Therapy.mp3	1.6 MB
6-17 - Risks Associated with Bariatric Surgery.mp3	1.6 MB
8-02 - Dry Eye.mp3	1.6 MB
10-18 Close to Section.mp3	1.5 MB
9-07 - Medical Complications of Eating Disorders.mp3	1.5 MB
7-26 - Conjunctivitis.mp3	1.5 MB
2-02 - Hepatitis A and B Vaccinations.mp3	1.5 MB
5-17 - Bursitis.mp3	1.5 MB
7-12 - Intrauterine Devices and Barrier Methods.mp3	1.5 MB
4-13 - Orthostatic Hypotension.mp3	1.5 MB
3-27 - Hemoptysis.mp3	1.5 MB
2-23 - National Patient Safety Goals.mp3	1.5 MB
3-30 - Management of Chronic Fatigue and Chronic Fatigue Syn.mp3	1.5 MB
2-25 - Decision Making and Informed Conse.mp3	1.5 MB
5-08 - Diagnosis and Evaluation of Elbow Pain.mp3	1.4 MB
4-25 - Further Diagnostic Testing.mp3	1.4 MB
9-19 - Levels of Care and Polypharmacy.mp3	1.4 MB
1-07 - The Bayes Theorem.mp3	1.4 MB
9-12 - Assessing Functional Status in the Older Patient.mp3	1.4 MB
7-08 - Tissue Sampling Procedures.mp3	1.4 MB
7-28 - Corneal Conditions.mp3	1.4 MB
3-29 - Diagnosis and Evaluation of Chronic Fatigue.mp3	1.4 MB
6-19 - Diagnosis and Evaluation.mp3	1.4 MB
1-31 - Measles, Mumps, Rubella and Menigococcal Disease.mp3	1.3 MB
9-09 - Attention-Deficit Hyperactivity Disorder.mp3	1.3 MB
5-21 - Hind Foot Pain.mp3	1.3 MB
10-12 Thyroid Disease.mp3	1.3 MB
1-21 - Prostate Cancer Screening.mp3	1.3 MB
10-03 Perioperative Medication Manag.mp3	1.3 MB
1-30 - Human Papillomavirus.mp3	1.2 MB
1-12 - USPSTF Screening Recommendations.mp3	1.2 MB
2-16 - Measurement of Quality Improvement.mp3	1.2 MB
4-18 - Differential Diagnosis of Chest Pain.mp3	1.2 MB
2-11 - Sexual Behavior.mp3	1.2 MB
6-11 - Treatment.mp3	1.2 MB
8-04 - Central Retinal Vein Occlusion.mp3	1.2 MB
3-03 - Medical Error Disclosure.mp3	1.2 MB
3-08 - Assessment and Communication.mp3	1.2 MB
9-04 - Management.mp3	1.2 MB
7-11 - Long-Acting Contraceptives.mp3	1.2 MB
4-20 - Other Causes of Chest Pain.mp3	1.2 MB
5-13 - Diagnosis and Evaluation of Hip Pain.mp3	1.1 MB
3-04 - Sexual Contact between Physician and Patient.mp3	1.1 MB
3-16 - The Physical Examination.mp3	1.1 MB
1-23 - Taking A Family History.mp3	1.1 MB
4-02 - Dizziness.mp3	1.1 MB
3-26 - Cough in the Immunocompromised Patient.mp3	1.1 MB
8-18 - Hemorrhoids and Rectal Bleeding.mp3	1.1 MB
1-15 - Screening for Coronary Artery Disease.mp3	1.1 MB
1-09 - Sources of Evidence.mp3	1.0 MB
8-06 - Eye Emergencies.mp3	1.0 MB
3-12 - Anorexia and Nutrition.mp3	1.0 MB
8-24 - Treatment Options.mp3	1.0 MB
8-05 - Central Retinal Artery Occlusion.mp3	990.9 KB
9-17 - Hearing Impairment in the Elderly.mp3	989.2 KB
8-09 - Otitis Media.mp3	983.7 KB
8-16 - Burning Mouth Syndrome.mp3	963.7 KB
2-19 - Medication Errors.mp3	915.2 KB
6-07 - Dyslipidemia Management in Older Patients.mp3	878.9 KB
7-03 - Classification of Female Sexual Disorders.mp3	861.4 KB
8-28 - Close to Session.mp3	774.3 KB
2-31 - Close to Session.mp3	743.9 KB
3-32 - Close to Session.mp3	714.6 KB
7-15 - Initiating Hormone Therapy.mp3	708.8 KB
1-13 - Periodic Health Examination.mp3	701.3 KB
9-25 - Close to Session.mp3	697.0 KB
9-01 - Intro to Session 9.mp3	654.8 KB
8-01 - Intro to Session 8.mp3	630.6 KB
3-01 Intro to Session 3.mp3	630.2 KB
5-01 - Intro to Session 5.mp3	623.9 KB
10-01 Intro to Session 10.mp3	603.3 KB
7-01 - Intro to Session 7.mp3	603.1 KB
2-01 - Intro to Session 2.mp3	578.0 KB
7-34 - Close to Session.mp3	575.9 KB
6-01 - Intro to Session 6.mp3	554.5 KB
4-30 - Close to Session.mp3	532.4 KB
4-01 - Intro to Session 4.mp3	524.9 KB
1-33 - Close to Session.mp3	503.6 KB
8-08 - Tinnitus.mp3	493.9 KB
5-32 - Close to Session.mp3	462.2 KB
/Part A/Oncology/04b Oncology/
3-27 Treatment Of Rectal Cancer.mp3	7.2 MB
6-21 Classification, Staging And Pro.mp3	7.2 MB
7-41 Session Key Points.mp3	7.1 MB
1-11 Newer Cancer Treatment Options.mp3	6.7 MB
1-07 Partial And Complete Response R.mp3	6.5 MB
6-23 Item 132 Evaluating A Patient W.mp3	6.5 MB
1-19 Chemoprevention And Other Risk.mp3	6.3 MB
1-02 Basic Concepts In Oncologic Sta.mp3	6.3 MB
7-06 Cancer Of Unknown Primary Site.mp3	6.2 MB
5-24 Item 124 A 24-Year-Old Man With.mp3	6.2 MB
5-16 Item 122 Breast Cancer Screenin.mp3	5.8 MB
2-15 Item 092 A 66-Year-Old Man With.mp3	5.7 MB
2-19 Common Side Effects.mp3	5.5 MB
4-10 Gastrointestinal Neuroendocrine Tumors.mp3	5.4 MB
5-27 Diagnosis And Staging.mp3	5.4 MB
5-12 Diagnosis And Staging.mp3	5.4 MB
4-31 Session Key Points.mp3	5.3 MB
4-20 Item 120 A Woman with Severe Hot Flushes.mp3	5.3 MB
5-17 Treatment Of Prostate Cancer.mp3	5.2 MB
3-26 Treatment Of Colon Cancer.mp3	5.0 MB
2-10 Item 087 A 64-Year-Old Woman Wi.mp3	5.0 MB
2-21 Metastatic Breast Cancer.mp3	4.9 MB
4-04 Treatment.mp3	4.8 MB
1-09 Item 084 Managing Low-Risk Pros.mp3	4.8 MB
6-27 Chronic Lymphocytic Leukemia.mp3	4.6 MB
2-06 ADJuvant Systemic Therapy For E.mp3	4.6 MB
4-06 Esophageal Cancer.mp3	4.5 MB
3-33 Session Key Points.mp3	4.5 MB
1-05 ADJuvant Therapy.mp3	4.5 MB
6-14 Item 128 Treating A Man With Bu.mp3	4.4 MB
1-10 Era Of Personalized Cancer Trea.mp3	4.3 MB
6-19 Diagnosis.mp3	4.3 MB
2-16 Locally Advanced And Inflammato.mp3	4.1 MB
5-05 Diagnosis And Staging.mp3	4.1 MB
7-16 ADJuvant Therapy.mp3	4.1 MB
1-22 Ductal Carcinoma In Situ.mp3	4.1 MB
2-03 Breast-Conserving Therapy.mp3	4.1 MB
5-31 Session Key Points.mp3	4.0 MB
6-33 Session Key Points.mp3	4.0 MB
7-03 Hodgkin Lymphoma.mp3	4.0 MB
3-29 Metastatic Chemotherapy.mp3	3.9 MB
3-15 Item 097 Initiating ADJuvant Ch.mp3	3.9 MB
1-14 Item 086 Managing A Patient Wit.mp3	3.8 MB
5-29 Treating Seminomas.mp3	3.8 MB
2-09 Treatment Strategies.mp3	3.8 MB
5-19 Radiation Therapy.mp3	3.8 MB
4-12 Item 109 Woman with Intense Headaches Upon Waking.mp3	3.7 MB
6-06 Treatment.mp3	3.7 MB
7-26 Malignant Pleural And Pericardi.mp3	3.7 MB
4-15 Screening for Lung Cancer.mp3	3.7 MB
4-17 Diagnosis of Lung Cancer.mp3	3.7 MB
7-18 Primary Central Nervous System.mp3	3.6 MB
2-11 ADJuvant Chemotherapy.mp3	3.6 MB
3-25 Item 104 A Patient With A 4-Cm.mp3	3.5 MB
1-01 Introduction To Section.mp3	3.5 MB
6-32 Diffuse Large Cell Lymphoma.mp3	3.4 MB
7-33 Neutropenia and Fever.mp3	3.4 MB
6-17 Epidemiology And Risk Factors F.mp3	3.3 MB
4-22 Treatment.mp3	3.3 MB
6-04 Diagnosis And Staging.mp3	3.3 MB
6-11 Treatment.mp3	3.3 MB
2-02 Invasive Breast Cancer.mp3	3.3 MB
4-18 Diagnostic Evaluation of a Lung Mass.mp3	3.3 MB
1-06 Defining Treatment Goals.mp3	3.2 MB
7-08 Poorly Differentiatied Carcinom.mp3	3.1 MB
2-23 Session Key Points.mp3	3.0 MB
1-17 Gene Mutation Testing Criteria.mp3	3.0 MB
2-22 Treatment.mp3	3.0 MB
3-06 Diagnosis.mp3	3.0 MB
2-12 Commonly Used Agents.mp3	2.9 MB
5-07 Treatment.mp3	2.9 MB
5-21 Chemotherapy And Immunotherapy.mp3	2.9 MB
4-23 Treatment of Lung Cancer.mp3	2.9 MB
1-15 Epidemiology And Risk Factors O.mp3	2.9 MB
7-04 Cutaneous T-Cell Non-Hodgkin Ly.mp3	2.9 MB
3-30 Postoperative Colorectal Cancer.mp3	2.9 MB
7-28 Tumor Lysis Syndrome.mp3	2.9 MB
3-28 Treatment Of Metastatic Colorec.mp3	2.8 MB
5-13 Transrectal Ultrasonography.mp3	2.7 MB
7-20 Superior Vena Cava Syndrome.mp3	2.6 MB
6-25 Treatment Of Follicular Lymphom.mp3	2.6 MB
7-22 Brain Metastases Causing Increa.mp3	2.6 MB
4-24 Treatment of Stage IV Non-Small Cell Lung Cancer.mp3	2.5 MB
4-03 Signs and Symptoms of Pancreatic Cancer.mp3	2.5 MB
6-09 Diagnosis And Staging.mp3	2.5 MB
1-07 Appropriate Supportive Care.mp3	2.5 MB
5-20 Androgen Deprivation Therapy.mp3	2.4 MB
1-06 Treating Patients With Aplastic.mp3	2.4 MB
6-08 Renal Cell Cancer.mp3	2.4 MB
6-26 Mucosa-Associated Lymphoid Tiss.mp3	2.4 MB
7-24 Spinal Cord Compression.mp3	2.3 MB
2-18 Breast Cancer Follow-Up And Sur.mp3	2.3 MB
1-23 Session Key Points.mp3	2.3 MB
3-04 Screening And Risk Reduction St.mp3	2.3 MB
6-15 Lymphadenopathy.mp3	2.3 MB
3-16 Epidemiology And Risk Factors O.mp3	2.3 MB
3-11 Management Of Recurrent Ovarian.mp3	2.3 MB
7-09 Isolated Regional Lymphadenopat.mp3	2.3 MB
2-04 Postmastectomy Radiation.mp3	2.3 MB
1-05 PNH Clones.mp3	2.2 MB
3-08 Treatment Using Surgery.mp3	2.2 MB
2-08 ADJuvant Endocrine Therapy.mp3	2.2 MB
4-08 Gastric Cancer.mp3	2.1 MB
1-16 Brca1 Brca2 Gene Mutations.mp3	2.1 MB
7-15 Treatment For Melanoma.mp3	2.1 MB
3-22 Staging Of Colorectal Cancer.mp3	2.1 MB
5-08 Complications Of Radiation Ther.mp3	2.0 MB
3-19 Prognosis And Surveillance.mp3	2.0 MB
3-32 Anal Cancer.mp3	2.0 MB
5-30 Treating Nonseminomas.mp3	2.0 MB
4-25 Radiation Therapy.mp3	1.9 MB
5-14 Staging Of Prostate Cancer.mp3	1.9 MB
5-03 Risk Factors.mp3	1.9 MB
5-22 Prostate Cancer Follow-Up And P.mp3	1.9 MB
7-40 Other Issues.mp3	1.9 MB
6-28 Treatment.mp3	1.9 MB
6-29 Opportunistic Infections.mp3	1.9 MB
5-25 Testicular Cancer.mp3	1.8 MB
3-21 Colorectal Cancer.mp3	1.8 MB
3-18 Treatment.mp3	1.7 MB
3-10 Chemotherapy And Second-Look Su.mp3	1.7 MB
7-13 Risk Factors And Prognosis Of P.mp3	1.7 MB
3-09 Staging, Treatment And Prognosi.mp3	1.7 MB
1-20 Prophylactic Surgeries.mp3	1.7 MB
7-02 Mantle Cell Lymphoma.mp3	1.7 MB
7-36 Disorders Of Pulmonary Function.mp3	1.6 MB
6-24 Follicular Lymphoma.mp3	1.6 MB
4-28 Treatment of Limited-Stage Small Cell Lung Cancer.mp3	1.6 MB
6-30 Hairy Cell Leukemia.mp3	1.6 MB
4-27 Small Cell Lung Cancer.mp3	1.6 MB
2-13 Side Effects Associated With Tr.mp3	1.5 MB
1-12 Management Of Toxic Effects.mp3	1.5 MB
3-02 Epidemiology And Risk Factors F.mp3	1.5 MB
4-02 Pancreatic Cancer.mp3	1.5 MB
5-10 Epidemiology And Risk Factors F.mp3	1.5 MB
7-42 Close To Section.mp3	1.4 MB
3-13 Supportive Care.mp3	1.4 MB
4-13 Epidemiology of Lung Cancer.mp3	1.4 MB
7-30 Hypercalcemia.mp3	1.4 MB
2-07 Breast Cancer Staging.mp3	1.4 MB
1-04 Surgical Resection.mp3	1.4 MB
7-35 Disorders Of Cardiac Function.mp3	1.3 MB
3-17 Diagnosis And Staging.mp3	1.2 MB
7-37 Disorders Of Genitourinary And.mp3	1.2 MB
5-18 Surgery.mp3	1.2 MB
7-38 Sexual Function.mp3	1.1 MB
3-14 Key Points.mp3	1.1 MB
3-24 Treatment Of Colorectal Cancer.mp3	1.1 MB
4-21 Staging Non-Small Cell Lung Cancer.mp3	1.1 MB
7-05 Key Points.mp3	1.1 MB
6-12 Follow-Up Evaluation.mp3	1.1 MB
4-30 Prophylactic Cranial Radiation Therapy.mp3	999.0 KB
4-26 New Therapeutic Approaches.mp3	993.9 KB
3-20 Key Points.mp3	988.4 KB
6-02 Bladder Cancer.mp3	949.1 KB
5-23 Key Points.mp3	947.8 KB
5-02 Head And Neck Cancer.mp3	937.0 KB
3-12 Monitoring And Follow-Up.mp3	921.5 KB
2-24 Close To Session.mp3	917.3 KB
7-39 Secondary Malignancies.mp3	901.9 KB
6-31 Key Point.mp3	898.5 KB
2-14 Key Points.mp3	894.8 KB
2-01 Introduction To Session.mp3	874.3 KB
2-05 Key Points.mp3	867.6 KB
4-09 Key Points.mp3	853.9 KB
5-09 Key Points.mp3	839.2 KB
3-34 Close To Session.mp3	823.3 KB
7-07 Key Points.mp3	803.6 KB
7-32 Effects Of Cancer And Cancer Th.mp3	801.6 KB
7-27 Key Points.mp3	800.3 KB
1-24 Close To Session.mp3	772.7 KB
3-01 Introduction To Session.mp3	741.4 KB
4-07 Key Points.mp3	722.2 KB
7-31 Key Points.mp3	709.2 KB
5-01 Introduction To Session.mp3	705.0 KB
4-29 Treatment of Extensive-Stage Small Cell Lung Cancer.mp3	703.5 KB
5-32 Close To Session.mp3	703.3 KB
1-18 Key Points.mp3	699.2 KB
4-19 Key Points.mp3	674.6 KB
2-20 Key Points.mp3	664.0 KB
6-07 Key Points.mp3	637.7 KB
6-22 Key Points.mp3	633.5 KB
6-34 Close To Session.mp3	629.4 KB
7-34 Myelodysplasia And Leukemia.mp3	628.1 KB
3-07 Key Points.mp3	627.6 KB
7-01 Introduction To Session.mp3	622.7 KB
4-11 Key Points.mp3	621.9 KB
6-18 Key Points.mp3	612.6 KB
3-03 Key Points.mp3	611.8 KB
3-31 Key Points.mp3	604.7 KB
1-21 Key Points.mp3	585.0 KB
6-13 Key Points.mp3	572.9 KB
6-16 Key Points.mp3	565.8 KB
1-08 Key Points.mp3	553.3 KB
1-13 Key Points.mp3	539.5 KB
5-06 Key Points.mp3	539.1 KB
7-11 Management Of Patients Not In F.mp3	523.7 KB
4-16 Key Points.mp3	523.7 KB
6-01 Introduction To Session.mp3	519.0 KB
3-05 Key Points.mp3	514.8 KB
7-21 Key Points.mp3	514.0 KB
6-05 Key Points.mp3	504.0 KB
4-32 Close to Session.mp3	499.9 KB
4-05 Key Points.mp3	499.0 KB
7-10 Key Points.mp3	494.8 KB
2-17 Key Points.mp3	491.8 KB
7-25 Key Points.mp3	488.9 KB
4-01 Introduction to Session.mp3	485.7 KB
7-23 Key Points.mp3	484.3 KB
5-15 Key Points.mp3	484.3 KB
7-19 Key Points.mp3	463.4 KB
6-20 Key Points.mp3	455.5 KB
6-10 Key Points.mp3	445.0 KB
4-14 Key Points.mp3	444.3 KB
1-03 Key Points.mp3	440.9 KB
5-28 Key Points.mp3	437.5 KB
3-23 Key Points.mp3	417.0 KB
5-26 Key Points.mp3	403.7 KB
5-04 Key Points.mp3	400.7 KB
5-11 Key Points.mp3	384.4 KB
7-14 Key Point.mp3	367.7 KB
7-29 Key Point.mp3	336.4 KB
7-17 Key Points.mp3	319.2 KB
7-12 Key Point.mp3	301.7 KB
6-03 Key Points.mp3	290.8 KB
/Part A/Gastroenterology/03 Gastroenterology/
4-18 Item 023 A 60-Year-Old Woman Wi.mp3	6.9 MB
4-08 Item 020 A 76-Year-Old Woman Wi.mp3	6.1 MB
6-13 Item 046 A Woman With Constant.mp3	5.9 MB
2-14 Item 007 A Man Is Evaluated In.mp3	5.9 MB
5-14 Item 027 A 45-Year-Old Man With.mp3	5.5 MB
2-03 Screening, Diagnosis And Manage.mp3	5.4 MB
2-12 Management.mp3	5.4 MB
3-11 Item 017 A Woman Is Evaluated F.mp3	5.2 MB
6-20 Item 047 A Woman With Abdominal.mp3	5.2 MB
1-22 Item 003 A Man Is Admitted To T.mp3	5.2 MB
8-41 Characteristics Of Pregnancy-Re.mp3	5.2 MB
3-19 Item 018 A Man Is Admitted For.mp3	5.1 MB
2-27 Prevention Of NSAID-Induced Inj.mp3	5.1 MB
1-15 Item 002 A Man Is Evaluated For.mp3	4.9 MB
9-51 Session Key Points.mp3	4.9 MB
7-33 Treatment and Prevention.mp3	4.7 MB
4-29 Evaluation And Management.mp3	4.6 MB
7-26 Approach to the Patient.mp3	4.5 MB
5-18 Item 041 A 42-Year-Old Woman Is.mp3	4.5 MB
8-31 Causes Of Fulminant Hepatic Fai.mp3	4.4 MB
2-19 Item 010 A 42-Year-Old Woman Wi.mp3	4.3 MB
6-11 Management.mp3	4.3 MB
5-20 Diagnosis.mp3	4.2 MB
3-05 Medications.mp3	4.2 MB
7-38 Alcohol-Induced Liver Disease.mp3	4.1 MB
8-11 Primary Biliary Cirrhosis.mp3	4.0 MB
6-10 Evaluation.mp3	4.0 MB
1-18 Eosinophilic Esophagitis.mp3	3.9 MB
6-32 Session Key Points.mp3	3.9 MB
7-02 Hereditary Nonpolyposis.mp3	3.9 MB
4-03 Clinical Presentation And Diagn.mp3	3.8 MB
1-21 Diagnosis.mp3	3.8 MB
5-12 Risk Factors For Inflammatory B.mp3	3.8 MB
3-26 Nutritional Complications.mp3	3.7 MB
6-07 Management.mp3	3.7 MB
5-24 ADJunctive Treatment.mp3	3.7 MB
7-39 Drug- and Toxin-Induced Liver Disease.mp3	3.7 MB
4-02 Acute Pancreatitis.mp3	3.7 MB
4-05 Management.mp3	3.7 MB
8-42 Session Key Points.mp3	3.6 MB
2-28 Session Key Points.mp3	3.6 MB
3-02 Gastroparesis.mp3	3.6 MB
7-10 Screening.mp3	3.6 MB
2-20 Clinical Features Of Helicobact.mp3	3.5 MB
5-05 Screening For Celiac Disease.mp3	3.5 MB
5-09 Short Bowel Syndrome.mp3	3.5 MB
1-20 Gastroesophageal Reflux Disease.mp3	3.5 MB
1-31 Session Key Points.mp3	3.5 MB
7-29 Management.mp3	3.5 MB
9-30 Evaluation Of Upper GI Bleeding.mp3	3.5 MB
6-18 Acute Mesenteric Ischemia.mp3	3.4 MB
8-17 Treatment.mp3	3.4 MB
2-23 Treatment.mp3	3.3 MB
5-17 Crohns Disease.mp3	3.3 MB
6-06 Evaluation And Management.mp3	3.3 MB
8-05 Nonalcoholic Fatty Liver Diseas.mp3	3.3 MB
4-28 Diarrhea.mp3	3.3 MB
5-25 Treatment Of Ulcerative Colitis.mp3	3.3 MB
9-28 Causes.mp3	3.3 MB
1-10 Achalasia And Pseudoachalasia.mp3	3.2 MB
2-21 Diagnostic Tests.mp3	3.2 MB
6-28 Pathophysiology.mp3	3.2 MB
5-10 Lactose Malabsorption.mp3	3.2 MB
3-15 Gastric Adenocarcinoma.mp3	3.1 MB
4-10 Clinical Presentation And Diagn.mp3	3.1 MB
4-31 Session Key Points.mp3	3.1 MB
3-06 Enteral Nutrition And Other Opt.mp3	3.1 MB
6-02 Microscopic Colitis.mp3	3.1 MB
5-21 Serologic Markers.mp3	3.1 MB
4-26 Pancreatic Neuroendocrine Tumor.mp3	3.1 MB
2-22 Other Diagnostic Tests.mp3	3.0 MB
3-27 Other Gastric Resection Complic.mp3	2.9 MB
4-19 Autoimmune Pancreatitis And IgG.mp3	2.9 MB
1-01 Introduction To Gastroenterolog.mp3	2.8 MB
5-07 Small Intestinal Bacterial Over.mp3	2.8 MB
4-12 Non-Enteric-Coated Pancreatic E.mp3	2.8 MB
5-08 Testing.mp3	2.8 MB
1-25 Medications.mp3	2.8 MB
9-33 Low- And High-Risk Stigmata.mp3	2.8 MB
9-12 Epidemiology And Clinical Manif.mp3	2.8 MB
2-15 Clinical Manifestations Of Dysp.mp3	2.8 MB
9-32 Management.mp3	2.8 MB
8-22 Diagnosis And Management.mp3	2.7 MB
4-16 Diagnosis And Staging.mp3	2.7 MB
3-24 Stomal Stenosis.mp3	2.6 MB
5-02 Types Of Malabsorption.mp3	2.6 MB
9-22 Cholangiocarcinoma.mp3	2.6 MB
8-27 Hepatocellular Carcinoma.mp3	2.6 MB
7-40 Session Key Points.mp3	2.6 MB
3-13 Gastric Carcinoid Tumors.mp3	2.6 MB
7-16 Colonoscopy.mp3	2.6 MB
4-11 Management.mp3	2.5 MB
5-15 Ulcerative Colitis.mp3	2.5 MB
3-08 Gastric Polyps.mp3	2.5 MB
4-24 Mucinous Cystadenoma.mp3	2.5 MB
4-30 Diagnosis.mp3	2.5 MB
1-02 Dysphasia.mp3	2.5 MB
4-20 Clinical Presentation And Diagn.mp3	2.5 MB
8-24 Diagnosis And Treatment.mp3	2.4 MB
7-28 Hepatitis B.mp3	2.4 MB
9-04 Medications To Avoid.mp3	2.4 MB
1-27 Antireflux Surgery.mp3	2.4 MB
6-05 Constipation.mp3	2.4 MB
7-06 Peutz-Jeghers Syndrome.mp3	2.4 MB
4-06 Complications.mp3	2.4 MB
9-37 Causes Of Lower GI Bleeding.mp3	2.4 MB
9-26 Gastrointestinal Bleeding.mp3	2.3 MB
8-20 Spontaneous Bacterial Peritonit.mp3	2.3 MB
6-29 Environmental Exposures.mp3	2.3 MB
9-29 Hemobilia And Other Causes.mp3	2.3 MB
2-26 Gastrointestinal Complications.mp3	2.3 MB
8-14 Treatment.mp3	2.3 MB
1-16 Infectious Esophagitis.mp3	2.3 MB
7-19 Surveillance.mp3	2.3 MB
5-26 Healthcare Maintenance For The.mp3	2.3 MB
6-14 Diverticular Disease.mp3	2.3 MB
7-27 Hepatitis A.mp3	2.3 MB
8-33 Liver Transplantation.mp3	2.3 MB
1-04 Esophageal Dysphasia.mp3	2.3 MB
1-12 Diffuse Esophageal Spasm And Nu.mp3	2.2 MB
3-25 Biliary Stone Disease.mp3	2.2 MB
8-19 Ascites.mp3	2.2 MB
8-09 Wilsons Disease.mp3	2.2 MB
6-23 Colonic Ischemia.mp3	2.2 MB
8-21 Hepatic Encephalopathy.mp3	2.2 MB
3-20 Bariatric Surgery Complications.mp3	2.2 MB
8-02 Autoimmune Hepatitis.mp3	2.2 MB
3-18 Complications Of Gastric Surgic.mp3	2.2 MB
4-04 Prognostic Criteria For Acute P.mp3	2.1 MB
6-09 Irritable Bowel Syndrome.mp3	2.1 MB
9-18 Common Bile Duct Stones.mp3	2.1 MB
8-28 Treatment.mp3	2.1 MB
7-07 Juvenile Polyposis Syndrome.mp3	2.1 MB
6-30 Predisposing Conditions.mp3	2.1 MB
7-17 Increased Risk.mp3	2.1 MB
8-26 Portopulmonary Hypertension.mp3	2.1 MB
1-26 Common Side Effects.mp3	2.1 MB
9-47 Push And Spiral Enteroscopy.mp3	2.1 MB
3-10 Gastric Subepithelial Masses.mp3	2.1 MB
2-16 Management Of Dyspepsia.mp3	2.1 MB
1-13 Hypotonic Motility Disorders.mp3	2.1 MB
5-19 Extraintestinal Manifestations.mp3	2.0 MB
5-04 Celiac Disease.mp3	2.0 MB
9-02 Metabolic Bone Disease.mp3	2.0 MB
8-13 Diagnosis.mp3	2.0 MB
5-06 Associated Conditions.mp3	2.0 MB
7-03 Familial Adenomatous Polyposis.mp3	2.0 MB
9-39 Evaluation.mp3	2.0 MB
1-03 Oropharyngeal Dysphasia.mp3	2.0 MB
5-23 Treatment Of Crohns Disease.mp3	1.9 MB
3-03 Testing.mp3	1.9 MB
3-12 Gastrointestinal Stromal Tumors.mp3	1.9 MB
8-12 Primary Sclerosing Cholangitis.mp3	1.9 MB
9-21 Gallbladder Cancer.mp3	1.9 MB
3-23 GI Bleeding After Bariatric Sur.mp3	1.9 MB
8-34 Hepatic Cysts.mp3	1.9 MB
2-11 Complications Of PUD.mp3	1.9 MB
1-06 Chest Pain.mp3	1.9 MB
9-11 Asymptomatic Gallstones.mp3	1.9 MB
9-40 Management.mp3	1.8 MB
1-05 Reflux.mp3	1.8 MB
2-10 Clinical Features, Diagnosis An.mp3	1.8 MB
2-07 Diagnosis And Staging.mp3	1.8 MB
3-22 Malabsorptive Procedure Complic.mp3	1.8 MB
9-07 Budd-Chiari Syndrome.mp3	1.8 MB
3-16 Screening And Surveillance.mp3	1.8 MB
2-02 Barrett Esophagus.mp3	1.8 MB
8-18 Surveillance Endoscopy.mp3	1.8 MB
8-03 Treatment.mp3	1.8 MB
5-03 Protein Malabsorption.mp3	1.7 MB
4-15 Clinical Presentation.mp3	1.7 MB
4-23 Cystic Neoplasms Of The Pancrea.mp3	1.7 MB
2-09 Peptic Ulcer Disease.mp3	1.7 MB
7-14 Flexible Sigmoidoscopy.mp3	1.7 MB
9-08 Diagnosis And Treatment.mp3	1.7 MB
8-25 Hepatopulmonary Syndrome.mp3	1.7 MB
8-08 a1-Antitrypsin Deficiency.mp3	1.7 MB
7-11 Guaiac Fecal Occult Blood Test.mp3	1.7 MB
1-17 Pill-Induced Esophagitis.mp3	1.6 MB
9-16 Acalculous Cholecystitis.mp3	1.6 MB
5-16 Manifestations Of Ulcerative Co.mp3	1.6 MB
3-28 Session Key Points.mp3	1.6 MB
6-21 Chronic Mesenteric Ischemia.mp3	1.6 MB
9-45 Angiography And Technetium-Labe.mp3	1.6 MB
3-17 Clinical Manifestations And Dia.mp3	1.6 MB
9-09 Portal Vein Thrombosis.mp3	1.6 MB
7-08 Hyperplastic Polyposis.mp3	1.5 MB
4-09 Chronic Pancreatitis.mp3	1.5 MB
6-26 Colorectal Neoplasia.mp3	1.5 MB
9-52 close to section.mp3	1.5 MB
7-13 Stool DNA Testing.mp3	1.5 MB
1-11 Treatmen.mp3	1.5 MB
7-34 Coinfection of Hepatitis C Virus and HIV.mp3	1.5 MB
2-17 Alarm Features.mp3	1.5 MB
7-31 Hepatitis C.mp3	1.4 MB
7-22 Clinical Presentation.mp3	1.4 MB
8-06 Hereditary Hemochromatosis.mp3	1.4 MB
3-04 Management.mp3	1.4 MB
8-16 Portal Hypertension And Gastroe.mp3	1.4 MB
2-06 Risk Factors.mp3	1.4 MB
9-50 Treatment.mp3	1.4 MB
7-23 Diagnosis and Staging.mp3	1.4 MB
8-07 Treatment.mp3	1.3 MB
7-36 Hepatitis E.mp3	1.3 MB
8-23 Hepatorenal Syndrome.mp3	1.3 MB
1-09 Esophageal Motility Disorders.mp3	1.3 MB
6-15 Natural History Of Diverticulit.mp3	1.3 MB
4-14 Pancreatic Adenocarcinoma.mp3	1.3 MB
8-35 Focal Nodular Hyperplasia.mp3	1.3 MB
2-24 Eradication Testing.mp3	1.3 MB
9-13 Diagnosis.mp3	1.3 MB
9-05 Nutrition.mp3	1.3 MB
8-37 Hepatic Hemangioma.mp3	1.2 MB
7-05 MYH-Associated Polyposis.mp3	1.2 MB
7-30 Extrahepatic Manifestations and Prevention.mp3	1.2 MB
4-07 Key Points.mp3	1.2 MB
9-49 Small-Bowel Radiography And Int.mp3	1.2 MB
6-31 Nonsyndromic Family History.mp3	1.2 MB
1-30 Syndromes Associated With Gerd.mp3	1.2 MB
1-28 Endoscopic Therapy.mp3	1.2 MB
6-24 Treatment.mp3	1.2 MB
7-15 CT Colonography.mp3	1.2 MB
9-19 Cholangitis.mp3	1.2 MB
2-05 Epidemiology Of Esophageal Carc.mp3	1.2 MB
9-27 Upper Gastrointestinal Bleeding.mp3	1.1 MB
9-03 Immunizations.mp3	1.1 MB
5-22 Treatment.mp3	1.1 MB
7-20 Post-Colorectal Cancer Treatment.mp3	1.1 MB
6-04 Key Points.mp3	1.1 MB
9-24 Biliary Cysts.mp3	1.1 MB
9-46 Wireless Capsule Endoscopy.mp3	1.1 MB
1-07 Odynophagia And Globus Sensatio.mp3	1.1 MB
1-19 Key Points.mp3	1.1 MB
8-30 Fulminant Hepatic Failure.mp3	1.0 MB
3-21 Restrictive Procedure Complicat.mp3	1.0 MB
9-23 Ampullary Adenocarcinoma.mp3	1.0 MB
8-36 Hepatic Adenoma.mp3	1.0 MB
8-10 Key Points.mp3	998.8 KB
7-12 Fecal Immunochemical Test.mp3	995.7 KB
7-35 Hepatitis D.mp3	963.5 KB
7-04 Attenuated Familial Adenomatous Polyposis.mp3	952.3 KB
4-13 Key Points.mp3	951.6 KB
1-24 Lifestyle Modifications.mp3	936.6 KB
9-36 Lower Gastrointestinal Bleeding.mp3	935.4 KB
7-32 Diagnosis.mp3	934.7 KB
9-43 Causes.mp3	924.4 KB
9-14 Management.mp3	916.5 KB
6-25 Key Points.mp3	906.9 KB
8-29 Key Points.mp3	882.2 KB
7-24 Chemoprevention.mp3	872.4 KB
1-14 Key Points.mp3	868.9 KB
9-25 Key Points.mp3	867.6 KB
1-23 Treatment.mp3	854.2 KB
6-19 Treatment.mp3	851.7 KB
1-29 Extraesophageal Manifestations.mp3	827.9 KB
6-16 Key Points.mp3	827.9 KB
9-34 Surveillance Endoscopy.mp3	827.5 KB
2-29 Close To Session.mp3	826.7 KB
5-13 Clinical Manifestations Of IBD.mp3	818.7 KB
8-43 Close To Session.mp3	803.7 KB
8-39 Amebiasis.mp3	799.1 KB
5-11 Key Points.mp3	789.9 KB
2-25 Key Points.mp3	789.4 KB
5-27 Session Key Points.mp3	786.5 KB
8-40 Key Points.mp3	785.3 KB
8-38 Liver Abscesses.mp3	784.0 KB
9-48 Single- And Double-Balloon Ente.mp3	775.3 KB
9-31 Prognostic Scoring Systems.mp3	771.1 KB
3-29 Close To Session.mp3	762.3 KB
9-06 Key Points.mp3	742.2 KB
9-42 Obscure Gastrointestinal Bleedi.mp3	738.1 KB
6-03 Other Effective Therapies.mp3	733.9 KB
9-41 Key Points.mp3	725.9 KB
2-18 Key Points.mp3	709.6 KB
9-01 Introduction To Session.mp3	705.5 KB
3-01 Introduction To Session.mp3	700.4 KB
6-33 Close To Session.mp3	697.1 KB
5-01 Introduction To Session.mp3	694.6 KB
8-01 Introduction To Session.mp3	682.0 KB
7-01 intro to session.mp3	676.0 KB
9-38 Angioectasias.mp3	675.8 KB
4-21 Treatment.mp3	673.3 KB
2-01 Introduction To Session.mp3	672.0 KB
6-17 Ischemic Bowel Disease.mp3	669.9 KB
6-12 Key Points.mp3	668.7 KB
7-09 Key Points.mp3	658.8 KB
6-08 Key Points.mp3	658.2 KB
7-41 Close to Session.mp3	657.6 KB
4-17 Key Points.mp3	644.4 KB
9-35 Key Points.mp3	635.2 KB
7-21 Key Points.mp3	627.1 KB
2-04 Key Points.mp3	626.4 KB
4-32 Close To Session.mp3	618.5 KB
6-22 Treatment.mp3	613.9 KB
1-08 Key Points.mp3	610.6 KB
4-01 Introduction To Session.mp3	607.2 KB
9-44 Evaluation.mp3	606.4 KB
6-01 Introduction To Session.mp3	602.6 KB
1-32 Close To Session.mp3	600.1 KB
2-13 Key Points.mp3	598.4 KB
7-37 Key Points.mp3	588.2 KB
2-08 Key Points.mp3	586.3 KB
9-17 Key Point.mp3	546.2 KB
5-28 Close To Session.mp3	543.7 KB
8-15 Key Points.mp3	537.8 KB
4-25 Key Points.mp3	511.9 KB
9-10 Key Points.mp3	509.0 KB
4-22 Key Points.mp3	499.4 KB
9-15 Key Points.mp3	457.6 KB
8-04 Key Points.mp3	445.0 KB
9-20 Key Points.mp3	436.3 KB
7-18 Key Points.mp3	419.3 KB
3-09 Key Point.mp3	409.5 KB
4-27 Key Points.mp3	400.7 KB
6-27 Key Points.mp3	396.1 KB
3-14 Key Point.mp3	366.1 KB
3-07 Key Points.mp3	350.6 KB
7-25 Key Point.mp3	335.3 KB
8-32 Key Point.mp3	232.7 KB
Total files 3419